Genome sequence of <i>Escherichia coli</i> 536: insights into uropathogenicity through comparison with genomes of <i>Escherichia coli</i> MG1655, CFT073, and EDL933 by Brzuszkiewicz, Elzbieta Barbara
  
Genome sequence of Escherichia coli 536: insights 
into uropathogenicity through comparison with 
genomes of Escherichia coli MG1655, CFT073, 
and EDL933 
 
 
 
Dissertation 
zur Erlangung des Doktorgrades 
der Mathematisch-Naturwissenschaftlichen Fakultäten 
der Georg-August-Universität zu Göttingen 
 
 
 
 
vorgelegt von 
Elżbieta Barbara Brzuszkiewicz 
aus Warschau, Polen 
 
 
Göttingen, 2005 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 7 
Referent:     Prof. Dr. G. Gottschalk 
Korreferent:    Prof. Dr. W. Liebl 
Tag der mündlichen Prüfung:        30.06.2005 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data is not information. 
Information is not knowledge. 
Knowledge is not understanding. 
Understanding is not wisdom. 
 
Cliff Stoll and Gary Schubert 
Table of contest 
TABLE OF CONTEST  
 
1. INTRODUCTION……..……………...…………………………………………….………..1  
 
 
1.1. PATHOGENESIS OF E. COLI………………………………………………….…….2 
1.1.1.  INTESTINAL DISEASES CAUSED BY E. COLI ………………………………….3 
1.1.2. EXTRAINTESTINAL DISEASES CAUSED BY E. COLI …………………………...4 
1.1.2.1. NEONATAL MENINGITIS……………………………………………...4 
1.1.2.2. URINARY TRACT INFECTION………………………………………...4 
1.1.2.2.1. ETIOLOGY…………………………………………………...4 
1.1.2.2.2. EPIDEMIOLOGY…………………………………...…………5 
1.1.2.2.3. PATHOGENESIS OF INFECTION…………………..………….6 
1.1.2.3. VIRULENCE FACTORS ASOCIATED WITH UTI……………...……...…8 
1.1.2.3.1. ADHERENCE…………………………………………………8  
1.1.2.3.2. CAPSULES AND SURFACE COMPONENTS……..………….…11 
1.1.2.3.3. BIOFILM……………………………………………………13 
1.1.2.3.4. ENDOTOXINS (LPS)…………………………...………...…14 
1.1.2.3.5. EXOTOXINS ………………………………………...…...…15 
1.1.2.3.5.1. HEMOLYSIN (HLY)……………………………..……...15 
1.1.2.3.5.2. CYTOTOXIC NECROTIZING FACTOR (CNF1)…….……..15 
1.1.2.3.5.3. AUTOTRANSPORTER TOXIN (SAT)……………….……15 
1.1.2.3.6. IRON ACQUISITION…………………………………..…….16 
 
 
2. MATERIALS…………………………...………...……………………………………….17 
 
 
2.1.  BACTERIAL STRAIN AND PLASMIDS ………………………………..………17 
2.2. CULTURE MEDIA…………………………………………………….……....18 
2.3. BUFFERS, SOLUTIONS AND CHEMICAL REAGENTS……………………….…19 
2.4.  DNA SIZE MARKERS……………………………………………..………....21 
2.5. ENZYMES AND COMMERCIALLY PREPARED KITS…………………………...22 
 
 
 
 I
Table of contest 
 
3. METHODS…………………………...………..………………………………………......23 
  
 
3.1. BACTERIAL GROWTH CONDITIONS……………………..…………….…..…23 
3.2. COMPETENT CELLS PREPARATION……………………………………….....23 
3.3. RUBIDIUM CHLORIDE METHOD FOR TRANSFORMATION COMPETENT                                  
E. COLI  CELLS………………………………………..………….……….…23 
3.4. ELECTROCOMPETENT CELLS PREPARATION………………….……………..24 
3.5. ELECTROPORATION AND BLUE-WHITE SELECTION………………………....24 
3.6. GENERAL DNA MANIPULATION METHODS……………………….…….…..24 
3.6.1. ISOLATION OF PLASMID DNA……………………………………...….…....24 
3.6.1.1. PLASMID ISOLATION USING A KIT…………………………………..24 
3.6.1.2. QIAGEN BIO ROBOT 9600………………………………………..…25 
3.6.2. PURIFICATION AND PRECIPITATION OF DNA FRAGMENTS……………...….25 
3.6.2.1. PURIFICATION USING A KIT………………………………………....25 
3.6.2.2. DNA PRECIPITATION……………………………………………….26 
3.6.3. CHROMOSOMAL DNA ISOLATION…………………………...……………..26 
3.6.4. DNA RESTRICTION ENDONUCLEASE DIGESTION……………………………26 
3.6.5. DNA: FILLING IN 3’-RECESSED ENDS OF DNA, KLENOW…………………..26 
3.6.6.  T4 DNA POLYMERASE ….............................................................................27 
3.6.7. MODIFICATION OF 3’ ENDS WITH A TAQ DNA POLYMERASE ……..………27 
3.6.8. DEPHOSPHORYLATION……………………………………………………....28 
3.6.9. LIGACJA Z VECTOREM.....………………..……………………………….....28 
3.6.10. DNA AMPLIFICATION (PCR, POLYMERASE CHAIN REACTION)……………28 
3.6.11. DNA GEL ELECTROPHORESIS………………………………….……………29 
3.7.  GENE BANK PREPARATION…………………………….……….…………..30 
3.7.1. SHEARING THE DNA……………………………………………………..…30 
3.7.2. SUCROSE GRADIENT – SIZE FRACTIONATION AND PURIFICATION OF SHEARED 
DNA…………………………………………………………………...……31 
3.7.3. TOPO CLONING………………………………………………..…………....32 
3.8. DNA SEQUENCING ………………………………………………...…….....33 
3.8.1. SAMPLE PREPARATION……………………………………………………...33 
3.8.2. DNA SEQUENCING WITH THE ABI PRISM® 377 AUTOMATED SEQUENCER 
(APPLIED BIOSYSTEMS)…………………………………..………………...34 
3.8.3. DNA SEQUENCING USING MEGABACE DNA SEQUENCING SYSTEMS 1000 
AND 4000 (AMERSHAM BIOSYSTEMS)………………………………...…..35 
 II
Table of contest 
3.8.4. DNA SEQUENCING WITH THE ABI 3730XL AUTOMATED SEQUENCER 
(APPLIED BIOSYSTEMS)…………………………………………….………36 
3.9.  RAW DATA PROCESSING ……………………………………………..…….36 
3.9.1. PHRED – BASE-CALLING SOFTWARE WITH QUALITY INFORMATION………..36 
3.9.2. PREGAP4 - PREPARING SEQUENCE TRACE DATA FOR ANALYSIS OR 
ASSEMBLY……………………………………………………………….….37  
3.9.3. PHRAP - SEQUENCE-ASSEMBLY PROGRAM………………………………….37 
3.9.4. GAP4 - A GENOME ASSEMBLY AND EDITING PROGRAM………………….....37 
3.10.  SEQUENCE ANALYZE………………………………………..……..………38 
3.10.1. ORF FINDING.…………………………………………………..………......38 
3.10.2. ANNOTATION……………………………………………………………..…38 
3.11. DETECTION OF PKS TOXIN-PRODUCING ESCHERICHIA COLI ISOLATES BY 
PCR SCREENING…………...……………………………...………………...40 
3.11.1. PCR SCREENING FOR THE POLYKETIDE-PAI (ASNW) IN DIFFERENT                     
E. COLI ISOLATES……………………………………………………………40 
3.11.2. IDENTIFICATION OF HEMOLYSIN-PRODUCING E. COLI ISOLATES……...……46 
3.11.3. MAMMALIAN CELL LINE GROTH CONDITIONS……………………………....46  
3.11.4. TOXIN ACTIVITY ASSAYS…………………………………………………..47 
 
 
4. RESULTS………………………………………………………………………………….47 
 
 
4.1. GENOME PROJECT E. COLI 536………………………..……………….……..47 
4.1.1. SEQUENCING………………………………..………………………...48 
4.1.1.1. SHOTGUN STRATEGY……………………………………………….48 
4.1.1.2. RAW SEQUENCE PROCESSING AND ASSEMBLY……………………..50 
4.1.1.3. EDITING AND GAP CLOSING………………………………………..51 
4.1.1.3.1. STRATEGIES FOR CLOSING SEQUENCE GAPS……………….53 
4.1.1.3.1.1. STRATEGY FOR CLOSING THE GAPS IN A SEQUENCE –    
GAP4 …………………….…….…………………...…54 
4.1.1.3.1.2. PRIMER WALKING………………...…………………...55 
4.1.1.3.1.3. STRATEGY FOR CLOSING THE GAPS IN A SEQUENCE – 
LARGE FRAGMENT LIBRARY (COSMIDS)………………55 
 
 
 III
Table of contest 
4.1.1.3.1.4. STRATEGY FOR CLOSING THE GAPS IN A SEQUENCE – 
MUMMER SOFTWARE………………………..……….56 
4.1.1.3.2. REPEATS – ASSEMBLY PROBLEMS……………….………..59 
4.1.1.3.3. EDITING OF CONSENSUS SEQUENCE………………………..61 
4.1.2. SEQUENCE ANALYZING…………………………………..………...…62 
4.1.2.1. ORF FINDING…………………………………………………….....62 
4.1.2.2. ANNOTATION…………………………………………………….…62 
4.2.    THE 536 GENOME SEQUENCE………………...…………………………….…64 
4.2.1. GENERAL FEATURES………………………………………..……...…64 
4.2.1.1. INSERTION ELEMENTS…………………………………………...…66 
4.2.2. COMPARATIVE GENOMICS…………………………..……………..…69 
 
4.3. SEQUENCING AND ANALYSIS OF PLASMID PARK2 ENTEROTOXIGENIC 
ESCHERICHIA COLI STRAIN 2173…………………….…………….……….…73 
4.3.1. INTRODUCTION………………..…………………………………...…74 
4.3.2. SEQUENCING OF THE PARK2 PLASMID……………………..……..…75 
4.3.3. SEQUENCE ANALYZING……………………………………………….75 
4.3.3.1. ORGANIZATION AND PHYSICAL PROPERTIES………………………75 
4.3.3.2. ANNOTATION……………………………………………………….78 
4.3.3.3. TRANSFER REGION…………………………………………………82 
 
4.4. SEQUENCING AND ANALYSIS OF A POLYKETIDE SYNTHASE GENE CLUSTER 
(PKS-PAI (ASNW)) OF THE NEWBORN MENINGITIS ISOLATE  E. COLI                  
IHE3034………………….…………………………………………………….83 
4.4.1. INTRODUCTION………………………………………………………..83 
4.4.2. PKS/NRPS………………………………………………..…………..84 
4.4.3. SEQUENCING…………………………………..……………………...85 
4.4.3.1. SEQUENCE ANALYZING…………………………………………….85 
4.4.4. DETECTION OF THE POLYKETIDE-PAI (ASNW) TOXIN - PRODUCING 
ESCHERICHIA COLI ISOLATES BY PCR SCREENING…………………...87 
4.4.5. IDENTIFICATION OF HEMOLYSIN-PRODUCING E. COLI  ISOLATES…….89 
4.4.6. TOXIN ACTIVITY ASSAYS………………………………………...…...90 
 
 
 
 
 
 IV
Table of contest 
 
5. DISCUSSION……………………...…………………………………………………..…..99 
 
 
5.1. INSERTION ELEMENTS……………………………………………………...99 
5.2. VIRULENCE FACTORS……………………………………………………..101 
5.2.1. PATHOGENIC ISLANDS…………………….……………………..101 
5.2.2. SMALL GENE CLUSTER/SINGLE GENES SPECIFIC TO   
UROPATHOGENIC STRAINS…………………………………….…104 
5.2.3. AUTOTRANSPORTERS……………………………………………110 
5.3. ANALYSIS OF THE POLYKETIDE SYNTHASE GENE CLUSTER (PKS-PAI 
(ASNW)) OF NEWBORN MENINGITIS E. COLI STRAIN IHE3034 AND 
UROPATHOGENIC STRAIN 536……………………………………………114 
 
 
6. SUMMARY…………………..………...…….…………………………………………..121 
 
 
6.1. GENOME PROJECT ESCHERICHIA COLI 536………………………………..121 
6.2. SEQUENCING AND ANALYSIS OF PLASMID PARK2 ENTEROTOXIGENIC 
ESCHERICHIA COLI STRAIN 2173………………………………………….122 
6.3. SEQUENCING AND ANALYSIS OF A POLYKETIDE SYNTHASE GENE CLUSTER 
(PKS-PAI (ASNW)) OF THE NEWBORN MENINGITIS ISOLATE  E. COLI 
IHE3034………………………………………………………………..…123 
 
 
7. REFERENCES………………………………...………………………………………….125 
 
8. ACKNOWLEDGMENTS………………………………………………………………….140 
 
9. CURRICULUM VITAE ……………………………………………………………………142 
 
 V
List of abbreviations 
LIST OF ABBREVIATIONS 
 
 
°C   degree Celsius 
µ   micro (10-6) 
µg   microgram 
µl   microlitre 
µm   micrometer 
µM   micromolar 
A   adenine 
A   ampere 
aa   amino acid 
ABI   Applied Biosystem Instrument 
Ala  alanine 
Amp  ampicillin  
AP   alkaline phosphatase 
APS   ammonium persulphate 
Asp  aspartate 
Asx  asparagine 
ATP   adenosine triphosphate 
BAC   Bacterial Artificial Chromosome 
BLAST   Basic Local Alignment Search Tool 
bp   base pair 
BrET   ethidium bromide 
C   cytosine 
ca.   circa 
cDNA   complementary desoxyribonucleic acid 
cfu   colony forming units 
CIP   calf intestine phosphatase 
cm   centimetre 
co   company 
Da  Dalton 
dH2O   distilled Water 
 VI
List of abbreviations 
DMSO  dimethylsulfoxide 
DNA   deoxyribonucleic acid 
dNTP   deoxyribonucleotide phosphate 
E. coli   Escherichia coli 
EDTA  ethylenediaminetetraacetic acid 
et al.   et alei (and others) 
Fig.   figure 
g   gram 
G   guanine 
Gln  glutamine 
Glu  glutamate   
Gly  glycine 
h   hour(s) 
HPLC   High Performance Liquid Chromatography 
IPTG   Isopropyl-s-thiogalactopyranoside 
Iva  isovaline  
kb   kilo base 
kDa   kilo Dalton 
l   liter 
LB   Luria Broth 
Leu  leucine 
LPS   lipopolysaccharides 
Lys  lysine 
M   molar (moles per litre) 
Mbp   mega base 
MCS   Multicloning 
Met  methionine 
mg   milligram 
min   minute(s) 
ml   millilitre 
mM   millimolar 
mRNA  messenger RNA 
MW   molecular weight 
n   nano (10-9) 
 VII
List of abbreviations 
NaAc  sodium acetate 
NCBI   National Center for Biotechnology Information 
ng   nanogram 
nl   nanolitre 
nt   nucleotide 
OD   optical density 
ON   over night 
ORF   open reading frame 
Orn  ornithine 
p   pico (10-12) 
PCR   Polymerase chain reaction 
pH   negative logarithm of hydrogen ion concentration 
pmol   picomole 
Phe  phenylalanine 
Pheol  phenylalaninol 
Pro  praline 
psi  pounds per square inch 
RNA   ribonucleic acid 
RNase   ribonuclease 
rpm   revolution per minute 
RT   room temperature 
SDS   sodium dodecyl sulphate 
sec   second(s) 
sp  species (singular) 
spp  species (plural)  
Taq   Thermus aquaticus 
TE   Tris EDTA 
TEMED  N,N,N,N,-Tetramethy –Ethylenediamine 
TRIS   tris(hydroxymethyl)aminomethane 
tRNA  transfer RNA 
Trp  tryptophan 
U   unit 
UPEC  uropathogenic Escherichia coli 
UTI  urinary tract infection  
 VIII
List of abbreviations 
UV   ultraviolet 
V   potential in volts 
Val  valine 
VF  virulence factor(s) 
v/v   volume per volume 
w/v   weight per volume 
w/w   weight per weight 
wt   wild type 
 IX
Introduction 
1. INTRODUCTION 
 
 
 
Microbial genome sequencing and analysis is a rapidly expanding and increasingly 
important strand of microbiology. Until whole genome analysis become available, life 
sciences have been based on a reductionist principle – dissecting cell and systems into 
fundamental components for further study. Recent studies on whole genomes and 
whole genome comparisons in particular give us a possibility to receive more 
information leading to better understanding of the general feature of pathogenic and 
nonpathogenic lifestyle.  
The urinary tract is among the most common sites of both community-acquired and 
nosocomial infections, and Escherichia coli is the most common etiologic agent of 
these infections. The ability to inhabit the different niches during the ascending 
urinary tract infections (UTIs) and cause particular pathologies at each site resides 
largely in the island genes specific to uropathogenic E. coli. The genome sequence 
has revealed many possible factors that may contribute to colonisation of the urinary 
tract tissues and the disease. Analysis of whole genome of uropathogenic E. coli 536 
strain provides insight into pathogenecity of E. coli.  
 
E. coli, a venerable “workhorse” for biochemical and genetic studies, and for the 
large-scale production of recombinant proteins, is one of the most intensively studied 
organisms. 
E. coli is the head of the large bacterial family, Enterobacteriaceae, the enteric 
bacteria, which are Gram-negative rods that live in the intestinal tract of animals. The 
Enterobacteriaceae are among the most important bacteria medically. A number of 
genera within the family are human intestinal pathogens (e.g. Salmonella, Shigella, 
Yersinia). Several others are normal colonists of the human gastrointestinal tract (GI) 
(e.g. Escherichia, Enterobacter, Klebsiella), but these bacteria, as well, may 
occasionally be associated with disease. 
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1.1. PATHOGENESIS OF E. COLI 
 
Macroorganisms live intimately together with microorganisms throughout their entire 
live, and to their mutual benefit in the overwhelming number of cases. Infection is just 
an interruptive aberration of the balance. Nevertheless, the experience can be anything 
from mild to extremely dramatic or even fatal. Bacteria express various virulence 
factors such as: toxins, adhesins, factors promoting endocytosis or preventing 
phagocytosis and factors aiding to overcome mechanisms of host defence. 
The natural habitat of E. coli is the gastrointestinal tract of warm-blooded animals and 
the human body, where it is the most common facultative anaerobe in the gut. 
Although most strains exist as harmless symbionts, there are many pathogenic                   
E. coli strains that are capable of causing a variety of diseases in animals and humans. 
In addition, from an evolutionary perspective, strains of the genus Shigella are so 
closely related phylogenetically that they should also be included in the group of 
organisms recognized as E. coli. [1,2]   
 
 
Pathogenic E. coli strains differ from those that predominate in the feces of healthy 
individuals in that they are more likely to express virulence factors (molecules 
directly involved in pathogenic processes but ancillary to normal metabolic 
functions). Known virulence determinants of pathogenic E. coli are summarised in    
Table 1. 
In addition to their role in disease, these virulence factors presumably enable the 
pathogenic strains to explore niches unavailable to commensal strains, and thus to 
spread and persist in the bacterial community.  Yet, for all the differences among 
pathogenic and non-pathogenic E. coli, they all evolved from a common ancestor with 
Salmonella enterica some 100 million years ago.   
 
E. coli is responsible for three types of infections in humans: intestinal diseases 
(gastroenteritis), neonatal meningitis and urinary tract infections (UTI). These three 
diseases depend on a specific array of pathogenic (virulence) determinants.  
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TABLE 1. SUMMARY OF KNOWN VIRULENCE DETERMINANTS OF PATHOGENIC E. COLI 
ADHESINS CFAI/CFAII, Type 1 fimbriae, P fimbriae, S fimbriae, intimin (non-fimbrial adhesin) 
INVASINS, FITNESS Hemolysisn, siderophores and siderophore uptake systems, Shigella-like "invasins" for intracellular invasion and spread 
MOTILITY/CHEMOTAXIS Flagella 
TOXINS LT toxin, ST toxin, Shiga-like toxin, cytotoxins, endotoxin LPS 
ANTIPHAGOCYTIC SURFACE 
PROPERTIES Capsules, K antigens, LPS 
DEFENCE AGAINST SERUM 
BACTERICIDAL REACTIONS LPS, K antigens 
DEFENCE AGAINST IMMUNE 
RESPONSES Capsules, K antigens, LPS, antigenic variation 
GENETIC ATTRIBUTES 
Genetic exchange by transduction and conjugation, transmissible 
plasmids, R factors and drug resistance plasmids, toxin and other 
virulence plasmids 
 
1.1.1.  INTESTINAL DISEASES CAUSED BY E. COLI  
 
Five classes of E. coli that cause diarrheal diseases are now recognised: 
enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC), enterohemorrhagic            
E. coli (EHEC), enteropathogenic E. coli (EPEC), and enteroaggregative E. coli 
(EAggEC). Each class falls within a serological subgroup and manifests distinct 
features in pathogenesis. A short characterization of each group is presented                         
in Table 2.  
 
TABLE 2. SUMMARY OF VIRULENCE CHARACTERISTICS OF INTESTINAL PATHOGENS 
 ETEC EIEC EPEC EAGGEC EHEC 
ADHESIN Fimbrial adhesins 
Nonfimbrial 
adhesins, 
possibly OMP 
Nonfimbrial 
adhesin 
(intimin) 
Adhesins not 
characterized 
Adhesins not 
characterized, 
probably fimbriae 
INVASIN Non invasive 
Invasive 
(penetrates and 
multiplies 
within epithelial 
cells) 
Moderately 
invasive Non invasive 
Moderately 
invasive 
TOXINS Produce LT and/or ST toxin 
Does not 
produce shiga 
toxin 
Does not 
produce LT or 
ST; some 
reports of shiga-
like toxin 
Produces ST-
like toxin and 
hemolysin 
Does not produce 
LT or ST but does 
produce shiga toxin
SYMPTOMS 
Watery 
diarrhea in 
infants and 
travellers; no 
inflammation, 
no fever 
Dysentery-like 
diarrhea 
(mucous, 
blood); severe 
inflammation, 
fever 
Usually 
infantile 
diarrhea, watery 
diarrhea similar 
to ETEC; some 
inflammation, 
no fever 
Persistent 
diarrhea in 
young 
chilidren; 
without 
inflammation, 
no fever 
Pediatric diarrhea, 
copious bloody 
discharge 
(hemorrhagic 
colitis), intense 
inflammatory 
response, may be 
complicated by 
hemolytic uremia 
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1.1.2. EXTRAINTESTINAL DISEASES CAUSED BY E. COLI  
 
1.1.2.1. NEONATAL MENINGITIS 
 
Neonatal meningitis affects 1,000-4,000 infants per year in the United States. E. coli 
strains invade the blood stream of infants from the nasopharynx or GI tract and are 
carried to the meninges. The K-1 antigen is considered the major determinant                      
of virulence among strains of E. coli that cause neonatal meningitis. K-1                             
is a homopolymer of sialic acid. It inhibits phagocytosis, and responses from the 
host's immunological mechanisms. K-1 may not be the only determinant of virulence 
as siderophore production and endotoxin are also likely to be involved.  
 
 
1.1.2.2. URINARY TRACT INFECTION 
 
1.1.2.2.1. ETIOLOGY 
 
UTI is defined as a significant bacteraemia in accompanied by symptoms. The 
bacteria most often seen in UTIs are of fecal origin. These organisms are a subset of 
the organisms found in the feces. Strict anaerobic bacteria rarely cause UTIs. More 
than 90% of acute UTIs in patients with normal anatomic structure and function are 
caused by certain strains of E. coli, these are currently defined as uropathogenic 
Escherichia coli (UPEC). 
 
 This is especially true of spontaneous UTI in females (cystitis and pyelonephritis). 
Other strains are less common, including Proteus mirabilis and more rarely Gram-
positive microbes. Among the latter, Staphylococcus saprophyticus deserves special 
mention, as this Gram-positive pathogen is responsible for 5% to 15% of such 
primary infections, is not detected by the leukocyte esterase dipstick, and is resistant                       
to antimicrobial agents that are active on Gram-negative rods. [3, 17] 
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Figure 1. Main pathogens responsible for urinary tract infections (UTIs) 
 
1.1.2.2.2. EPIDEMIOLOGY 
 
UTI is an extremely common medical problem, with an unpredictable natural history.  
Many infections resolve spontaneously, but others can progress to destroy the kidney, 
and in case of Gram-negative sepsis, the entire host.  Intelligent management of UTI 
requires a thorough knowledge of the pathophysiology involved and a medical care, 
which is tailored to the clinical setting. 
The incidence of UTI's ranks second after respiratory infections in the United States             
of America and Germany. Each year, urinary tract infections (UTIs) account for more 
than 8 million physician visits in the United States (mostly for cystitis) and are 
estimated to cause more than 100,000 hospital admissions per year in this country 
(mostly for acute pyelonephritis) [4]. UTI is a common diagnosis among patients 
evaluated in the emergency department as well. [5] The majority of the cases seen                    
in the doctor's office are women (30:1, female: male ratio). 40% of all women have              
at least one episode of a UTI at some time in their lives. Up to 20% of young women 
with acute cystitis develop recurrent UTIs.  
 5
Introduction 
Males experience a rapid increase in the incidence UTIs sometime in their 40s. This is 
about the time that males are experiencing prostate gland hypertrophy. The direct cost 
of treating UTIs in the United States is estimated at $ 1 billion per year or greater. [6] 
 
 
1.1.2.2.3. PATHOGENESIS OF INFECTION 
 
 
The urinary system is structured in a way that prevents bacterial infection. The ureters 
and bladder normally prevent urine from flowing backwards towards the kidneys, and 
the flow of urine from the bladder washes bacteria out of the body. Apart from the 
lowermost part of the urethra (tube that carries urine from the bladder), which is 
usually colonized with various species of bacteria, the urinary tact is normally a sterile 
system that is protected from the nearby colonic microflora by non-specific defence 
including the epithelial barrier, the antibacterial properties of the bladder mucosa and 
the flow of urine. The low pH and osmolarity of urine is inhibitory to bacterial growth 
and the salts, urea and organic acids present in urine can reduce bacterial survival 
within urinary tract. Despite these natural safeguards, symptomatic urinary tract 
infections (UTIs) are among the most frequent infections in both the general 
community and in hospital.  
The colonizing bacteria derived from the feces or perineal region ascend the 
urinary tract to the bladder. Depending on the location of infecting bacteria, distinct 
diseases can be defined, such as cystitis (infection of the bladder) or (pyelo-)nephritis, 
when the kidneys are involved (Figure 2.). Table 3 outlines individual factors 
increasing the risk of getting UTIs. 
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C
 
 
 
 
 
 
 
 
 
 
Figure 2. Classification of Urinary Tract Infections. Blue colour in this figure symbolises the presence 
of bacteria and leukocytes (i.e., infection) in the relevant organ. A. cystitis, B. pyelonephritis in a 
female patients;  C. prostatitis, D. pyelonephritis in males. 
 
 
 
TABLE 3. RISK FACTORS 
 ANY ABNORMALITY OF THE URINARY TRACT THAT OBSTRUCTS OR SLOWS THE FLOW OF URINE    
MAKES IT EASIER FOR BACTERIA TO GROW 
 SHORT URETHRA 
 A STONE IN THE KIDNEY OR ANY PART OF THE URINARY TRACT CAN FORM SUCH A BLOCKAGE, 
CREATING THE CONDITIONS FOR A UTI 
 IN MEN, AN ENLARGED PROSTATE GLAND CAN OBSTRUCT URINE FLOW AND MAKE INFECTION 
DIFFICULT TO TREAT 
 ONE OF THE MOST COMMON SOURCES OF INFECTION IS CATHETERS, OR TUBES, PLACED IN THE 
BLADDER 
 PEOPLE WHO HAVE DIABETES MELLITUS 
 IMMUNOSUPPRESSED PATIENTS UTIS OCCUR IN A SMALL PERCENTAGE OF INFANTS DUE TO 
CONGENITAL ABNORMALITIES THAT SOMETIMES REQUIRE SURGERY 
 FOR MANY WOMEN, SEXUAL INTERCOURSE SEEMS TO PRECIPITATE UTIS 
 WOMEN WHO USE THE DIAPHRAGM AND/OR SPERMICIDES ARE MORE LIKELY TO DEVELOP A UTI 
THAN WOMEN WHO USE OTHER FORMS OF CONTRACEPTION 
 PATIENTS WITH A NEUROGENIC BLADDER OR BLADDER DIVERTICULUM 
 POSTMENOPAUSAL WOMEN WITH BLADDER OR UTERINE PROLAPSE 
 PREGNANT WOMEN ARE MORE SUSCEPTIBLE TO UTIS 
 INCREASED UROEPITHELIAL RECEPTOR DENSITY THAT CREATES GENETIC PREDISPOSITION 
          DELAYED POSTCOITAL URINATION 
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1.1.2.3. VIRULENCE FACTORS ASOCIATED WITH UTI 
 
The ability of E. coli to cause an illness is influenced by the production of 
virulence factors (VFs). These include tissue-specific adhesins, toxins, siderophores, 
secretion systems, etc. VFs allow the colonization of specific host surfaces, avoiding 
or subverting the host defence system and stimulating a noxious host inflammatory 
response. 
 
 
Host tissue
LPS
Fimbriae
E. coli OM
CM
Fe3+
Toxins
siderophore
Fe3+
Siderophore Fe3+ 
complex 
Capsular polysaccharides 
Flagella 
 
Figure 3. Schematic representation of an E. coli cell interacting with host tissue, highlighting features 
relevant to bacterial pathogenicity OM, Outer membrane; CM, cytoplasmic membrane; LPS, 
lipopolysaccharide [7, adopted] 
 
 
 
1.1.2.3.1. ADHERENCE 
 
UTI-causing E. coli have to be able to adhere to the urinary tract epithelium in order 
to prevent being washed out. They do so by expressing adherence factors. In addition, 
the physical attachment of bacteria to host cells can also serve as a signal for the 
activation of genes involved in bacterial virulence via signal transduction. A specific 
adhesion is associated with the host and tissue tropism (Figure 4.). The adhesive 
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organelles that are associated with UPEC strains include P and Type 1 fimbriae, S pili 
and Dr family adhesins.  
 
 
        A.                             B.  
 
 
 
 
  
Figure 4.  Two types of adhesions: A. pili and B. afimbrial adhesions 
 
The adhesin that has been most closely associated with uropathogenic E. coli is the             
P fimbriae (or pyelonephritis-associated pili [PAP] pili). The designation is derived 
from the ability of P fimbriae to bind specifically to the P blood group antigen, which 
contains a D-galactose-D-galactose residue. The fimbriae bind not only to red blood 
cells but also to a specific galactose dissaccharide that is found on the surface                   
of uroepithelial cells in approximately 99% of the population. 
Uropathogenic strains of E. coli possess other determinants of virulence in addition to 
P fimbriae. E. coli with P fimbriae possess also the genes for Type 1 fimbriae, and 
there is strong evidence that P fimbriae are derived from Type 1 fimbriae by insertion 
of a new fimbrial tip protein to replace the mannose-binding domain of Type 1 
fimbriae. In any case, Type 1 fimbriae could provide a supplementary mechanism               
of adherence or play a role in aggregating the bacteria to a specific mannosyl-
glycoprotein that occurs in urine.  This type of fimbriae consist of a helical rod made 
up of repeating FimA subunits and a distal tip containing two adaptor proteins (FimF 
and FimG) and the adhesin FimH. The interaction between FimH and bladder 
epithelial cells induces host-signalling cascades that lead to cytoskeletal 
rearrangements and the envelopment of the attached bacterium. Invasion of bladder 
epithelial cells triggers the production of proinflammatory cytokines, chemokines and 
epithelial cells apoptosis, leading to the recruitment of inflammatory cells and 
exfoliation, respectively. To prevent bacterial clearance by exfoliation of superficial 
bladder epithetical cells UPEC may invade the underlying bladder epithelial cells, 
potentially facilitating long-term persistence of bacteria within the bladder mucosa.  
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Figure 5. Type 1 pilus-mediated bacterial attachment to the bladder epithelium. After inoculation of 
C57BLy6 mice with type 1-piliated UPEC, numerous bacteria (yellow) can be found attached to the 
luminal surface of the bladder (blue) as detected by scanning EM (A) and high-resolution freeze-
dryydeep-etch EM (B) [8] 
 
 
 
 
 
Bacterium being enveloped by the
membrane of bladder epithelia cells.
 
 
 
 
 
Figure 6. Type 1 fimbriae mediated invasion [9] 
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S fimbriae are designated according their specific binding to terminal sialyl-
galactoside residues. Expression of S fimbriae can be modified by phase variation. 
Binding sites for S fimbriae are found on epithelial cells of the proximal and distal 
tubes, collecting ducts, and glomerulus, in the renal interstitium and on renal vascular 
endothelium. Recognize sialosyloligosaccharide residues on host cells and may help 
promote colonization of the upper urinary tract by UPEC. 
 
 
 
 
 
 
 
 
 
 
Figure 7. S-fimbriated bacteria, P-fimbriated bacteria [11] 
 
 
Dr family adhesins, including Dr fimbriae and the afimbrial adhesins AFA-I and 
AFA-II, bind to the Dra blood group antigen present on decay accelerating factors and 
may also facilitate ascending colonization of the urinary tract.  
 
 
1.1.2.3.2. CAPSULES AND SURFACE COMPONENTS 
 
 
The cell surface of E. coli is a complex array of proteins and glycoconjugates. The 
capsular polysaccharides (CPSs) and the O-polysaccharides of the lipopolysaccharide 
(LPS) molecules are the major surface polysaccharides expressed.  
These polymers are serotype-specific and give rise to the K- and O-antigens, 
respectively. Different K and O serotypes result from variation in sugar composition 
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and linkage specificity in the polysaccharides, as well as their substitution with non-
carbohydrate residues. There are 167 different O-serogroups and more than 80 
polysaccharide K antigens in E. coli. Capsular polysaccharides are linear polymers               
of repeating carbohydrate subunits that sometimes include a prominent amino acid           
or lipid component. They coat the cell, interfere with O-antigen detection and protect 
the cell from host defence mechanisms. The capsules are mostly thin, patchy, acidic, 
thermostable, and highly anionic. 
 
 
 
Figure 8. Bacteria membrane - diagram [12] 
 
 
The K1 polysaccharide is a homopolymer of sialic acid units linked C2-C8 and 
randomly acetylated at C7 and C9. The presence of K antigens is associated with 
upper urinary tract infections, and antibody to the K antigen has been shown to afford 
some degree of protection in experimental infections. Regardless of their chemistry, 
these capsules may be able to promote bacterial virulence by decreasing the ability           
of antibodies and/or complement to bind to the bacterial surface, and by preventing 
phagocytes to recognise and engulf the bacterial cells. The best studied K antigen,            
K-1, repetition has besides being antiphagocytic, the additional property of being an 
antigenic disguise.    
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1.1.2.3.3. BIOFILM 
 
Uropathogenic strains of E. coli have got the ability to adhere to epithelial cells and 
they form a biofilm. [13.14] They secrete a slime matrix, which surrounds and 
protects them (Table 3.) 
 
 
 
TABLE 3. SOME ADVANTAGES OF BIOFILM FORMATION 
Protection from the environment: macrophages, antibodies do not penetrate readily 
Facilitiates nutrient sharing, metabolic cooperativity, syntrophisms 
Horizontal gene transfer favoured: possibility of acquiring new genetic traits 
Sessile cells are more resistant to antibiotics than are planctonic cells - very difficult to eradicate 
biofilmic infections 
 
 
Host defence mechanisms and antibiotic therapy kill most of the bacteria during 
infection, though some can remain within the bladder tissue. But a bacterial biofilm 
persists in the urinary tract and on catheter surfaces because microorganisms, which 
are organized in a biofilm, are strongly resistant to host defence and antibiotic 
treatment. [15,16,17] Biofilms facilitate the survival of bacteria because the bacteria 
are protected from the urine flow and the antimicrobial attacks. However, the 
mechanisms involved in bacterial persistence within the urinary tract are still unclear. 
Gregory G. Anderson and colleagues showed that E. coli forms intracellular bacterial 
biofilm-like pods in bladder, favouring the recurrence of UTIs. [18] They showed, 
using the scanning electron microscopy, that E. coli invaded the bladder superficial 
cells, and these intracellular bacteria matured into biofilms, creating pod-like bulges 
on the luminer surface of the bladder. The pods contained bacteria encased                        
in polysaccharide-rich matrix surrounded by a protective shell of uroplakin. 
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1.1.2.3.4. ENDOTOXINS (LPS) 
 
Bacterial lipopolisaccharides (LPS) are the major outer surface membrane 
components consisting of a predominantly lipophilic region, lipid A and a covalently 
hydrophilic polyoligosaccharide region.  
Bacteria are killed by normal human serum through the lytic activity of the 
complement system. The alternative pathway is activated by bacteria in the absence  
of a specific antibody and plays a more important role in serum killing than does the 
classical pathway. Lipid A can activate the classical pathway in the absence of an 
antibody, but its location deep within the outer membrane probably makes                           
it inaccessible to complement components. Bacterial resistance to serum complement 
results from the individual or combined effects of capsular polysaccharides,                      
O-polysaccharide side chain, and surface proteins. Figure 9.  
 
 
 
 
 
Antigenic part of LPS (highly 
hydrophilic region)  
Core polysaccharide  
Genus-specific antigens  
Toxic moiety  
Hydrophobic region of LPS  
 
 
 
Figure 9. LPS – diagram [19; adopted] Kdo – 2-keto-3-deoxyoctonic acid – unusual sugar, unique to 
LPS and invariably present in LPS. 
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1.1.2.3.5. EXOTOXINS  
 
1.1.2.3.5.1. HEMOLYSIN (HLY) 
 
UPEC produces hemolysins that are cytotoxic due to the formation of transmembrane 
pores in the host cells. They belong to the RTX (repeat-in-toxin) toxin family.                      
A possible strategy for obtaining iron and other nutrients for bacterial growth may 
involve the lysis of host cells to release these substances. The activity of hemolysins 
is not limited to red blood cells since the alpha-hemolysins of E. coli also lyse 
lymphocytes, and the beta-hemolysins inhibit phagocytosis and chemotaxis                         
of neutrophils.  
 
1.1.2.3.5.2. CYTOTOXIC NECROTIZING FACTOR (CNF1) 
 
Among the putative virulence factors produced by E. coli are the cytotoxic 
necrotizing factors (CNFs). Cytotoxic necrotizing factor type 1 (CNF1)                              
is  chromosomally encoded - 115-kDa toxin that catalyzes the deamidation of the 
small GTPases RhoA, Rac, and Cdc42. [20] Rippere-Lampe et al. propose that CNF1 
production increases the capacity of UPEC strains to resist killing by neutrophils, 
which in turn permits these bacteria to gain access to a deeper tissue and persist better 
in the lower urinary tract. [21] 
 
1.1.2.3.5.3. AUTOTRANSPORTER TOXIN (SAT) 
 
UPEC strains secrete specific proteins that may contribute to pathogenesis of UTI. 
Among these proteins, the most recently described is the secreted autotransporter 
toxin (Sat). Sat is a large (107kDa) serine protease, which exhibits cytopathic activity 
on kidney, bladder and other cell lines, as well as eliciting a strong antibody response 
after experimentally infection. [22] The protein appears to fall within one subgroup  
of autotransporters recently classified as the SPATE (serine protease autotransporters 
of Enterobacteriaceae) family. There are eight known SPATE proteins: Sat                         
of uropathogenic E. coli [30], Pet of enteroaggregative E. coli [23], EspC                            
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of enteropathogenic E. coli [24], Pic of enteroaggregative E. coli and Shigella [25], 
SigA of Shigella [26], SepA of Shigella [27], Tsh of avian E. coli [28], and EspP                        
of enterohemorrhagic E. coli [29]. SPATE autotransporters are identified by the 
presence of a serine protease active site motif in the passenger domain. It has been 
shown that the motif is necessary for phenotypic functions (e.g., adhesin, invasin, 
protease, or cytotoxin) as demonstrated by site-directed mutagenesis with Pet and Tsh 
[30]. Interestingly, no SPATE proteins have been identified in nonpathogenic 
organisms. 
 
1.1.2.3.6. IRON ACQUISITION 
 
The host environment is ideal for bacteria in every way except for one: iron           
is plentiful but tightly bound in haem, ferritin, transferrin, or lactoferin. It can be                
a limiting factor in growth. Therefore, uropathogenic strains of E. coli have evolved 
virulence factors that mediate the release of the host iron. As an example  
siderophores  play an essential role in iron acquisition for the bacteria during or after 
colonisation. Siderophores are low-molecular weigh, high-affinity iron-binding 
compounds. [31] 
 
 
TABLE 4. IRON ACQUISITION SYSTEMS 
SIDEROPHORE CHARACTERISATION 
ENTEROBACTIN 
(Also known as a enterochelin) It is a cyclic trimester of 2,3-dihydroxy-N-
benzoyl-L-serine that removes iron-binding proteins and transports it into 
the bacterial cell. The products of seven chromosomal genes are required 
to synthesise enterobactin, which can be used only once, because the 
molecule is cleaved within the cell and the remnants discarded for the iron 
to become available. It is thus very energy expensive process. 
AEROBACTIN 
Aerobactin is a conjugate of 6-(N-acetyl-N-hydroxylamine)-2-
aminohexanoic acid and citric acid. It forms an octahedral complex with 
ferric iron. This siderophore can be recycled and unlike enterobactin, it is 
not bound by serum albumin. 
TONB AND THE TONB-
DEPENDENT IRON 
UPTAKE SYSTEMS 
TonB is known to be required by E. coli for high-affinity transport and 
utilization of several nutrients including chelated iron and vitamin B12. 
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2. MATERIALS 
 
 
2.1.  BACTERIAL STRAIN AND PLASMIDS  
 
The bacterial strains and plasmids used in this study are described in Table 5. 
 
TABLE 6. BACTERIAL STRAINS, MAMMALIAN CELL LINE AND PLASMIDS 
BACTERIAL STRAINS 
STRAINS GENOTYPE/FENOTYPE SOURCE 
E. coli 536 WT urinary tract isolate of the serogrup O6:K15:H31 U. Dobrindt * 
E. coli IHE3034 WT meningitis isolate of the serogrup 18ac:K1:H7 U. Dobrindt * 
IHE3034∆PKS IHE3034 mutant, deleted PKS gene cluster  
J96-M1∆PKS J96-M1 mutant, deleted PKS gene cluster  
E. coli DH5α supE44, Φ80lacZ∆M15, ∆lacU169, hsdR17, recA1, 
endA1, gyrA96, thi-1, relA1 
Gibco [33] 
E. coli TOP10 
F-, mcrA, -80lacZΦM15, ∆(mrrhsdRMS-mcrBC), 
∆lacX74, recA1,araD139, (ara-leu)7697, galU, 
galK,rpsL, (StrR), endA1, nupG 
Invitrogen 
MAMMALIAN CELL LINE 
HeLa Human cervix epithelioid carcinoma U. Dobrindt * 
PLASMIDS 
pTZ19R 2,8kb, lacZα, MCS, AmpR Fermentas 
PCR4-TOPO 3.9 kb, AmpR, KanR, lacZα-ccdB Invitrogen 
IHE3034 BAC11 IHE3034, PKS coding region S. Homburg * 
pAKR2 AmpR, KmR, p15or, delivered from pTC ETEC 2173 G. Blum-Oehler * 
* Institut für Molekulare Infektionsbiologie, Würzburg, Germany 
 
 
All bacterial strains were stored in 20% glycerol at –80°C. 
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2.2. CULTURE MEDIA 
 
All culture media were sterilized by autoclavation (121˚C, 40 minutes) just after 
preparation (Table 6.). pH of the medium was adjusted to 7.2 [32] 
 
TABLE 7. MEDIA 
BACTERIAL MEDIA 
LIQUID MEDIA 
LB (Luria-Bertani medium) 10 mg/ml bacto-tryptone 
5 mg/ml yeast extract 
10 mg/ml NaCl 
(pH 7.4) 
SOLID MEDIA 
To obtain solid media (hard agar-based culture plates for growth of bacterial colonies), 15 g/l 
agar were added to the liquid medium (LB) before autoclavation. After cooling, the agarose-
medium was poured directly into Petra dishes, allowing about 30-35 ml per 85mm dish.  
Blood agar plate (BAP) contains LB supplemented with 15 g/l agar and 5% sheep 
blood.   
MAMMALIAN CELL LINE MEDIUM 
MEM – Minimal Essential Medium with Earle’s Salts supplemented with: 
10% FCS (heat-inactivated fetal calf serum) 
2 mM glutamine 
1 ml/100 ml MEM Non-Essential Amino Acids 
 
DMEM – Dulbecco’s Minimal Essential Medium with high Glucose supplemented with: 
10% FCS (heat-inactivated fetal calf serum) 
2 mM glutamine 
 
The cell culture media and supplements were obtained from GIBCO BRL. 
 
 
Antibiotics were used at the following final concentrations: ampicillin – 100 µg/ml, 
kanamycin – 30-50 µg/ml, tetracycline 12,5 µg/ml, and chloramphenicol 12,5 µg/ml. 
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2.3. BUFFERS, SOLUTIONS AND CHEMICAL REAGENTS 
 
All solutions and buffer stocks were prepared using chemicals of analytical grade or 
better. Aqueous solutions were prepared using bidistilled water only. All solutions 
were sterilized by autoclavation (121˚C, 30min) or filtration (pore size 0,22 m). 
 
TABLE 8. BUFFERS, SOLUTIONS AND REAGENTS 
STOCK SOLUTIONS 
Agarose, 2,5-0,8% 
2,5-0,8 g agarose dissolve in 100 ml TAE Buffer. Biozym GmbH, 
Hessisch Oldendorf, Gibco 
CaCl2, 1 M 147 g/l CaCl2.  Autoclaved, stored at room temperature. Merck 
EDTA, 0.5 M 
 
186 g/l ethylenediamine tetraacetic acid (disodium salt and 10 N 
NaOH were used to set pH 8.0), autoclaved, stored at room 
temperature. Serva 
Ethidium bromide 
10 mg/ml; used to visualize DNA: emits fluorescence when excited 
at 250-320 nm. Stored at 4 ˚C in dark. Handle with gloves and avoid 
inhalation!  Strong mutagen! Sigma 
Glucose, 20% 
20 g glucose dissolved in 100 ml water, sterile filtered, stored at      
4 ˚C 
IPTG, 100 mM 
23,8 mg isopropyl-D-thiogalactopyranoside in 1 ml H2O, stored at –
20˚C. Biomol 
NaAc, 3 M 
408 g CH2COONa 3H2O in 1 liter H2O. Acetic acid to pH 5,2; 
autoclaved 
PEG6000/NaCl 
20% PEG6000 (Polyethylene Glycol)/2.5 NaCl: 
40 g PEG600, 29.22 g NaCl in 200 ml of water, autoclaved 
SDS 20% 
200 g SDS (Sodium dodecyl sulfate) dissolved in 1-liter water at 
60˚C, not autoclaved! 
Sucrose gradient 
solutions: 40%, 
32,5%, 25%, 17,5% 
end 10% 
40%, 32,5%, 25%, 17,5% end 10% dissolve in Buffer: 1M NaCl, 
20mM Tris-HCl, 5mM EDTA pH 8,0 
 
Xgal, 2% 
2 mg Xgal  (5-bromo-4-chloro-3-indolyl-D-galactoside, 1 ml of 
dimethylformamide (DMF). Stored dark at –20˚C. Biomol 
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BUFFERS 
EBSS (washing 
buffer) 
382,5 ml water, 50 ml EBSS1, 50 ml EBSS2, 10 ml EBSS3, 15 ml 
EBSS4 
EBSS1 1.06 g CaCl2, 0.79 g MgSO4 in 400 ml water, autoclaved 
EBSS2 
1.58 g KCl2, 27.35 g NaCl, 0.62 g NaH2PO4 in 400 ml water, 
autoclaved 
EBSS3 5.55 g Glucose in 25 ml water 
EBSS4 7.5 g NaHCO3 in 100 ml water 
Gel loading buffer, 5x 
50% glycerol, 0,5% bromophenol blue, 0,5% xylene cyanol in 5x 
TAE, stored at 4 ˚C 
Loading dye 
5 vol. Deionized formamide, 1 vol. 25 mM EDTA (pH 8,0) with 
blue dextran (50 mg/ml) 
Shearing buffer TE, pH 8 containing 10% glycerol 
TAE Buffer, 50x 
242 g Tris base, 57,1 ml glacial acetic acid, 37,2 g Na2EDTA-2H2O 
(2mM) dissolved in 1000 ml water, (pH 8,0). Stored at room 
temperature 
TE buffer 
10 mM Tris-Cl (pH 7,4) and 1 mM EDTA (pH 8,0), stored at room 
temperature 
TfbI 
30 mM potassium acetate, 100 mM rubidium chloride, 10 mM 
calcium chloride, 50 mM manganese chloride, 15% glycerol, pH 5,8 
with dilute acetic acid 
TfbII 
10 mM MOPS, 75 mM calcium chloride, 10 mM rubidium chloride, 
15% glycerol, pH 6,5 with dilute NaOH 
 
CHEMICAL REAGENTS SOURCE 
Acrylamide Serva 
Ampicillin Sigma 
APS Sigma 
dATP MBI, Fermentas 
Agar-Agar Roth 
Tryptone Oxoid 
Bisacrylamide Serva 
DMSO (Dimethylsulfoxid), Sigma 
Ethanol Merc 
dNTPmix Promega 
Glycerol Fuka Biochemica 
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Glycine Serva 
Isopropanol Roth 
MOPS Sigma 
Phenol Biomol 
Primers Gibco 
TEMED (N,N,N,N,-Tetramethy –Ethylenediamine), Sigma 
Tris HCl Sigma 
Urea Serva 
Yeast extract Oxoid 
 
 
 
2.4.  DNA SIZE MARKERS 
 
For estimation of the DNA fragments size GeneRulerTM  
10000 bp     
8000 
6000 
5000 
4000 
3500 
3000 
2500 
 
2000 
 
1500 
 
1200 
 
1031 
900 
800  
700 
600 
500 
400 
 
300 
 
200 
 
100 
DNA Ladder Mix (MBI, Fermentas) was used (Figure 10).  
 
 
 
 
 
 
 
 
 
 
Figure 10. DNA Ladder Mix 
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2.5. ENZYMES AND COMMERCIALLY PREPARED KITS 
 
TABLE 9. ENZYMES AND KITS 
ENZYME SOURCE 
Taq DNA Polymerase Qiagen, Fermentas, Promega, TaKaRa Bio inc., Bioline 
T4 Polymerase MBI, Fermentas 
T4-DNA-Ligase MBI, Fermentas 
Calf Intestin Alkaline Phosphatase MBI, Fermentas 
Klenow Fragment DNA Polymerase I large fragment, MBI Fermentas  
Proteinase K Boehringer Mannheim GmbH 
Rnase (ribonuclease) Boehringer Mannheim GmbH 
EcoRI MBI, Fermentas 
AluI MBI, Fermentas 
SmaI MBI, Fermentas  
Lysosym Biomol 
 
KITS SOURCE 
Qiaprep Spin Miniprep Kit Qiagen 
QIAEX II Gel Extraction Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
DirectPrep 96 BioRobot Kit Qiagen 
Qiagen Plasmid Mini Kit Qiagen 
BigDye Terminator Cycle Sequencing Kit Applied Biosystem 
TopoTA Cloning Kit For Sequencing with Top 10 Cells Invitrogen 
AquaPure Genomic DNA Isolation Kit Bio-Rad 
DYEnamic ET Dye Terminator Kit Amersham Bioscience 
Megabase 4000 Long Read Matrix Amersham Bioscience 
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3. METHODS 
  
3.1. BACTERIAL GROWTH CONDITIONS  
 
In most cases, cells were grown to early log phase (OD600 0,2 to 0,4); LB medium was 
used in most experiments, supplemented with glucose and/or antibiotic. Cultures were 
grown at 37˚C and shaken at 180-350 rpm.  
 
 
3.2. COMPETENT CELLS PREPARATION 
 
1ml from overnight culture was inoculated into 100 ml LB medium and incubate at 
37˚C with aeration to early log phase (OD600 0,2 to 0,4). The sample was incubated on 
ice for 15 minutes. Cells were pelleted in appropriate centrifuge tube 3-5000 x g 5 
min (~5000 rpm in a Sorvall SS-34 rotor). Pellet was resuspended with 40 ml TfbI 
and incubated on ice for 15 minutes. After this time samples were centrifuge (with the 
same condition) and the obtained pellet was resuspended in 40 ml TfbII,and incubated 
on ice for 15 minutes and either use immediately or quick freeze at -70C for storage. 
Samples were usually saved these in 0,25 to 0,5 ml aliquots. 
 
 
3.3. RUBIDIUM CHLORIDE METHOD FOR TRANSFORMATION 
COMPETENT E. COLI CELLS 
 
Methods for E. coli transformation were adapted from Sambrook et al. (1989). [32] 
Approximately 40-100 µl of competent cells were transferred to microcentrifuge 
tubes and 6 µl pCR4 Topo ligation sample to Top 10 cells (3.7.3.) or1-2 µl of plasmid 
were added (approximately 50 ng plasmid per 10 µl of competent cells). The samples 
were incubated on ice for 10 minutes, followed by incubation in 42 °C water bath for 
45 sec. 400-800 µl of LB medium were added. Next, the samples were incubated in 
37 °C for 45-60 minutes. 50-100 µl of the putative transformed cells were transferred 
to LB plates containing selective antibiotic and Xgal and IPTG. Plates were then 
incubated at 37 °C overnight. 
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3.4. ELECTROCOMPETENT CELLS PREPARATION 
 
1ml from overnight culture was inoculated into 100 ml LB medium and incubate at 
37˚C with aeration to early log phase (OD600 0,2 to 0,4). The sample was incubated on 
ice for 15 minutes. Cells were pelleted in appropriate centrifuge tube 3-5000 x g 5 
min (~5000 rpm in a Sorvall SS-34 rotor). Pellet was washed with prechilled, sterile 
water two times and resuspended with 1 ml of 10% glycerol. Samples were use 
immediately or quick freeze at -70C for storage. Samples were usually saved these in 
0,25 to 0,5 ml aliquots. 
 
3.5. ELECTROPORATION AND BLUE-WHITE SELECTION 
 
40 µl electrocompetent cells were thawed on ice and transferred into a prechilled 0.1 
cm electrode Gene Pulser Cuvette (Bio-Rad). 1 µl DNA solution (1 ng/µl) or 1.5 µl 
ligation product was added directly into the competent cells and mixed well by gently 
flicking. Then, the surface of the cuvette was completely dried and the electroporation 
was performed using Gene Pulser (Bio-Rad) under the condition of 1.8 kV voltage, 
200 Ω resistance, 25 µF capacitance. Afterwards, 700-1000 µl prewarmed LB 
medium was immediately supplied to the electroporated E. coli for recovery. The cells 
were recovered at 37 °C rotating for 1 hour, followed by plating 100 µl and 900 µl on 
separate plates containing selective antibiotic, X-gal and IPTG. 
 
3.6. GENERAL DNA MANIPULATION METHODS 
 
3.6.1. ISOLATION OF PLASMID DNA 
 
3.6.1.1. PLASMID ISOLATION USING A KIT  
 
The plasmids were isolated from the fluid E. coli cultures using Qiaprep Spin 
Miniprep Kit (Qiagen, Valencia, CA). The procedures were followed as described by 
Qiagen instructions.  
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3.6.1.2. QIAGEN BIO ROBOT 9600 
 
DNA was isolated using a Qiagen Bio Robot 9600 (Qiagen GmbH, Germany).  
The BioRobot 9600 is designed to automate routine liquid-handling tasks and nucleic 
acid purification for general molecular biology research laboratories and core 
facilities. This workstation integrates proven QIAGEN chemistries, ready-to-run 
protocols, and dependable instrumentation for consistent, reliable results in molecular 
biology projects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Qiagen Bio Robot 9600 
 
 
3.6.2. PURIFICATION AND PRECIPITATION OF DNA 
FRAGMENTS 
 
3.6.2.1. PURIFICATION USING A KIT 
 
Before performing ligation reactions and sequencing reactions, all DNA fragments 
were purified using PCR Purification Kit (Qiagen, Valencia, CA).  
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3.6.2.2. DNA PRECIPITATION 
 
Precipitation was performing by adding to the DNA sample 1/10 volume NaAC and 3 
volumes of EtOH absolute. Mixture was chilled for at least 10 min. Frequently; this 
precipitation was performed by incubation at –20°C overnight. To recover the 
precipitated DNA, sample was centrifuged for at 4°C for 30 min at 12000 rpm, 
supernatant discarded and the DNA palled washed with: 70 % EtOH (cold), and 
centrifuged at 4°C, 12000 rpm, 3 min. The pellet was dried and resuspended in water.  
 
3.6.3. CHROMOSOMAL DNA ISOLATION 
 
Genomic DNA was extracted from E. coli 536 urinary tract isolate using the AquaPure 
Genomic DNA Isolation Kit (Bio-Rad) according to manufacture protocol.  
 
3.6.4. DNA RESTRICTION ENDONUCLEASE DIGESTION 
 
Restriction digests were carried generally using the specific buffer provided by the 
manufacturer.  Multiple restrictions were combined in a single digest provided the 
buffers are compatible. Digestion volumes varied depending on the amount of DNA 
being digested, normally 200-300 ng DNA were digested in a 20 ml volume using 1 
unit of enzyme for 1 hour at 37°C. Digestions were stopped by the addition of DNA 
sample loading solution.  
 
3.6.5. DNA: FILLING IN 3’-RECESSED ENDS OF DNA, 
KLENOW 
 
DNA polymerase I large fragment (Klenow fragment) (2U/µl, Fermentas) was used to 
fill-in the ends of 5’-overhang DNA fragment. After clean up of the digested DNA 
pellet (0,1 – 4 µg) were resuspended in 32 µl of water, 4 µl of 10X Klenow buffer and 
4 µl dNTP solution (0,05 mM – final concentration) and 1 unit of Klenow Fragment 
per microgram of DNA. The reaction was incubated at 37°C for 10 minutes and 
stopped by heating the mixture at 75°C for 10 minutes. 
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3.6.6.  T4 DNA POLYMERASE  
 
3’-overhang DNA fragment was sharpened blunt using T4 DNA Polymerase (5U/µl, 
Fermentas). T4 DNA polymerase catalyzes 5’Æ 3’ synthesis of DNA and has got a 3’ 
Æ 5’ exonuclease activity.  
 
Reaction mixture was prepared on an ice by adding the following: 
5x reaction buffer  10 µl 
digested/sheared DNA 20-25 µl (5 µg) 
2 mM dNTPmix  1,5 µl 
T4 DNA Polymerase   1 µl (5 U/µl) 
water    to 50 µl, 
 
then incubated the mixture at RT for 1,5 h.  
 
 
3.6.7. MODIFICATION OF 3’ ENDS WITH A TAQ DNA 
POLYMERASE  
 
The adenine overhangs at the 3'-blunt ends were created using the template-
independent terminal transferase activity of Taq DNA polymerase. 
 
The reaction was performed on an ice by adding the following: 
 DNA      50 µl 
 2 mM dATP    6 µl 
 25 mM MgCl2    6 µl 
 10x PCR Buffer without MgCl2 7 µl 
Taq DNA Polymerase 5U/µl  0.5 µl, 
then incubated the mixture at 72°C for 25 min. 
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3.6.8. DEPHOSPHORYLATION 
 
The enzyme catalyzes the release of 5’-phosphate groups from DNA.  
5’-ends of DNA fragment dephosphorylation was performed by directly adding: 
DNA   50 µl 
10x CIAP Buffer 10 µl 
CIAP 1U/µl  2 µl 
water   40 µl, 
mixture was incubated at 37 °C for 30 min. (max. 35 min.!) 
 
 
3.6.9. LIGACJA Z VECTOREM 
 
25-100 ng purified vector fragment was mixed with 3-10 folds (molecular ratio) of 
purified insert fragment, 1 µl 10×T4 DNA ligase buffer (MBI Fermentas), and 1 µl T4 
DNA ligase (3 U/µl, MBI Fermentas) in a total volume of 10 µl. This ligation mixture 
was incubated at RT for at least 2 hours or at 15°C overnight. 
 
 
3.6.10. DNA AMPLIFICATION (PCR, POLYMERASE CHAIN 
REACTION) 
 
The Polymerase Chain Reaction makes possible the synthesis of specific DNA 
sequences using two oligonucleotides complement to the two DNA strands. The 
reaction requires a Thermocycler, which controls the exact temperature for each of the 
different steps that characterize the PCR: melting, annealing and amplification. The 
amplification reaction is carried out by the special heat resistant Taq-polymerase. The 
reaction provides several factors, beside of the temperature, to adjust the reaction to 
optimal conditions, as the concentration of magnesium chloride. PCR reactions were 
performed according to instructions for each Polymerase used. 
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Standardized PCR protocol: 
Reaction mix:   
DNA    10-200ng 
PCR-buffer*   1x 
dNTPmix   200µM 
MgCl2     1mM - 5mM 
Primer1   100pmol 
Primer2   100pmol 
Taq-polymerase  2,5 U/50µl reaction volume 
H2O    to a final volume of 50µl or 20µl 
 
* PCR buffer 10x: 500mM KCL, 200mM Tris-HCl pH 8,6, 1% Triton x-100 
 
Cycle parameters: 
Initial denaturation:  3 min 94°C 
3-step cycling 
Denaturation:   0.5–1 min 94°C 
Annealing:   0.5–1 min 50–68°C 
(approximately 5°C below Tm of primers) 
Extension:  1 min 72°C For PCR products longer than 1 Kb, 
increase the extension time by approximately 1 min per 
kb DNA 
Number of cycles:  25–35 
Final extension:  10 min 72°C 
 
 
3.6.11. DNA GEL ELECTROPHORESIS 
 
Molecules in a mixture can be separated according to size by electrophoresis, a 
technique dependent on the fact that dissolved molecules in an electric field move at a 
speed determined by their charge-mass ratio. Nucleic acids in solution generally have 
a negative charge because their phosphate groups are ionized; thus they migrate 
toward a positive electrode. However, nucleic acid molecules consisting of long 
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chains have almost identical charge-mass ratios, whatever their length, because each 
residue contributes about the same charge and mass. Therefore, if the 
electrophoresis of nucleic acids were simply carried out in solution, little or no 
separation of molecules of varying lengths would occur.  
Agarose gels were prepared in 1x TAE Buffer containing 250 ng/µl ethidium bromide 
and the appropriate percentage of agarose according to the size of fragments being 
separated: 2.5 % agarose gels were used for electrophoresis of fragments below 1 kb; 
1.0% agarose gels were used for analysis of larger fragments. Electrophoresis was 
performed at 50 - 90 V for 15 - 45 minutes depending on the separation required.  
 
 
3.7.  GENE BANK PREPARATION 
 
Prior to beginning the process of gene bank preparation, agar plates (hard agar-based 
culture plates supplemented with Amp, X-gal and IPTG) must be prepared. 
 
 
3.7.1. SHEARING THE DNA 
 
The DNA was shred using a nebulizer. It is a small plastic device which allow to 
atomize liquids with a compressed air to shear DNA to 0.5-6 kb in just a few seconds. 
The size of the sheared DNA is inversely proportional to the amount of pressure. 
 
 
 
  
 
 
 
 
 
Figure 12. Nebulizer 
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After connection the nebulizer to the compressed air source, the following steps were 
performed: 
- 3-25 µg DNA was added to 750 µl of shearing buffer into the bottom of the 
nebulizer 
- to keep the DNA cold, nebulizer was placed in an ice 
- the DNA was sheared for 45-90 s at 9-10 psi (0.62 bar) 
- the sheared DNA was transferred to a sterile microcentrifuge tube 
- sodium acetate precipitation was done and the DNA was resuspended to a 
concentration of ~50 ng/µl in a sterile water 
 
 
3.7.2. SUCROSE GRADIENT – SIZE FRACTIONATION AND 
PURIFICATION OF SHEARED DNA 
 
One of the most important parameters determining the success of gene bank 
construction is the quality and the fragments size of the DNA. For this purpose 
sucrose density gradient ultracentrifugation was used. 
 
Procedure: 
1. Prepare sucrose gradient solutions: 40%, 32,5%, 25%, 17,5% end 10%    
(Table. 7) 
2. Add 1.9 ml the following sucrose solution sequentially into the 10 ml 
ultracentrifugation tube (use a glasspipette or cut off approximately 2 mm 
from the top of a 1 ml pipette tip; after each sucrose solution incubate a tube in 
–20°C for ca. 45 min.) 
a. 1.9 ml of 40% sucrose solution 
b. 1.9 ml of 32.5% sucrose solution 
c. 1.9 ml of 25% sucrose solution 
d. 1.9 ml of 17.5% sucrose solution 
e. 1.9 ml of 10% sucrose solution 
3. Keep the tube at –20°C for at least 12-16 h (i.e., overnight). A linear gradient 
will form. 
4. Layer ca. 850 µl sheared DNA on a top of the sucrose gradient solution 
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5. Gently insert the tube into a pre-chilled Swing Out Rotor TH641, balance the 
rotor and centrifuge the sucrose density gradient using ultracentrifuge Sorvall 
Ultra Pro 80, Sorvall ODT50B or ODT55B at 20°C for 20 h at 27000U. 
6. After centrifugation prepare 26 microcentrifuge tubes 
7. Remove the centrifuge tube from the rotor and carefully transfer 400 µl of 
fraction from the top of the gradient to the microcentrifuge tubes with 1 ml 
pipette tip. 
8. Add 200 µl PEG6000/NaCl (Table 7.) and mix the samples. 
9. Incubate samples at RT, overnight. 
10. DNA purification: 
a. Centrifuge the samples for 30 min, RT and descent the supernatant 
b. Mix the samples with 700 µl of 70% EtHO 
c. Repeat the centrifugation. 
d. Dry the DNA pellet in the Speed Vac at 30°C for 20 min. 
e. Resuspend the DNA in a 25 µl of sterile water. 
 
 
3.7.3. TOPO CLONING 
 
Topo cloning it is a few step procedure: 
1. Sharpening blunt 3’-overhang DNA fragment using T4 DNA Polymerase 
(3.6.6.) 
2. Modification of 3’ ends with a Taq DNA Polymerase (3.6.7.) 
3. Dephosphorylation (3.6.8) 
4. Ligation with a Topo vector 
Reaction mix: 
  DNA    4 µl 
  Salt solution       1 µl 
  Vector pCR4Topo   1 µl 
(includes topoisomerase)  
       Incubation: 2h, RT 
5. Transformation using competent Top 10 cells and clone selection (3.3.) 
 
 32
Methods 
Figure shows the principles of Topo cloning strategy using a pCR4Topo cloning 
vector. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCCTT. 
GGGAA 
AAGGG 
TTCCC. 
P P 
Vector
Blunt-endred genomic DNA 
CCCTT. 
GGGAA*Vector *AAGGG  TTCCC
 
. VectorBlunt-endred genomic DNA 
Topoisomerase I 
released
Topoisomerase I 
released 
Covalently
bounded
topoisomeerase I
Topoisomerase I recognition sites
3’ phosphate
Vector
Figure 13. Topo cloning strategy 
 
 
3.8. DNA SEQUENCING  
 
3.8.1. SAMPLE PREPARATION 
 
The sequencing reactions are carried out with AmpliTaqTM DNA Polymerase FS dye 
terminator cycle sequencing chemistry using the “ABI PRISM BigDye Terminator 
Cycle Sequencing Ready Reaction Kit”. This Kit contains the four ddNTPs with 
different fluorescence labels. Reactions components and parameters were shown in a 
Table 9. 
After sequencing reaction samples were purify with NaOAc (3M, pH4.6) and 99% 
ethanol. Finally the DNA pellet was resuspended in 2 µl loading dye.  
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TABLE 10. THE SEQUENCING REACTION COMPONENTS AND PATAMETERS 
REACTION COMPONENTS REACTION PARAMETERS** 
Premix* 
DMSO 
Betain (5M) 
Primer (5pmol/ µl) 
H2O 
DNA (400ng) 
 
4µl 
1µl 
1µl 
1µl 
xµl 
xµl 
--------- 
20µl 
01 LIDHT 
02 PAUSE 
03 TEMP 
04 LOOP [ 
05 TEMP 
06 TEMP 
07 TEMP 
08 LOOP ] 
09 LIDHT 
10 TEMP 
11 END 
110°C 
98°C 
98°C 
---25x--- 
96°C 
50°C 
60°C 
--------- 
OFF 
4°C 
 
ON 
FOREVER 
2min 
--------- 
20 sec (degradation) 
15 sec (annealing) 
4 min (extension) 
--------- 
--------- 
FOREVER 
* ABI Big Dye Terminator Kit, reactions mix. 
** Reaction cycle with 96er PCR-Thermo block (MWG-Primus 96 plus) 
 
 
3.8.2. DNA SEQUENCING WITH THE ABI PRISM® 377 
AUTOMATED SEQUENCER (APPLIED BIOSYSTEMS) 
 
The ABI PRISM® 377 DNA Sequencer automatically analyzes DNA molecules 
labeled with multiple fluorescent dyes (Figure 13.). After samples are loaded onto the 
system's vertical gel, they undergo electrophoresis, laser detection, and computer 
analysis. Electrophoretic separation can be viewed on-screen in real-time, and final 
data can be output in a variety of formats. The 377 systems accept gel plates in 
different lengths for flexibility in sample 
analysis. The systems ship with the Apple 
Data Collection and Analysis software 
modules. Software versatility enables this 
system to support sequencing and fragment 
analysis applications Reads up to and beyond 
900 bases per sample generating long reads 
Electrophoresis optimizes speed, resolution, 
and read length (Figure 14.). 
 
 
 
Figure 14. The ABI PRISM® 377 DNA automated DNA sequencer  
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Figure 15. The ABI PRISM® 377 DNA automated DNA sequencer  - diagram  
 
 
3.8.3. DNA SEQUENCING USING MEGABACE DNA 
SEQUENCING SYSTEMS 1000 AND 4000 (AMERSHAM 
BIOSYSTEMS) 
 
DNA samples were all sequenced using BigDye Terminator chemistry and resolved 
on the MegaBACE 1000 and 4000 Sequence Analyzer. The instrument is a 96-
capillary array fluorescence-based DNA sequencer with interchangeable filter sets, 
confocal detection, and NT workstation. It automates gel matrix replacement, sample 
injection, DNA separation, and data analysis; uses a linear polyacrylamide separation 
matrix; and has a turnaround time of 2 hr per run. Minimal sample loading volume is 
5 µL and the samples are introduced into the system in a 96-well format. Read lengths 
was excess of 800 bp. 
 
 
 
 
 
 
  
Figure 16. MegaBace4000 DNA sequencer. 
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3.8.4. DNA SEQUENCING WITH THE ABI 3730XL 
AUTOMATED SEQUENCER (APPLIED BIOSYSTEMS) 
 
For pARK2 and IHE3034 BAC11 the ABI 3730xl DNA Analyzer was used. All 
inserts from shotgun library were sequenced using BigDye Terminator chemistry and 
run on ABI 3730xl DNA Analyzer. The ABI 3730xl uses a 96-capillary 
electrophoresis system that creates a sensitive detection system, long sequence reads 
(up to a 1000 bases for high quality DNA). The instrument is an automated system 
(sample loading, separation matrix preparation, and sequence analysis), which 
coupled with the facility's liquid handling robot, dramatically reduces the introduction 
of human error. 
 
 
3.9.  RAW DATA PROCESSING  
 
Sequences were processed first with Phred and Pregap4, assembled into contigs by 
using Phrap assembling tool and edited with Gap4, witch is a part of the Staden 
package software (http://staden.sourceforge.net/). [34, 35] 
 
 
3.9.1. PHRED – BASE-CALLING SOFTWARE WITH QUALITY 
INFORMATION 
 
Phred reads DNA sequencer trace data, calls bases, assigns quality values to the bases, 
and writes the base calls and quality values to output files. Phred can read trace data 
from SCF files and ABI model 373 and 377 DNA sequencer chromate files, 
automatically detecting the file format. After calling bases, Phred writes the 
sequences to files in either FASTA format, the format suitable for XBAP, PHD 
format, or the SCF format. Quality values for the bases are written to FASTA format 
files or PHD files, which can be used by the Phrap sequence assembly program in 
order to increase the accuracy of the assembled sequence. 
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3.9.2. PREGAP4 - PREPARING SEQUENCE TRACE DATA FOR 
ANALYSIS OR ASSEMBLY 
 
Before entry into a Gap4 database the raw data from sequencing instruments needs to 
be passed through several processes, such as screening for vectors, quality evaluation, 
and conversion of data formats. Pregap4 is used to pass a batch of readings through 
these steps in an automatic way. It provides an interface for setting up and configuring 
the processing and for controlling the passage of the readings through each stage. The 
separate tasks are termed "modules" and a dedicated program typically manages each 
module. Pregap4 wraps all of these modules into a single easy to use environment, 
whilst maintaining the flexibility to select and extend the processing modules.  
 
3.9.3. PHRAP - SEQUENCE-ASSEMBLY PROGRAM 
 
Phrap ("phragment assembly program", or "phil's revised assembly program") is a 
program for assembling shotgun DNA sequence data. Some of its key features are: (1) 
allows use of entire read, not just highest quality part; (2) uses a combination of user-
supplied and internally computed data quality information to improve accuracy of 
assembly in the presence of repeats; (3) constructs contig sequence as a mosaic of the 
highest quality parts of reads, rather than a consensus. Phrap does not provide editing 
or viewing capabilities; these are available with consed or phrapview 
(http://www.phrap.org). 
 
3.9.4. GAP4 - A GENOME ASSEMBLY AND EDITING PROGRAM 
 
The program contains all the tools that would be expected from an assembly program 
plus many unique features and a very easily used interface. [36] 
Gap4 is very big and powerful tool: performs assembly, contig joining, and assembly 
checking, repeat searching, experiment suggestion, and read pair analysis and contig 
editing. Has graphical views of contigs, templates, readings and traces which all scroll 
in register. Contig editor searches and experiment suggestion routines use Phred 
confidence values to calculate the confidence of the consensus sequence and hence 
only identify places requiring visual trace inspection or extra data.  
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3.10.  SEQUENCE ANALYZE  
 
3.10.1. ORF FINDING  
 
Initial gene prediction was accomplished using a YACOP program. The predictions 
generated by this tool are based on the output of existing gene finding programs. In 
present YACOP supports the boolean combination of predictions from Critica105b 
(with wublast2), Glimmer2.02 or Glimmer2.10 (with RBSfinder), Orpheus (with dps) 
and ZCurve1.0. The current version is realized in Perl (v.5.6.1). [37] The output was 
verified and edited manually using criteria such as the presence of a ribosome-binding 
site (consensus Shine-Delgarno sequence for prokaryotic organisms: 5’AGGAGG3’) 
and codon usage analysis. This was done with an Artemis - free genome viewer and 
annotation tool that allows visualization of sequence features and the results of 
analyses within the context of the sequence, and its six-frame translation. 
www.sanger.ac.uk/Software/Artemis) 
 
 
 
3.10.2. ANNOTATION 
 
Automatic annotation was done using the ERGO tool (Integrated Genomics, Inc., 
http://www.integratedgenomics.com). The predictions were verified and modified 
manually by searching derived protein sequences against public nucleotide or protein 
domain databases such as GenBank or PFAM, respectively. All software and 
databases are listed in Table 10. 
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TABLE 11. SOFTWARE AND DATABASES USED FOR AN ANNOTATION 
PROGRAM DESCRIPTION 
Basic Local Alignment Search Tool (BLAST) is a program for rapid searching 
of nucleotide and a protein database developed at NCBI, and is instrumental in 
identifying genes and genetic features. Sequence alignments provide a 
powerful way to compare novel sequences with previously characterized genes. 
Both functional and evolutionary information can be inferred from well-
designed queries and alignments.  
BLAST 2.0 
http://www.ncbi.nlm.nih.gov/BLAST
Clusters of Orthologous Groups of proteins (COGs) were delineated by 
comparing protein sequences encoded in complete genomes, representing 
major phylogenetic lineages. Each COG consists of individual proteins or 
groups of paralogs from at least 3 lineages and thus corresponds to an ancient 
conserved domain. [38] 
COGs 
http://www.ncbi.nlm.nih.gov/COG  
Protein Families database of alignments and HMMs (Pfam) is a large collection 
of multiple sequence alignments and hidden Markov models covering many 
common protein domains and families. For each family in Pfam you can: ook 
at multiple alignments, view protein domain architectures, examine species 
distribution, follow links to other databases, view known protein structures. 
[39, 40] 
Pfam 
http://pfam.wustl.edu/hmmsearch.shtml , 
http://www.sanger.ac.uk/Software/Pfam  
It is a database of protein families and domains. It consists of biologically 
significant sites, patterns and profiles that help to reliably identify to which 
known protein family (if any) a new sequence belongs. [41] 
PROSITE 
http://ca.expasy.org/prosite/  
The LipoP 1.0 server produces predictions of lipoproteins and discriminates 
between lipoprotein signal peptides, other signal peptides and n-terminal 
membrane helices in Gram-negative bacteria. [42] 
LipoP 1.0 
http://www.cbs.dtu.dk/services/LipoP/  
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SignalP 3.0 server predicts the presence and location of signal peptide cleavage 
sites in amino acid sequences from different organisms: Gram-positive 
prokaryotes, Gram-negative prokaryotes, and eukaryotes. The method 
incorporates a prediction of cleavage sites and a signal peptide/non-signal 
peptide prediction based on a combination of several artificial neural networks 
and hidden Markov models. [43] 
SignalP 3.0 
http://www.cbs.dtu.dk/services/SignalP  
Dense Alignment Surface (DAS) - prediction of transmembrane alpha helices 
in prokaryotic membrane proteins. [44] 
DAS 
http://www.sbc.su.se/~miklos/DAS  
Prediction of Transmembrane (Tmpred) regions and orientation  - program 
makes a prediction of membrane-spanning regions and their orientation. The 
algorithm is based on the statistical analysis of TMbase, a database of naturally 
occurring transmembrane proteins. The prediction is made using a combination 
of several weight-matrices for scoring. [45] 
TMpred 
http://www.ch.embnet.org/software/TMPRED_form.html  
 
 
 
3.11. DETECTION OF PKS TOXIN-PRODUCING ESCHERICHIA COLI 
ISOLATES BY PCR SCREENING 
 
3.11.1. PCR SCREENING FOR THE POLYKETIDE-PAI (ASNW) 
IN DIFFERENT E. COLI ISOLATES  
 
In order to investigate the occurrence of the identified PKS cluster in an E. coli strain 
collection PCR screening was applied.  
A total of 185 isolates (Table 12) were subjected to PCR assay. Based on a conserved 
region within the PKS cluster of the 536 sequence eight pairs of primers were 
designed (Table 13). Bacterial strains were grown on agar plates at 37ºC overnight. 
Samples were collected from plates and resuspended in 500 µl of sterile water and 
boiled for 5 min.1 µl of the lysate was used as template DNA in a 20-µl PCR. PCR 
was performed, using eight  pairs of primers to amplify 1.4 to 2.4 kb fragments. The 
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amplification programme consisted of 30 cycles of 30 seconds at 94ºC, annealing for 
30 seconds at 55ºC for and a 2-minute extension at 72ºC with a final extension at 
72ºC. The PCR products were separated in a 1.7% agarose gel. Electrophoresis was 
performed in 0.5 X Tris-borate-EDTA buffer for 1 h at 100 V. Amplicons were 
visualized with UV light after the agarose gel had been soaked in ethidium bromide 
solution (0.5 µg/ml) for 15 min. 
 
TABLE 12. BACTERIAL STRAINS USED FOR PCR SCREENING 
STRAIN SEROTYPE DESCRIPTION 
MG1655 K12 Laboratory strain 
EcoR50 O2:HN UPEC (Gr.D)* 
EcoR40 O7:NM UPEC (Gr.D)* 
EcoR48 ON:HM UPEC (Gr.D)* 
EcoR62 O2:NM UPEC (Gr.B2)* 
EcoR55 O25:H1 UPEC (Gr.B2)* 
EcoR60 O4:HN UPEC (Gr.B2)* 
EcoR14 OM:HN UPEC (Gr.A)* 
EcoR71 O78:NM UPEC (asymptomatic bacteuria) (Gr.B1)* 
2980 018ac:K5:H- UPEC 
AE5 NS UPEC 
2A1 NS UPEC 
2A2 NS UPEC 
3B5 NS UPEC 
3N1 NS UPEC 
3N2 NS UPEC 
3N5 NS UPEC 
5A1 NS UPEC 
5A1U NS UPEC 
8B2 NS UPEC 
8F4 NS UPEC 
16A3 NS UPEC 
16B1 NS UPEC 
19B1 NS UPEC 
A284 NS UPEC 
764 O18:K5:H5/11 UPEC 
764-2 O18:K5:H5/11 UPEC 
J96 O4:K-:H5 UPEC 
J96-M1 O4:K:H5 UPEC 
E-B35 O4:K12:H5 UPEC 
AD110 O4:K6 UPEC 
CFT073 O6:H1:K2 UPEC 
RZ411 O6:K-:H1 UPEC 
RZ532 O6:K-:H31 UPEC 
RZ479 O6:K+:H- UPEC 
RZ451 O6:K+:H31 UPEC 
RZ-436 O6:K13:H1 UPEC 
RZ422 O6:K14:H- UPEC 
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RZ505 O6:K14:H- UPEC 
536 O6:K15:H31 UPEC 
RZ454 O6:K2:H- UPEC 
RZ-458 O6:K2:H1 UPEC 
RZ-443 O6:K5:H- UPEC 
RZ-495 O6:K5:H- UPEC 
RZ-439 O6:K5:H1 UPEC 
RZ-441 O6:K5:H1 UPEC 
RZ-468 O6:K5:H1 UPEC 
RZ-475 O6:K5:H1 UPEC 
RZ-500 O6:K5:H1 UPEC 
RZ-525 O6:K5:H1 UPEC 
RZ-526 O6:K5:H1 UPEC 
RZ-446 O6:K53:H1 UPEC 
20A1 NS UPEC 
20A1U NS UPEC 
20A2 NS UPEC 
22B2U NS UPEC 
7521/94-1 NS UPEC 
2E2U NS UPEC 
3D5 NS UPEC 
13A1 NS UPEC 
1G1U NS UPEC 
1H1 NS UPEC 
1H1U NS UPEC 
19A1 NS UPEC 
1G1 NS UPEC 
2E1U NS UPEC 
16A-2U NS UPEC 
4405/1 NS UPEC 
S5 NS UPEC 
8B1 NS UPEC 
100. NS UPEC 
RB9 NS (Sheep) 
HK8 269/93 NS Sepsis (blood culture) 
HK24 10413/93 NS Sepsis (blood culture) 
HK1 NS Sepsis (Blood culture) 
HK8 NS Sepsis (Blood culture) 
AC/I O78 Sepsis (Avian) 
HK4 NS Sepsis 
HK17 NS Sepsis 
HK19 NS Sepsis 
HK25 NS Sepsis 
E642 NS Sepsis 
HK54 NS Sepsis 
B616 NS Sepsis 
HK2 NS Sepsis 
E457 NS Sepsis 
IHE3036 O18:K1:H7 NBM 
IHE3080 O18:K1:H7 NBM 
IHE3034 O18:K1:H7/9 NBM 
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RS218 O18ac:H7:K1 NBM 
RS226 O18ac:H7:K1 NBM 
RS176 O7:K1: H /3 NBM 
B13155 NS NBM 
Ve1140 NS NBM 
Ve239 NS NBM 
BK658 O75:K1:H7 NBM 
B10363 NS NBM 
DSM6601 (Nissle 1917) O6:K5 Faecal isolate 
EcoR52 O25:H1 Faecal isolate (Orangutan) (Gr.B2)* 
EcoR07 O85:HN Faecal isolate (Orangutan) (Gr.A)* 
EcoR58 O112:H8 Faecal isolate (Lion) (Gr.B1)* 
EcoR31 O79:H43 Faecal isolate (Leopard)  (Gr.E)* 
EcoR16 ON:H10 Faecal isolate (Leopard)  (Gr.A)* 
EcoR42 ON:H26 Faecal isolate (Gr.E)* 
EcoR43 ON:HN Faecal isolate (Gr.E)* 
EcoR35 O1:NM Faecal isolate (Gr.D)* 
EcoR51 O25:HN Faecal isolate (Gr.B2)* 
EcoR53 O4:HN Faecal isolate (Gr.B2)* 
EcoR54 O25:H1 Faecal isolate (Gr.B2)* 
EcoR56 O6:H1 Faecal isolate (Gr.B2)* 
EcoR59 O4:H40 Faecal isolate (Gr.B2)* 
EcoR61 O2:NM Faecal isolate (Gr.B2)* 
EcoR63 ON:NM Faecal isolate (Gr.B2)* 
EcoR01 ON:HN Faecal isolate (Gr. A)* 
EcoR57 ON:NM Faecal isolate (gorilla) (Gr.B2)* 
EcoR32 O7:H21 Faecal isolate (giraffe) (Gr.B1)* 
EcoR23 O86:H43 Faecal isolate (Elephant)  (Gr.A)* 
EcoR25 ON:HN Faecal isolate (dog)  (Gr.A)* 
EcoR65 ON:H10 Faecal isolate (Celebese ape) (Gr.B2)* 
EcoR66 O4:H40 Faecal isolate (Celebese ape) (Gr.B1)* 
EcoR18 O5:NM Faecal isolate (Celebese ape)  (Gr.A)* 
EcoR28 O104:NM Faecal isolate  (Gr.B1)* 
EcoR24 O15:HN Faecal isolate  (Gr.A)* 
F18 NS Faecal isolate 
F18Col - NS Faecal isolate 
E351 NS Faecal isolate 
147/1 O:128:H- ETEC 
C9221a O6:K15:H16 ETEC 
E 1392/75 06:H16 ETEC 
E57  IMI775 O138:K81 ETEC 
H10407 O78:H11 ETEC 
 O149:K88 ETEC 
156A 055:H7 EPEC 
179/2 055:H6 EPEC 
182A NS EPEC 
37-4 055:H- EPEC 
E2348/69 O127:H6 EPEC 
12860 NS EIEC 
76-5 O143 EIEC 
EDL-7284 NS EIEC 
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78-5 NS EIEC 
4608-58 NS EIEC 
107-11 NS EIEC 
W7062 NS EIEC 
EDL-1284 O124:H- EIEC 
95004730 O111:H- EHEC 
2-45 NS EHEC 
2455/99 O128:H2 EHEC 
2576/97 O103:H2 EHEC 
2851/96 O103:H2 EHEC 
2905/96 O103:H2 EHEC 
2907/97 NS EHEC 
3115/97 O128:H2 EHEC 
3117/98 O128:H- EHEC 
3172/97 O128:H2 EHEC 
3574/92 O157:H7 EHEC 
3697/97 NS EHEC 
3978/91 O157:H- EHEC 
4356/96 O26:H- EHEC 
4417/96 O111:H- EHEC 
4797/97 O91:H- EHEC 
5291/92 O157:H- EHEC 
5714/96 O103:H2 EHEC 
5720/96 026:H11 EHEC 
6037/96 O111:H- EHEC 
6105/96 O26:H- EHEC 
6578/93 O157:H7 EHEC 
78/92 O111:H- EHEC 
86-24 O157:H7 EHEC 
9167/91 O157:H7 EHEC 
933W O157:H7 EHEC 
ED 147 O26:H11 EHEC 
ED142 O111 EHEC 
EDL-880 NS EHEC 
PIG E57 NS EHEC 
SF493/89 O157:H- EHEC 
189 NS EAggEC 
17-2 O3:H2 EAggEC 
7484/94 NS EAggEC 
DDC 4441 NS EAggEC 
5464/95 NS EAggEC 
DPA065 O119 EAggEC 
5477/94 O86:H7 EAggEC 
042 NS EAggEC 
TA109 NS (Rattus fuscipers) 
TA349 NS (Nyctophilus geoffroyi) 
TA024 NS (Sarcophilus harrisii) 
TA083 NS (Dasyurus geoffroii) 
ON, HN = non-typeable with standard antisera 
NM = non-motile strain NS = not serotyped * = 
EcoR phylogenetical group 
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All bacterial isolates were provided by prof. J. Hacker (Institut für Molekulare 
Infektionsbiologie, Würzburg, Germany) and were stored in 20% glycerol at –80°C. 
 
 
 
TABLE 13. PRIMERS USED FOR SCREENING 
PRIMER’S NAME (POSITION) SEQUENCE  5’Æ 3’ PRODUCT SIZE 
asnW-PAIleftend1 (784-803) aatcaacccagctgcaaatc 
asnW-PAIleftend2 (2588-2607) cacccccatcattaaaaacg 1824 bp 
asnW-PAIrightend1 (51940-51959) agccgtatcctgctcaaaac 
asnW-PAIrightend2 (53333-53352) tcggtatgtccggttaaagc 1413 bp 
ORF1907-1908.1 (6271-6290) tctgtcttggtcgcgttagtg 
ORF1907-1908.2 (8555-8574) tcagttcgggtatgtgtgga 2304 bp 
ORF1911-1912.1 (19912-19931) attcgatagcgtcacccaac 
ORF1911-1912.2 (22011-22030) taagcgtctggaatgcagtg 2119 bp 
ORF1913-1914.1 (29674-29693) cgcttcatcaacacgcttta 
ORF1913-1914.2 (31772-37191) cgcatcaggatgttctgcta 2118 bp 
ORF1915-1918.1 (36626-36645) tcatcgcaatttggatttca 
ORF1915-1918.2 (38861-38880) tgatgaacgtggcggtaata 2255 bp 
ORF1919-1920.1 (41353-41372) cctcgctaaagaaggtgacg 
ORF1919-1920.2 (43754-43773) accgttgactgtgatggaca 2421 bp 
ORF1920-1922.1 (50211-50230) attcgccctgatattgtcg 
ORF1920-1922.2 (52651-52670) ccttcgttggcagattgatt 2460 bp 
 
 
 
3.11.2. IDENTIFICATION OF HEMOLYSIN-PRODUCING E. COLI 
ISOLATES 
 
 
Culture of bacteria on blood agar (BAP) for the purpose of hemolysis classification 
was performed for overnight at 37°C in the presence of 5% CO2. Hemolysis indicates 
a zone of clearing in the blood agar in the area surrounding a bacterial colony.  
 
 
3.11.3. MAMMALIAN CELL LINE GROTH CONDITIONS 
 
 
HeLa cells were cultured in MEM (Minimal Essential Medium) supplemented with 
10% of FCS, glutamine and non-essential amino acids.  
Adherent cell lines will grow in vitro until they have covered the surface area 
available or the medium is depleted of nutrients. At this point the cell line was sub-
cultured in order to prevent the culture dying. Before splitting, cultures needed to be 
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viewed using an inverted microscope to assess the degree of confluency (cells should 
be passaged after reaching 70-80% confluency) and confirm the absence of bacterial 
and fungal contaminations.  
 
For splitting of HeLa cells, medium was removed, cells were treated with pre-warmed 
to 37°C 0.05% trypsin /0.02% EDTA in PBS (1 ml per 25 cm2 of surface area) until 
they no longer adhered to the plate (approximately 5 min of incubation at 37°C). The 
side of the flask could be gently tapped to release any remaining attached cells. 
Trypsin/EDTA was removed; cells were resuspend in 5 ml of fresh and pre-warmed 
to 37°C MEM medium to inactivate the trypsin. Required number of cells (dilution 
1:10 or 1:20) was transferred to a new-labeled flask containing pre-warmed medium.  
Cells were grown at 37°C, 5% CO2, 95% humidity and splited every 3-4 days.  
 
 
3.11.4. TOXIN ACTIVITY ASSAYS 
 
For the toxin activity assay eukaryotic cells were seeded into 96-well plates (Falcon) 
and incubated in MEM medium overnight at 37°C.  Prior to the start of the toxin test 
the MEM medium was exchanged to 150 µl DMEM medium. 10 µl of overnight 
culture (OD600 = 0.6) were added to confluent monolayer cells per well and incubated 
for 3.5 h at 37°C in a 5% CO2 and 95% air atmosphere. After this time cells were 
washed two times with the EBSS buffer and once with MEM medium containing of 
gentamicin (100 µg/ml). Fresh MEM medium with gentamicin was added. Cells were 
grown at 37°C, 5% CO2, 95% humidity and controlled after 24-48 hours.  
Assay for each isolate was conducted in quadruplicate and was independently 
repeated at least three times. Toxin effect was viewed using an inverted microscope.  
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4. RESULTS 
 
 
4.1. GENOME PROJECT E. COLI 536 
 
The uropathogenic Escherichia coli strain 536 (O6:K15:H31), isolated from                   
a patient with acute pyelonephritis, is one of the model organisms of extraintestinal  
E. coli.  
In an attempt to analyze the genetic basis of urovirulence the entire genome         
of strain 536 were sequenced and compared to the genome sequence of strain CFT073 
(O6:K2:H1), another well-studied highly virulent uropathogenic E. coli (UPEC) 
strain, as well as to the genomes of non-pathogenic MG1655 (K12) and 
enterohemorrhagic strain EDL933 (O157:H7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Bladder epithelial cell with adherent uropathogenic E. coli strain 536 cells (www.uni-
wuerzburg.de/) 
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4.1.1. SEQUENCING 
 
4.1.1.1. SHOTGUN STRATEGY 
 
According to the whole genome shotgun 
(WGS) sequencing approach, developed by 
Sanger, the entire DNA was first randomly 
broken into fragments (usually about 1-3 kb) 
and subcloned into the cloning vector 
pCR4Topo (Figure 18) or pTZ19R. 
 
 
 
 
Figure 18. pCR4Topo vector used for shotgun library preparation.  
 
 
Three shotgun libraries were used: two small insert libraries (DNA sheared using a 
nebulizer and partially digested DNA with AluI enzyme) and a large insert library 
(cosmide library provided by U. Dobrindt).  The small insert library was used for 
random shotgun sequencing and the cosmide library for gap closure and finishing 
procedures. In the first shotgun sequencing phase a number of 45800 sequence reads 
were generated using universal forward and reverse primers, which directed 
sequencing from within the cloning vector into the inserts. Subsequently, these 
sequence reads have been assembled into contigs by exploiting sequence overlaps 
(Figure 22). A contig is a set of overlapping sequence reads. The sequence reads in a 
contig can be summed to form a contiguous consensus sequence, which corresponds 
to the length of the contig. Sequencing strategy is illustrated in Figure 19. 
 
 
 
 
    pCR4 
     Topo 
         3.9 kb 
Blunt-endred genomic 
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Covalently bound topoisomerase I 
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Figure 19. Shotgun strategy 
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4.1.1.2. RAW SEQUENCE PROCESSING AND ASSEMBLY 
 
Lander and Waterman suggested that the number of times a base is sequenced follows 
a Poisson distribution. [46] There are two key assumptions they made. First, reads are 
randomly distributed in the genome, and second the ability to detect an overlap 
between two truly overlapping reads does not vary from clone to clone.  
 
 
 
 
 
 
Figure 20. Lander and Waterman formula; P – probability of any base being unsequenced, e – constant, 
e=2.718, N – number of clones, w – average read length in bp, and L – genome length  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21.The end of raw sequencing phase; In black: optimal progression (genome size 5 Mb, average 
reading lenth 650 bp), In bleu: observed progression 
 
0
250
500
750
1000
1250
1500
1750
2000
2250
2500
2750
3000
3250
3500
0 10.000 20.000 30.000 40.000 50.000 60.000
Sequences
G
ap
s
P = e –Nw/L 
Results 
 51
The formula was used to plan and predict the progression of a shotgun-sequencing 
project.  It helps to estimate the number of clones to be sequenced in order to get                    
a certain average coverage of each base. In the E. coli 536 project 42,400 readings 
were generated, which led to an average coverage of 5.9. 
In the assembly phase (Figure 22), all sequence reads were first compared to each 
other in order to identify overlapping parts. Identities between the sequences of 
different reads were noted, and these identities are used to align the sequences into 
sequence contigs. 739 contigs were obtained out of the first raw data processing 
event. 389 of them were bigger then 3 kb, and the predicted genome size was 
4,880,500 bp.  
 
 
 
 
 
 
 
 
 
 
Figure 22. Assembly steps 
 
 
4.1.1.3. EDITING AND GAP CLOSING 
 
The first stage of the editing and gap-closing phase is resolving of misassembly 
problem.  Misassemblies are caused by several factors, detailed below. 
 
 Assembly problems: 
- repetitive elements 
- clone gaps (cloning bias): 
 missing large insert clones 
 missing small insert clones 
One was taken and compared to all other 
(until each sequence was tested) 
 
 
 
Information of best alignment (depending on thresholds) 
was kept 
 
 
Targets were reconstructed from best alignment 
 
 
Assembled sequence 
Sequence fragments 
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 unclonable sequences 
 low coverage (the coverage can be defined as the average number 
of times any given base in the genome is sequenced) 
- sequencing gaps (sequencing bias): 
 homopolymeric runs 
 high GC regions 
 inverted repeats 
- chimeric clones 
 
First all misassemblies were localized in all contigs bigger than 3 kb, disassembled 
and reassembled manually. An example of a misassembly is shown below (Figure 
23). The gap4 Contig Editor is designed to allow rapid checking and editing of 
characters in assembled readings. The figure 23 shows a screendump from the Contig 
Editor that contains segments of improperly aligned readings; this misassembled 
region was identified manually during the finishing phase. Disagreements between the 
consensus and individual base calls are shown in green. Notice that these 
disagreements are not in poor quality base calls (reads a. and f. on a picture have got a 
based confidence more then 80%). 
 
 
 
 
  
 
 
 
 
 
Figure 23. An example of misassembly. The gap4 Contig Editor window: the bottom line gives the 
contig sequence (consensus), and above it are the read sequences (a.-f.). Along the top of the editor 
window is a row of command buttons and menus. The background grey scale indicates base quality, 
with the highest quality being white and the lowest quality black. (*) A pad that is inserted by Phrap to 
align reads that have insertions and deletions. Disagreements between the consensus and individual 
base calls are shown in green. 
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spanned gap    unspanned gap 
BACs 
 CONSENSUS 
READINGS 
CONTIG 1 CONTIG 2 CONTIG 3 
Sequence reads with direction Paired plasmid end reads: 
          Belong to one contig 
     Belong to different contigs    
            (spanning clone) 
4.1.1.3.1. STRATEGIES FOR CLOSING SEQUENCE GAPS  
 
Gap closing was a challenging phase in the sequencing project, in particular since 
genome assemblies were complicated by the presence of repeat elements (like rRNA 
operons), insertion sequences and other similar factors that contribute to sequence 
misassemblies. In order to close the gaps a contig order was established. Several, 
described below, strategies were used to achieve that.  
Generally speaking, there are two main types of gaps. One type of gaps is spanned 
(captured) by one or more plasmid read pairs (at least one clone spanning the gap).  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Anatomy of sequence assembly (described in details in a text above). Arrows represent 
reads, lines connecting arrows represent plasmid insert, line colour code: red – forward, reverse reads 
in a proper distance in one contig, yellow – forward, reverse reads belong to separate contigs, blue – 
missing complementary read, light green – complementary read belongs to not depicted contig.    
 
The second type is unspanned (uncaptured) gaps (Figure 24). In case of spanned gaps 
(contig 1 and contig 2 on Figure 24) the order and the orientation of the contigs were 
easily established. Unspanned gaps (contig 2 and contig 3, Figure 24.) gave no 
information about the adjacent contigs, or about the DNA spanning the gap. Contigs 
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separated with unspanned (physical) gaps were usually spanned by PCR on genomic 
DNA using primers from each end of the contigs and the PCR products could then be 
sequenced to close the gaps. 
 
4.1.1.3.1.1. STRATEGY FOR CLOSING THE GAPS IN A 
SEQUENCE – GAP4   
 
One of the most effective ways of contig ordering and gap filling was the usage of 
linking clones. The terminal sequences (from either end of the insert) of linking 
clones belong to different contigs. Mate pair analysis permitted to identify clones that 
bridge two contigs. Mate pairs are the two end sequences from one single clone; in the 
assembly they must point towards each other. Contigs were linked, if the orientation 
of the sequences and the distance to the end of the contig were compatible with the 
size of the insert.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Contig order according to Gap4 program. Arrows represent reads, lines connecting arrows 
represent plasmid insert, line colour code: red – forward, reverse reads in a proper distance in one 
contig, yellow – forward, reverse reads belong to separate contigs, blue – missing complementary read, 
light green – complementary read belongs to not depicted contig.    
Spanning 
clones 
  (all yellow    
bridges) 
contigs 
Designed primers
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The Gap4 program was used for the detection of bridging clones. When they were 
available, gaps were closed by primer walking. Figure 25 shows an example of 
linking 9 contigs.  
The larger the insert the more likely a clone will be a linking one. Therefore a large 
insert library is essential for gap closure. 
 
 
4.1.1.3.1.2. PRIMER WALKING 
 
Primer walking is the method of designing internal primers in order to "walk" along 
the DNA template. The DNA of interest was either a plasmid insert or a PCR product. 
Sequencing by primer walking is an effective strategy for the complete sequence 
determination. When the sequencing DNA fragment was between 1,5 to 5 kb series of 
sequencing reaction were performed. In this case, initial sequence data, obtained using 
the first pair of primers, was a base for designing the next primers. This process was 
repeated to complete the sequence of the entire DNA fragment. 
After the first round of gap closing and primer walking in the genome project 243 
contigs were obtain, 128 of them bigger then 3 kb.  
 
 
4.1.1.3.1.3. STRATEGY FOR CLOSING THE GAPS IN A 
SEQUENCE – LARGE FRAGMENT LIBRARY 
(COSMIDS) 
 
 
The assembly of the complete genome was largely facilitated due to the availability of 
a large clone library. It helped in the gap closure phase, allowed to cope with repeat 
sequences, and permitted to validate the genome assembly. 290 BAC (Bacterial 
Artificial Chromosome) readings were assembled. The BAC library was provided by 
Melanie Emmerth (Institut für Molekulare Infektionsbiologie der Universität 
Würzburg). Contigs number 2 and 3 (Figure 24.) show an example where it is 
possible to link two contigs without having spanned clones.  The BAC library - 
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derived sequence pairs allowed the mapping of the corresponding clone onto the 
existing contigs. The contig order was confirmed by PCR.  
 
 
4.1.1.3.1.4. STRATEGY FOR CLOSING THE GAPS IN A 
SEQUENCE – MUMMER SOFTWARE 
 
It is well known that the organization of genetic information is conserved between 
closely related species. This phenomenon was exploited to increase the efficiency of 
gap closing.  
The MUMmer system is useful for aligning whole genome sequences, whether in 
complete or draft form. [47] The system finds all maximal, unique, matching 
sequences (MUMs), extracts the longest possible set of matches that occur in the same 
order in both genomes and can be used for contigs ordering.  
Previously described strategies led to 18 contigs bigger then 10 kb. Finally, 18 contigs 
from the shotgun sequencing project were aligned to the related genome of    E. coli 
CFT073 using MUMmer. This alignment allowed to order contigs (Figure 26a); it 
also revealed major differences between these two genomes, especially with regard to 
the location and content of four major E. coli 536 pathogenic islands as well as 
CFT073 specific clusters (phage regions, pathogenic islands and other) (Figure 26). 
Primer walking strategy was applied to confirm the contig order which were shown 
by MUMmer comparison plots 
At that stage of the project it was possible to estimate the extent of genome syntheny- 
by whole genome DNA alignment. Few genome sequences were used for genome 
alignments: E. coli K12 (NC_000913), E. coli O157:H7 EDL933 (NC_002655),       
E. coli O157:H7 (Sakai) (NC_002695), Shigella flexneri 2a (NC_004337), Salmonella 
typhimurium LT2 (NC_003197), and Salmonella enterica subsp. enterica serovar 
Typhi Ty2 (NC_004631). Figure 27. 
 
The comparison confirmed the conservation of organization of genetic information, 
detected numerous large-scale inversions in bacterial genomes, and also indicated 
“hot-spot” rearrangement loci, where gene transfer could have occurred (pathogenic 
islands loci).  
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Figure 26. Dot-plot alignment of 18 contigs of E. coli 536 to a chromosome of   E. coli CFT073:          
a. random order; b. order according to E. coli CFT073 genome with identified major differences. 
Aligned segments are represented as dots. This alignment was generated by the MUMmer an open 
source package. 
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Figure 27. Between-species whole genome DNA alignment. Plot of maximally unique matching 
subsequences (MUMs) between genomes as identified by the MUMmer program. A dot indicates a 
DNA sequence that occurs once within each genome, at location x in one genome and y in the other 
genome. The matching sequences may occur on either the forward (red dots) or the reverse (green dots) 
strand. 
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4.1.1.3.2. REPEATS – ASSEMBLY PROBLEMS  
 
Repetitive sequences frequently caused troubles in genome assembly. Defining the 
unique flanks and mate pairs permitted to unravel the assembly problem, which can 
be either a misassembly or a gap. Figure 28 illustrates the anatomy of repeat 
misassembly and the way of problem solution.  
  
Figure 28. Misassembly caused by repeat. a. identification of unique and repeated sequences; b. mate 
pair analysis; c. identification of misassembled clones (dark blue); d.  PCR amplification in order to 
prove the sequence. Arrows represent reads and lines bridges between reads: red – forward, reverse 
reads in a proper distance in one contig, light green – complementary read belongs to not depicted 
contig.    
Left unique flank               REPEAT              Right unique flank 
a. 
Left unique flank               REPEAT              Right unique flank 
b.
Left unique flank               REPEAT              Right unique flank 
c. 
Primer
d.
Left unique flank               REPEAT              Right unique flank 
Primer 
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When the specific readings were identified (readings which definitely belongs to this 
genome region; Figure 28b; violet and dark green marked clones), it was possible to 
disassembly all incorrectly joined sequences (Figure 28c; dark blue readings). 
Depending o the gap size, primers walking sequencing reactions were performed. In 
case of a gap within a repeat, the procedure was the same (identification of the unique 
sequence and mate pair analysis and the and of contigs). 
The best examples of those kind problematical regions are rRNA operons. The E. coli 
genome carries seven rRNA (rrn) operons. A single rRNA operon contains three 
rRNA genes: 16S, 23S and 5S. Genes encoding transfer RNA (tRNA) are located in 
the internally transcribed spacer (ITS) region. The ITS is 355 bp in length. Figure 29 
shows a schema of rRNA operon. Assembler program joins all readings within rRNA 
operon producing misassembly and preventing a proper consensus sequence 
obtaining.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Typical rRNA operon (a.), sequencing strategy (primer walking steps) (b.), and template 
display from Gap4 program (c.) 
 120 bp 1543 bp 2904 bp 
16S 
Promoter 
16S 23S  5S 
Spacer 
region 
16S unique flank 5S unique flank 
a.
c. 
b.
Forward primer Reverse primer PCR products  
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4.1.1.3.3. EDITING OF CONSENSUS SEQUENCE 
 
Gap4, the contig building software, takes into account the "quality" of each base in a 
read (where quality represents the confidence that the base has been called correctly) 
and can display the trace files. Regions of insufficient sequence quality (base 
confidence lower then 65%) were identified and solved using primer walking 
techniques and additional sequencing reactions. A better way of displaying the 
accuracy of bases is to shade their surroundings so that the lighter the background the 
better the data. In the figure above, this grey scale encoding of the base accuracy or 
confidence has been activated for bases in the readings and the consensus. The Figure 
30 shows a typical display from the contig editor.  
 
 
 
 
 
 
 
 
 
 
 
Figure 30. Contig Editor (greyed section represents the currently displayed segment; intensity of the 
color indicates each base confidence) with traces (a.); high and (b.) c. low quality. The bottom line of 
the Contig Editor gives the contig sequence (consensus), and above it are the read sequences. 
 
c.
b.
a.
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4.1.2. SEQUENCE ANALYZING  
 
4.1.2.1. ORF FINDING 
 
All possible open reading frames ORFs have to be identified. Automatic ORF 
prediction was accomplished using the YACOP program. The correctness of the 
predicted protein inventory might be insufficient, especially for regions with a very 
high GC content (like pathogenic islands). Furthermore, the gene finder has generated 
many false positives ORFs. The output was verified and edited manually using 
criteria such as the presence of a ribosome-binding site, codon usage analysis and 
sequence homology analysis. 4,687 ORFs were identified.  
 
 
4.1.2.2. ANNOTATION  
 
A microbial genome sequence alone is only raw data – it needs to be interpreted in 
order to be of any scientific significance. The process of predicting the function of all 
possible coding sequences (genes) in a genome sequence is known as annotation. 
Although an annotated genome sequence provides a large amount of important 
information it is still merely a starting point for characterizing an organism. 
Automatic function annotation was done using the ERGO tool (Integrated Genomics, 
Inc., http://www.integratedgenomics.com).  
Manual annotation was done to evaluate the validity of automatic function 
assignments. All predicted ORF’s   were verified and modified manually by searching 
derived protein sequences against public (translated) nucleotide or protein domain 
databases such as GenBank or PFAM, respectively. All software and databases are 
listed in Table 10. Manual annotation confirmed full-length sequence homology to 
avoid problems resulting from partial, distant, or mistaken sequence homology. In 
case of partial sequence homology, it ensured that only functions related to the 
homologous region are transferred. It ensured that the function assigned to the 
homologous protein was experimentally validated and not the result of an incorrect 
function prediction. In addition, manual annotation identified and annotated complex 
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genetic, biochemical, and physiological data, e.g. signal transduction cascades, 
metabolic pathways, transcription units.  
 
For each ORF there were three possible results: 
− clear sequence homology indicating function 
− blocks of homology to defined functional motifs (these should be confirmed 
experimentally) 
− no significant homology or homology to proteins of unknown function 
 
Many of the ORFs identified could not be assigned to a specific function based on 
homology. These ORFs were divided into two categories: 
− conserved hypothetical proteins – ORFs with no homology to proteins of 
known function but with significant homology to unidentified ORFs of other 
species (these ORFs are therefore functionally conserved across numerous 
species and may represent  components of central metabolism and others that 
have not yet been identified. The more universal the distribution of these 
ORFs the more likely they have a fundamental role in cellular processes) 
− hypothetical ORFs – ORFs without homologues – these are ORFs that have no 
homology to any known sequences – these may represent genes related to 
more specific traits of the organism  
 
On one hand, function prediction is an advantage as many of the predicted functions 
turn out to be correct. On the other hand, function prediction can be a disadvantage. 
Although many of the predicted functions are correct, a significant fraction of the 
predicted functions is incorrect. The most prominent problem is overprediction of 
function based on partial, distant, or mistaken sequence homology. Overprediction or, 
more precisely, overly specific prediction, occurs during automathed transfer 
functional information from unreliable best hit. Far-reaching similarity is necessary to 
make similarity-based annotation sufficiently reliable. For enzymes it is often 
impossible to predict the specific substrates. The problem is enhanced, as most 
databases do not permit to discriminate between experimentally validated and merely 
predicted functions. Incorrectly predicted functions, once added to the database, will 
be further propagated to homologous sequences. 
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4.2.    THE 536 GENOME SEQUENCE  
 
4.2.1. GENERAL FEATURES 
 
Eventually, the genome sequence of Escherichia coli human pyelonephritis isolate 
536 was completed and would be compared to other completely sequenced E. coli 
genomes. The genome was sequenced with a six-fold coverage. The 45,800 sequence 
runs were assembled. The general properties of the sequenced E. coli genomes are 
shown in Table 14.  
 
 
TABLE 14: GENERAL FEATURES OF E. COLI 536 COMPARED TO OTHER SEQUENCED         
E. COLI STRAINS 
 536 CFT073 MG1655 EDL933 EDL933 Sakai [48] 
 O6:K15:H31 O6:K?:H1 K12 0157:H7 0157:H7 
CHROMOSOME 
LENGTH, BP 4,938,875 5,231,428 4,639,221 5,528,445 5,498,450 
PLASMIDS - - - - 
pO157 
(92,721) 
pOSAK1 
(3,308) 
DNA CODING 
SEQUENCE (%) 88 89 89 88 88 
ORFS 4,747 a 5,533  (5,379 a) 4,411 5,361 5,981 
G+C CONTENT 50.5% 50.5% 50.8% 50.5% 50.5% 
tRNA GENES 82 88 87 100 103 
rRNA GENES 22 22 22 22 22 
PREDICTED 
MISC. RNAS B 45 51 47 52 13 
BACKBONE (%) A 77 71 81 67 n.d. 
STRAIN SPECIFIC 
ORFS (%) 
374 
(8) 
867 
(16) 
406 
(9) 
1270 
(24) n.d. 
PROPHAGES 1 5 10 13 24 
a using the ORF prediction program YACOP b using the Rfam database (http://www.sanger.ac.uk/rfam) 
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Figure 31: Genetic map of the chromosome of E. coli 536. The inner circle represents all putative 
genes, depending on ORF orientation. The next circle gives the scale. The fourth circle shows the G+C 
distribution. Thereby, regions with a highly aberrant G+C content (above or below two-fold standard 
deviation) are highlighted in red. The most outer circles show the results of a three-way genome 
comparison with the genomes of CFT073 and MG1655: in blue, backbone genes found in all three 
organisms; in red, genes present in 536 and CFT073 but absent from MG1655; in green, genes found in 
536 only; in orange, genes of 536, which are present in CFT073 but located within a different genomic 
region. Pathogenic islands (PAIs) are highlighted; flanking tRNAs are given in brackets 
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The single circular chromosome of E. coli 536 is composed of 4,938,875 bp. The 
whole chromosome encodes 4,747 putative genes, no extrachromosomal plasmid was 
found.  The genome of strain 536 contains only one cryptic prophage region, which 
harbours among structural phage proteins several DNA modification enzymes, such 
as recombinases and nucleases, as well as an outer membrane porin.  
From analyses of the G+C variation throughout the genome it became apparent that 
divergences from the mean G+C content (50.5%) were found often in genomic 
regions, which were not present in strain MG1655. These regions include already 
known PAIs (pathogenic islands) as well as smaller clusters, which are often flanked 
by mobile elements. (Figure 31) 
 
In order to visualize the differences in E. coli genomes sequenced so far a four-way 
comparison was done (Figure 32), revealing a highly mosaic genome structure. It is 
apparent that genomic differences are not exclusively linked to the presence or 
absence of large PAIs. Instead, also the distribution of smaller gene clusters seems to 
confer strain-specific traits.   
 
4.2.1.1. INSERTION ELEMENTS 
 
Insertion sequences (IS) are mobile genetic elements, usually less than 2.5 kb in size, 
that are widely distributed in the genomes of most bacteria. IS elements are 
commonly defined as carrying only the genetic information related to their 
transposition and its regulation, in contrast to transposons that also carry genes 
involved in other functions (e.g., antibiotic resistance). IS activities cause mutations, 
promoting genetic diversity and sometimes adaptation. They are suggested to be 
involved in chromosomal rearrangements including the incorporation of foreign 
DNA. 
Seven types of IS elements were found in the 536 genome (Figure 32) (IS Finder; 
http://www-is.biotoul.fr/. [49] Interestingly, the 536 genome possess less IS in 
comparison to other pathogenic strains as well as laboratory strain MG1655 (Figure 
33). Table 15 shows a list of found IS for five complete E. coli genomes. Most of 536 
IS belong to the IS3 and IS21 families.  
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Figure 32. Distribution of IS found in the 536 E. coli genome. The inner circle gives a scale, The most 
outer circles show the results of a three-way genome comparison with the genomes of CFT073 and 
MG1655: in blue, backbone genes found in all three organisms; in red, genes present in 536 and 
CFT073 but absent from MG1655; in green, genes found in 536 only; in orange, genes of 536, which 
are present in CFT073 but located within a different genomic region. 
 
 
 
 
 
 
 
 
 
 
Figure 33. Total number of IS elements present in E. coli genomes – comparison.  
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One of the largest families of ISs is the IS3 family, which is widely distributed in both 
Gram-negative and Gram-positive bacteria. All E. coli genomes encode several types 
and a significant copy number of IS elements belongs to this family.   
This is in contrast to IS21 distribution. Although members of the IS21 family are 
widespread, they have been found in RP4, in Shigella sonnei, various clinical isolates 
of E. coli, in the EHEC plasmid p0157, flanking a high pathogenicity island in                  
Y. pestis Y. pseudotuberculosis, and in the Y. pestis virulence plasmid pCD1, but they 
are absent from the genome of both 0157:H7 and MH1655 strains. [49] UPEC strains 
differ significantly in number of IS21 copies. There are 13 copies in the 536 genome 
and 7 in case of CFT073. ISSfl18 and ISEc1 were found only in the 536 genome 
 
 
TABLE 15. IS FAMILY MEMBERS [COPY NUMBER] IN E. COLI GENOMES. 
Total number of copies is indicated between square brackets together with those that are only 
partial copies, indicated by a lower case "p". 
IS FAMILY MG1655 
O157:H7 
EDL933 
O157:H7 
SAKAI 
536 CFT073 
IS1 1[7] 1 [2] 1[4/2p] 0 1[1/1p] 
IS110 0 0 1[1/1p] 1[2] 1[1] 
IS1111 0 0 0 1[1] 0 
IS200* 0 0 0 0 19 
IS21 0 0 0 2[13/3p] 2[7] 
IS256 0 0 1[4/3p] 0 0 
IS3 5[16] 3[39/13p] 5[44/6p] 4[12/2p] 6[15/3p] 
IS30 1[4] 1[1] 1[4/3p] 0 1[1] 
IS4 2[4] 1[1/1p] 1[1/1p] 1[2/2p] 1[3/2p] 
IS5 1[11] 0 0 0 0 
IS605 0 1[4] 1[3] 0 0 
IS630 0 1[2/2p] 0 0 1[1] 
IS66 0 0 0 1[2/1p] 1[4/1p] 
ISAS1 0 0 0 1[1] 0 
ISNCY 0 0 1[1/1p] 0 0 
* In the case of IS200 only orfA is present.
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4.2.2. COMPARATIVE GENOMICS  
 
The genome sequence of 536 was searched for putative genes: 4,747 coding 
sequences were predicted. The four-way comparison revealed 3650 (77%) 
“backbone” genes, which have highly similar orthologues in MG1655 (Figure 33 and 
Figure 35). These “backbone” genes are present in all E. coli strains and are 
essentially co-linear. However, the backbone sequence is interrupted by numerous 
segments of strain-specific DNA, bearing features of genomic islands, mobile 
elements or phages (Figure 33, 35).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Linear DNA sequence comparison of whole genomes of E. coli 536  (1.) MG1655 (2.), and 
CFT073 (3.). Red blocks represent corresponding regions with a high similarity (98% or more). White 
spaces indicate strain differences   
 
 
1. 
2. 
3. 
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Figure 35. Four-way comparison of E. coli genomes. The most inner ring represents all putative genes 
of the genome of strain MG1655, the second and third rings show all ORFs of the uropathogenic 
strains 536 and CFT073, respectively. The most outer ring represents the ORFs of the genome of 
EDL933 (For simplicity reasons the genome of the Sakai strain has been left out). Larger islands are 
named according to their flanking tRNA genes.  In grey, genes present in all four genomes (E. coli 
backbone); in green, light blue, dark blue, dark yellow, genes specific to the respective genome; in red, 
genes specific to both uropathogenic strains; in pink, genes present only in the three pathogenic strains; 
in orange, genes present only in MG1655 and EDL933; in yellow, others (e.g. genes present in two 
genomes only). Abbreviations: pp, prophage (smaller prophages in MG1655 are not named), PAI, 
pathogenic islands 
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From the remaining ORFs, 563 are present also in CFT073, which means that 90% of 
all ORFs of E. coli 536 have got highly similar orthologues in the genome of CFT073 
(Figure 35.). The remaining 472 ORFs are located mainly within a region of a cryptic 
prophage and within the major PAIs. 374 of these ORFs are strain 536-specific, 
whereas the remaining 100 ORFs have orthologues in the genome of EDL933. 
 
The comparative analysis shown, that genomic differences are not exclusively linked 
to the presence or absence of large PAIs. Apart from the large pathogenic islands, 
other regions within the genome of E. coli 536 were identified, which are absent from 
MG1655. Table 19 summarizes the location and functional category of some genes or 
gene clusters found in such regions. Generally speaking, the majority of the regions 
encode proteins, which have either an implication on the provision or modification of 
cell membrane/surface components; putative virulence factors like adhesins or are 
involved in specialized metabolic activities (sugar utilization systems, mechanisms 
involve in pH homeostasis). Discussed below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Occurrence of homologous ORFs in E. coli MG1655, 536, CFT073 and EDL933.  
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Colour code: in grey, genes present in all four genomes (E. coli backbone); in green, light blue, dark 
blue, dark yellow, genes specific to the respective genome; in red, genes specific to both UPEC strains; 
in pink, genes present only in the three pathogenic strains; in orange, genes present only in MG1655 
and EDL933; in yellow, others (e.g. genes present in two genomes only).  
 
 
Comparative genomics with the known E. coli genome sequences revealed a lower 
number of 536-specific genes (374 OFRs) than in the cases of other sequenced E. coli 
genomes. Moreover, we could identify a number of genes present in all pathogenic 
strains; a large fraction of genes is present only in the UPEC strains. (Figure 33, 35, 
36) The genome comparison of three pathogenic and one non-pathogenic strain of     
E. coli revealed only 92 genes, which are present exclusively in all three pathogenic 
E. coli. These genes, arranged in small gene clusters that are scattered around the 
genome, can be classified in several heterogeneous functional categories such as 
transport (35 genes), iron acquisition (17), drug resistance (5), DNA modification (4), 
and others. No main virulence determinants are among these proteins. Rather, they 
seem to have an implication in improving the pathogens’ fitness with respect to e.g. 
utilization of additional nutrients. Apparently, no broad ‘pathogenic backbone’ has 
evolved in disease-causing E. coli isolates. 
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4.3. SEQUENCING AND ANALYSIS OF PLASMID pARK2 
ENTEROTOXIGENIC ESCHERICHIA COLI STRAIN 2173 
 
4.3.1. INTRODUCTION 
 
Enterotoxigenic Escherichia coli strains (ETEC) are the major cause of diarrhoeal 
diseases in humans and newborns and weaned piglets. ETEC produce enterotoxins.  
Several types of E. coli enterotoxins have been characterized [50]: 
- Heat-stable enterotoxins (ST): 
o Heat-stable enterotoxin I (ST-I). There are two slightly different toxins 
under this designation: ST-Ia and ST-Ib. Both have a molecular weight 
of around 2000, are resistant to 100°C for short times, resistant to 
proteolytic enzymes, as well as resistant to acids. ST-Ia and ST-Ib 
share a sequence motif of 11 amino acids but differ in their N-terminal 
sequences. Six cysteine residues are involved in disulfide bridges. 
They are antigenically related. ST-I production is under control of the 
catabolite repression, being optimally produced in the absence of 
glucose. ST-I binds to a heterogeneous group of glycoprotein receptors 
on the brush borders of intestinal epithelial cells. The genes for ST-I 
are generally plasmid-encoded, often associated with genes for 
fimbriae, drug resistance and colicinogeny. While porcine, bovine                
and human ETEC produce ST-Ia only human isolates produce ST-Ib in 
addition. 
o Heat-stable enterotoxin II (ST-II). The mechanism of action of this 
48amino acid long peptide with two disulfide bonds is at present not 
known. Although ST-II causes observable fluid responses in an 
experimental mouse model, the production of ST-II appears restricted 
predominantly to porcine ETEC, with occasional reports of ST-II 
producing strains isolated from humans with diarrhoea. The ST-II 
genes are generally plasmid-encoded and often found to be associated 
with genes for ST-I and the heat-labile enterotoxin LT. 
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- Heat -abile enterotoxins (LT) 
 
o Heat-labile enterotoxin I (LT-I) is the best studied heat-labile 
enterotoxin and often referred to as just LT. LT is an oligomeric 
protein of about 88kDa comprising one A subunit of 30kDa above                 
a central aqueous channel formed by the five B subunits each 11.5 kDa 
in size. The doughnut-shaped B pentamer is a very stable structure. 
Two disulfide bonds, which are part of the B subunit structure, are an 
integral part of the molecule. The A and B subunits are synthesized 
separately. The A subunits are required for the formation of the B 
pentamer, which also requires the disulphide bonds of the B subunits. 
The last four residues of the C-terminal sequence of the A subunit are 
essential for the stability of the final toxin. Protein assembly occurs in 
the periplasmic space from pre-A and pre-B subunits, separately 
transported across the cytoplasmic membrane. Iron starvation and the 
presence of bile salts and trypsin in the concentrations normally 
present in the intestine stimulate the release of LT from E. coli. While 
the structural genes of LT-1 are on plasmids, chromosomally encoded 
proteins may affect levels of expression. These plasmids additionally 
harbour resistance factors to antimicrobial agents as well as genes 
coding for the adherence factors associated with ETEC. There is a 
strong homology between LT and cholera toxin (CT), suggesting that 
the LT genes were derived from Vibrio cholerae. LT-I and CT are also 
closely related immunologically. 
 
o Heat-labile enterotoxin II (LT-II): There are two serologically 
distinguishable variants LT-IIa and LT-IIb. Both are not neutralised by 
anti-CT or anti-LT-I. Structurally, LT-II is similar to LT-I but its 
receptors are slightly different. The enzymatic activity of LT-II is 
similar to LT-I. Structural genes for LT-II are located on the 
chromosome and have been detected in E. coli isolates from human 
and bovine sources. 
 
Results 
 75
 Many ETEC strains have fimbrial structures on their surface, whose genes are, like 
the ones for LT, ST enterotoxins, plasmid-mediated. These fimbriae are termed 
colonization antigens (K88, K99, F41 and P987), and enable the bacteria to colonize 
the epithelial surface of the small intestine. 
The complete DNA sequence of plasmid pAKR2 of ETEC strain 2173 is presented 
here. Plasmid pARK2 is a result of a transposition experiment with the wild-type 
plasmid pTC used as a “transposition-donor” plasmid and vector pACYC177 (AmpR, 
KmR, p15ori) – recipient. [51] Plasmid pTC (sta+, stb+, TetR) was isolated from strain      
E. coli 2173 (O147, STa+, STb+, F18ac+). E. coli 2173 is the representative strain of 
porcine post weaning enterotoxigenicity. 
 
 
4.3.2. SEQUENCING OF THE PARK2 PLASMID 
 
To sequence the pARK2 plasmid, the same shotgun approach was used as in the case 
of the E. coli 536-genome project. The DNA was first randomly broken into 
fragments using the nebulizer technique and size fractioned by sucrose density 
gradients in the range of 1.0 to 4.0 kb. Purified, end repaired fragments were 
subcloned into the cloning vector pCR4Topo (Figure 18) forming a random library. 
Sequencing data were collected on ABI 3730xl sequencer.  The 1914 sequence runs 
were assembled and the resulting contigs were ordered. Remaining gaps were closed 
using PCR-based methods. The plasmid was sequenced with a 9-fold coverage. 
 
 
4.3.3. SEQUENCE ANALYZING 
 
4.3.3.1. ORGANIZATION AND PHYSICAL PROPERTIES 
 
The complete sequence of the 88,480 bp E. coli 2173 pARK2 plasmid was 
deciphered. Figure 36 represents a circular representation of the pARK2 genome. The 
sequence was searched for potential open reading frames: 104 ORFs were identified, 
most of them are encoded on the same DNA strand. The coding regions account for 
Results 
 76
83.6% of the plasmid. Analysis of base composition showed the G+C content of the 
plasmid is 51%, which is a little higher than in E. coli 536 (50.5%).  pARK2 
comprises  a mosaic structure of potential pathogenesis-associated genes, IS elements, 
maintenance genes, transfer genes and unknown ORFs.  
 
Plasmid pARK2 consists of two large distinct regions. The first is 71.7 kb large and is 
essentially homologous to the non-R-determinant region of plasmid R100, except of 
several point mutations and a few insertion elements (hypothetical elements 
RARK0008, RARK0009, RARK0010) and the plasmid stability inheritance proteins 
StbA and StbB (RARK0087, RARK0086). This region includes transfer genes, the 
origin of replication and genes involved in plasmid maintenance and stability.   
The second region is 16.7 kb in size, which is an extended version of the previously 
described 10 kb fragment designated toxin-specific locus (TSL) [2]. TSL carries the 
sta and stb genes encoding heat-stable enterotoxins. Interestingly, in contradiction to 
previous data the distance between sta and stb genes was established as 9,570 bp and 
not 4,047 bp. The previously determined TSL locus is disrupted by a 5,523 bp IS 
coding region (TSL1 and TSL2 on Figure 36). The whole TSL locus corresponds to a 
16,765 bp fragment consisting of 25 ORFs, five of which are hypothetical proteins 
with no significant homology to any known protein, two encode toxins and eighteen 
ORFs are known and newly identified insertion elements (IS Finder; http://www-
is.biotoul.fr/). [49] Directly downstream of the sta gene two IS elements were 
identified. Both belong to the well-known class IS21. One corresponds to IS640 from 
Shigella sonnei. The second is 98 % identical to IS21, which was first observed in the 
plasmid R68.45 as a direct duplication of a 2 kb fragment of the original R68 plasmid. 
It is involved in conduction of the bacterial chromosome and the pTi plasmid, via "co-
integrate formation", but also promotes adjacent deletions. Upstream of the sta gene, 
IS203, IS1 and three copies of IS91 were identified. IS1 is present in about 14% of the 
Salmonella strains tested but in more of 90% of E. coli. [52] IS91 produces both 
cointegrates (10-6) and simple insertions (10-4). IS91 always inserts with the same 
orientation into its specific targets. IS91 ORF is 36 % identical to that of IS801, and 
they are both related to the rolling-circle-type replication proteins of the pUB110 
family of plasmids, with which they share 4 conserved motifs. 
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Figure 36. Circular representation of the pARK2 genome. Outer ring depicts all identified ORFs, color-
coded according to functional categories: yellow – IS elements (known IS indicated by additional 
yellow block above); orange – genes identical or with essentially similar to known proteins; red – 
toxins encoding genes; grey – ORFs with unknown function. Next five rings indicate regions with high 
(at least 95%) identity to selected plasmids: violet – R100 plasmid, green - pAPEC-O2-R, pale blue - 
Shigella flexneri large virulence plasmid pWR501, red – F plasmid, grey – pC15-1a. Next ring shows 
positions of origin of replication oriR, origin of transfer oriT and localisation of toxin-specific locus 
(pale pink) TSL1 and TSL2 (described in a text). The eighth ring is a scale bar (in base pairs). The 
most inner ring represents all ORFs with their orientations.  
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Directly upstream of the stb gene, a 92 aa polypeptide was predicted. This ORF 
(RARK0062) shows 96% (83/86) identity to IS1351, which belongs to IS3 family 
originally found in Salmonella enteritidis).  
 
 
4.3.3.2. ANNOTATION 
 
Of the 104 potential ORFs, 35 (34%) encode genes required for conjugation transfer 
(a 33 kb tra region). Figure 37 visualises functional classification of pARK2 ORFs.  
Twenty-two ORFs (21%) are IS elements. Together, twenty-four putative proteins had 
insufficient homology to known protein to be assigned a putative function. These 
constitute the unknown ORFs, of which 16 (15%) had significant similarity to 
conserved hypothetical ORFs, and 8 had no significant similarity to any proteins in 
the databases. They form a group of strain specific proteins of unassigned function 
(Table 16).  
 
In addition to well-characterized ORFs from the tra region, twenty ORFs (19% of 
pARK2 OFRs) showed significant homology to proteins of known function. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Functional classification of pARK2 ORFs.  
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TABLE 16. OFR OF UNKNOWN FUNCTION 
ORF POSITION FIRST 
CODON 
NO. 
OF 
AA 
ORGANISM OF PROTEIN TO WHICH MOST SIMILAR HOMOLOG PROTEIN EXTENT OF SIMILARITY 
RARK0004 3,927 - 4,499 gtg 191 E. coli, plasmid pC15-1a YefA 178/191 (93%) 
RARK0011 9,486 - 9,004 atg 161 Shigella flexneri, plasmid R100 YehA 108/125 (86%) 
RARK0012 9,787 - 10,080 atg 98 Shigella flexneri, plasmid R100 YeiA 98/98 (100%) 
RARK0013 10,194 - 11,012 atg 273 Shigella flexneri,  plasmid R100 32 protein 273/273 (100%) 
RARK0025 19,045 - 19,455 atg 137 Shigella flexneri,  plasmid R100 YfhA 137/137 (100%), 
RARK0026 19,451 - 19,921 atg 157 Shigella flexneri,  plasmid R100 YfiA 129/157 (82%), 
RARK0027 20,250 - 20,594 atg 115 Shigella flexneri, plasmid R100 YfiC 115/115 (100%), 
RARK0032 25,378 - 25,686 atg 103 Shigella flexneri,,  plasmid R100 YgeA 103/103 (100%), 
RARK0045 36,743 - 37,543 gtg 267 Shigella flexneri,  plasmid R100 YhfA 224/260 (86%), 
RARK0051 47,578 - 47,787 atg 70 Shigella flexneri, plasmid R100 YigA 70/70 (100%), 
RARK0053 48,789 - 49,376 atg 196 Shigella flexneri,  plasmid R100 YihA 173/173 (100%) 
RARK0057 51,949 - 52,215 atg 89 E. coli, plasmid pAPEC-O2-R YacA 85/89 (95%), 
RARK0061 55,031 - 55,396 atg 122 No homology   
RARK0066 57,310 - 57,597 atg 96 No homology   
RARK0076 64,715 - 65,041 gtg 109 No homology   
RARK0077 65,118 - 65,489 gtg 124 No homology   
RARK0084 70,285 - 71,469 atg 395 No homology   
RARK0088 74,397 - 75,320 atg 308 Salmonella typhimurium, plasmid pU302L  289/308 (93%), 
RARK0089 75,287 - 75,628 gtg 114 E. coli, plasmid pAPEC-O2-R  110/114 (96%), 
RARK0091 76,593 - 77,057 atg 155 Salmonella typhimurium, plasmid pU302L  143/144 (99%), 
RARK0092 77,111 - 77,884 atg 258 Shigella flexneri, plasmid R100 YchA 221/257 (85%), 
RARK0093 78,219 - 77,968 atg 252 E. coli, plasmid pAPEC-O2-R  28/46 (60%), 
RARK0095 78,772 - 79,191 atg 140 E. coli, plasmid pAPEC-O2-R  140/140 (100%), 
RARK0096 80,156 - 79,737 ttg 140 E. coli, plasmid pAPEC-O2-R  138/140 (98%), 
RARK0097 80,702 - 82,060 atg 453 Plasmid R100, pC15-1a, pAPEC-O2-R, pU302L YdbA 436/453 (96%), 
RARK0098 82,110 - 82,670 atg 187 Shigella flexneri,  plasmid R100 YdcA 187/187 (100%), 
RARK0099 83,220 - 82,762 atg 153 E. coli ,plasmid pC15-1a YddA 122/153 (79%), 
RARK0101 84,101 - 84,337 atg 79 Shigella flexneri,  plasmid R100 YdeA 79/79 (100%), 
Results 
Among proteins with an assigned function are those, which are involved in plasmid 
replication, stabilisation and maintenance:  
 
 Three ORFs (RARK0054, RARK0055, RARK0056) code for the replication 
regulatory protein RepA2, the replication initiation protein, and the RepA4 
protein, respectively. RepA2 protein is essential for plasmid replication; it is 
involved in controlling the plasmid copy number. Initiation of DNA 
replication requires the presence of a replication initiator protein and of a cis-
acting DNA sequence, the origin of replication (oriR). The binding of the 
initiator protein to oriR is the first step in DNA replication. The oriR of the 
pARK2 plasmid was proposed to lie within a 150-bp sequence located 339 bp 
downstream of the coding sequence of the replication initiation protein 
(RARK00055) and 27 bp upstream of RepA4 protein (RARK00056). Analysis 
of the origin of replication revealed that pARK2 belongs to the IncFII group of 
self-transmissible plasmids. Members of this incompatibility group include 
R1, R6-5, pC15-1a, pTUC100, pO157, p1658/97, pWR100, pAPEC-02-R and 
R100 plasmids. These plasmids have a low copy number of 2-5 plasmids per 
cell. 
 
 Additionally, the conserved genes psiB (RARK0005), which acts to inhibit 
induction of bacterial SOS stress response in conjugation, and ssb  
(RARK0100), which encodes a single stranded DNA binding protein   
required for bacterial DNA replication, were found. [53-56] Plasmid ssb and 
psiB genes are thought to function in bacterial conjugation, as their expression 
is controlled indirectly by fertility inhibition and their products accumulate in 
a transient burst in the conjugatively infected cell. 
 
 RARK0094 probably endodes the antirestriction protein KlcA, which could be 
involved in overcoming restriction barriers after conjugative transfer. 
 
 RARK0007 encodes the FlmC protein (F-plasmid maintenance protein C). 
[57] 
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 A locus, parB, which is necessary for the stable maintenance of the IncFII 
plasmid R1 was also mapped (RARK0102). Functional studies have shown 
that parB exerts plasmid maintenance by host killing of plasmidless cells. [58, 
59] The product, a 52–aa polypeptide, is a lethal membrane associated protein, 
which causes a loss of the membrane potential. 
 
 RARK0050 encodes the fertility inhibition protein (conjugal transfer 
repressor). This is one of the components on the finOP fertility inhibition 
complex, that inhibits the expression of traJ gene, which in turn regulates the 
expression of some 20 transfer genes. RNA-binding that interacts with the traJ 
mRNA and its antisense RNA, finP, stabilizing finP against endonucleolytic 
degradation and facilitating sense-antisense RNA recognition. 
 
 Several ORFs involved in plasmid stability were detected: ORFs RARK0058 
and RARK0083 are homologs to YacB. Plasmid stable inheritance proteins 
StbA and StbB (RARK0086, RARK0087) were also identified on plasmid 
pARK2. 
 
 RARK0090, a DNA methylase, is probably involved in protecting host DNA 
by its methylation against degradation by restriction enzymes. 
 
 Two toxin-encoded genes are present on pARK2: RARK0063 – Heat-stable 
enterotoxin II precursor (STII, enterotoxin B, ST-B) and RARK0078 – Heat-
stable enterotoxin ST-IA/ST-P – published previously [51]. 
 
 Among other ORFs of predicted function are: RARK0052 – endonuclease, and 
RARK0014 and RARK0049: protein with transglycosylase SLT domain and 
protein with alpha/beta-hydrolase domain, respectively.  
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4.1.1.1. TRANSFER REGION 
 
A block of genes located between sequences coordinates 12,135 bp and 52,215 bp is 
almost identical to known transfer genes (up to 98% identity). In pARK2, this block 
has got the same genetic organization as the corresponding genes on plasmid R100, 
pC15-1a, F plasmid, pAPEC-O2-R, p1658/97, raising the possibility that the entire 
region was acquired by horizontal transfer from R100 (Figure 38). Conjugative 
plasmids are important mediators for genetic transfer between prokaryotes. During 
bacterial conjugation, a conjugative plasmid directs transfer of a copy of itself, in 
single-stranded form, to a recipient cell. 
 
 
 
R100 plasmid F plasmid  
 
 
 
 
pAPEC-02-R 
p1658/97  
pARK2 
pC15-1a 
pARK2 
 
 
Figure 38. Linear DNA sequence comparison of plasmids pARK2 and F plasmid, R100, pC15-1a, 
p1658/97, pAPEC-02-R. Red and blue bars represent corresponding regions with a high similarity, 
98% or more (forward and reverse strand, respectively). 
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4.2. SEQUENCING AND ANALYSIS OF A POLYKETIDE SYNTHASE 
GENE CLUSTER (PKS-PAI (ASNW)) OF THE NEWBORN 
MENINGITIS ISOLATE  E. COLI IHE3034 
 
 
4.2.1. INTRODUCTION 
 
Escherichia coli is a normal inhabitant of the gut. However, certain variants of E. coli 
are able to cause either intestinal or extraintestinal infectious diseases. Extraintestinal 
E. coli pathogens include those, which are able to evoke urinary tract infections 
(UTIs), sepsis, and newborn meningitis (NBM). 
Bacterial meningitis is a major cause of neonatal mortality worldwide and is 
associated with a high incidence of neurological sequels. E. coli is the second 
common cause of bacterial meningitis in newborns after group B streptococci (GBS). 
[60] 
 
The pathogenesis of E. coli neonatal meningitis is characterized by high-level 
bacteremia following the penetration of the blood-brain barrier (BBB). [61-64] The 
capsular polysaccharide K1 is a virulence factor with a key role in the bacteremic 
phase. [65, 66] Other bacterial traits contribute to E. coli survival in serum and may 
thus be involved in the pathogenicity of MNEC isolates. These factors include iron-
uptake systems encoded by the loci iro [67,68] and chu [69], the siderophores 
aerobactin [70] and yersiniabactin [71-73], and other factors, such as hemolysin that 
may facilitate access to iron and or resistance to phagocytic cells. [74-76] Several 
specific virulence factors facilitate BBB penetration, such as K1 [77], fimbrial 
adhesin S (sfaS) [78-80], the invasin IbeA (ibeA) [81, 82], and cytotoxic necrotizing 
factor (cnf1). [83, 84] E. coli strains invade the blood stream of infants from the 
nasopharynx or GI tract and are carried to the meninges, layers of tissue covering the 
brain and spinal cord. 
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Most cases of E. coli meningitis occur in newborn babies and. E. coli causes between 
one-quarter and one-third of cases of meningitis in newborns, but less than 2% of 
cases of meningitis at all other ages. Almost all infections of newborns are caused by 
one type of E. coli, the K-1 strain. Like many other forms of bacterial meningitis, it 
affects in particular those with a suppressed immune system (removal of the spleen, 
cancer, organ transplants, AIDS, etc.). E. coli meningitis is treated with antibiotics, 
but, like all forms of bacterial meningitis, it is a life-threatening disease. 
 
 
4.2.2. PKS/NRPS 
 
Microorganisms make a wealth of unusual metabolites that have a secondary role in 
the organism's ontogeny, such as self-defence, competitive aggression, or 
communication, as a response to environmental challenges.  Such secondary 
metabolites are known to possess a wealth of pharmacologically important activities, 
including antimicrobial, antifungal, antiparasitic, antitumor, immunosuppressive and 
agrochemical properties. These metabolites are ubiquitous in distribution and have 
been reported from organisms as diverse as bacteria, fungi, amoeba, plants, insects, 
dinoflagellates, molluscs and sponges. The wide spectrum of acticvity of polyketides 
makes them economically, clinically and industrially the most sought-after molecules. 
The preliminary investigation of the meningitis-causing E. coli strain IHE3034 led to 
the hypothesis that it might secrete a PKS-derived compound, which has got a 
cytotoxic effect on eukaryotic cells (Dobrindt U., not published).  
A better understanding of the molecular pathogenicity of MNEC, especially which 
regard to the impact of secondary metabolites in disease formation, is necessary in 
orderto develop new preventive strategies. 
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4.2.3. SEQUENCING 
 
 
To sequence the IHE3034 BAC11 insert, the same shotgun approach was used as in 
the case of genome sequencing project of 536 E. coli. The DNA was first randomly 
broken into fragments using nebulizer technology and size fractionation was 
performed by applying a sucrose density gradient in order to obtain fragments in the 
range of 1.0 to 4.0 kb. Purified, end repaired fragments were subcloned into the 
cloning vector pCR4Topo (Figure 18) forming a random DNA library. Data were 
collected on ABI 3730xl sequencer.  The 1,300 sequence runs were assembled and the 
resulting contigs were ordered. Remaining gaps were closed using PCR-based 
methods. The plasmid was sequenced with a 9-fold coverage. 
 
 
4.2.3.1. SEQUENCE ANALYZING  
 
 
Essentially, the whole sequence of IHE3034 BAC11 insert was obtained and analysed 
(Figure 39). It is composed of 67,932 bp. The sequence was search for potential open 
reading frames. 41 ORFs were identified most of them are oriented in the same 
direction. Obtained protein-coding regions include the PKS-PAI associated with the 
asnW tRNA gene and 15 flanking ORFs. The PKS-PAI shows 99% identity on 
nucleotide level to the homologous region of the sequenced uropathogenic strains              
E. coli 536 and CFT073. Analysis of base composition showed the G+C content of 
the insert is 53,2%, which is higher than in the E. coli 536 whole genome (50,52%).   
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Figure 39. Linear representations of the IHE3034 BAC11 insert sequence. Red blocks 
represent all putative PKS genes, yellow – IS elements, grey – hypothetical proteins, green – 
tRNA gene, and dark blue – others. Put. – putative, Hyp. – hypothetical, DH - dehydrogenase 
 
 
 
 86
Results 
 
4.2.4. DETECTION OF THE POLYKETIDE-PAI (ASNW) TOXIN 
-PRODUCING ESCHERICHIA COLI ISOLATES BY PCR 
SCREENING 
 
In order to investigate the occurrence of the identified PKS cluster in an E. coli strain 
collection PCR screening was applied. A total of 185 isolates (Table 12) were 
subjected to PCR assay. Based on a conserved region within the PKS cluster eight 
pairs of primers were designed (Table 13). 
The PCR results demonstrated that 61 (33%) of 185 strains were PKS-positive (Figure 
40). Table 17 shows all tested strains carrying a PKS gene cluster. 
 
 
 
 
TABLE 17.  E. COLI ISOLATES CARRYING A PKS-PAI ACCORDING TO PCR RESULTS. 
STRAIN SEROTYPE PATHOTYPE COMMENTS 
HLY 
TEST 
DSM6601 O6:K5 Faecal isolate probiotic Nissle 1917 strain Hly- 
EcoR51 O25:HN Faecal isolate EcoR gr. B2; kps1,2; sfa1,2; pap1,2,3; hly2 Hly+ 
EcoR52 O25:H1 Faecal isolate EcoR gr. B2; kps1,2; sfa1,2; pap1,2,3; hly2, (orangutan) Hly+ 
EcoR53 O4:HN Faecal isolate EcoR gr. B2; kps1,2; sfa1,2; pap1,2,3; hly2 Hly+ 
EcoR54 O25:H1 Faecal isolate EcoR gr. B2; kps1,2; sfa1,2; hly2 Hly+ 
EcoR56 O6:H1 Faecal isolate EcoR gr. B2; kps1,2; pap1,2,3; hly2 Hly+ 
EcoR57 ON:NM Faecal isolate EcoR gr. B2; kps1,2; sfa1,2; pap1,2,3; hly2, (gorilla) Hly+ 
EcoR63 ON:NM Faecal isolate EcoR gr. B2; kps1,2; sfa1,2; pap1,2,3; hly2 Hly+ 
EcoR65 ON:H10 Faecal isolate EcoR gr. B2; sfa1,2; hly2, (Celebese ape) Hly+ 
F18 NS Faecal isolate fimA Hly- 
F18Col - NS Faecal isolate fimA Hly- 
536 O6:K15:H31 UPEC  Hly+ 
764 O18:K5:H5/11 UPEC  Hly+ 
2980 018ac:K5:H- UPEC  Hly+ 
16A-2U NS UPEC  Hly+ 
19A1 NS UPEC  Hly+ 
1G1U NS UPEC  Hly+ 
1H1U NS UPEC  Hly+ 
1H1 NS UPEC  Hly+ 
20A1 NS UPEC  Hly+ 
20A1U NS UPEC  Hly+ 
20A2 NS UPEC  Hly+ 
22B2U NS UPEC  Hly+ 
2E1U NS UPEC  Hly- 
2E2U NS UPEC  Hly- 
7521/94-1 NS UPEC  Hly+ 
764-2 O18:K5:H5/11 UPEC  Hly- 
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CFT073 O6:H1:K2 UPEC  Hly+ 
EcoR55 O25:H1 UPEC EcoR gr. B2; kps1,2; pap1 Hly- 
EcoR60 O4:HN UPEC EcoR gr. B2; sfa1,2; pap1,2,3; hly2 Hly+ 
J96 O4:K-:H5 UPEC  Hly+ 
J96-M1 O4:K:H5 UPEC  Hly- 
RZ-411 O6:K-:H1 UPEC  Hly- 
RZ-422 O6:K14:H- UPEC  Hly+ 
RZ-439 O6:K5:H1 UPEC  Hly- 
RZ-441 O6:K5:H1 UPEC  Hly+ 
RZ-451 O6:K+:H31 UPEC  Hly+ 
RZ-454 O6:K2:H- UPEC  Hly+ 
RZ-468 O6:K5:H1 UPEC  Hly+ 
RZ-475 O6:K5:H1 UPEC  Hly+ 
RZ-479 O6:K+:H- UPEC  Hly+ 
RZ-495 O6:K5:H- UPEC  Hly- 
RZ-500 O6:K5:H1 UPEC  Hly- 
RZ-505 O6:K14:H- UPEC  Hly+ 
RZ-525 O6:K5:H1 UPEC  Hly- 
RZ-526 O6:K5:H1 UPEC  Hly+ 
RZ-532 O6:K-:H31 UPEC  Hly+ 
BK658 O75:K1:H7 MENEC expresses F1A and F1B fimbriae and S/F1C-related fimbria  Hly+ 
IHE3034 O18:K1:H7/9 MENEC  Hly- 
B13155 NS MENEC  Hly- 
IHE3036 O18:K1:H7 MENEC  Hly+ 
IHE3080 O18:K1:H7 MENEC  Hly- 
RS218 O18ac:H7:K1 MENEC  Hly+ 
RS226 O18ac:H7:K1 MENEC  Hly+ 
B616 NS Sepsis  Hly- 
E642 NS Sepsis  Hly+ 
HK2 NS Sepsis  Hly- 
HK4 NS Sepsis  Hly+ 
HK54 NS Sepsis  Hly+ 
HK8 269/93 NS Sepsis  Hly+ 
HK24 10413/93    NS Sepsis  Hly+ 
 
hly (a-hemolysin), kps (type II capsule), sfa (S-type. fimbrial adhesin), 
pap (P-type fimbrial adhesin),  fim – fimbriae, NS = not serotyped, 
Last column:  Hly- non-hemolytic and Hly+ hemolylit isolate 
 
 
 
 
Of 70 UPEC strains, 36 (51%) were positive. The PCR was also successful in 
screening for the PKS cluster in faecal isolates (38%), and in meningitis and sepsis 
causing E. coli strains (46% in both cases).  So there is no conncetion between the 
occurence of the PKS-cluster to a special E. coli-caused disease.  
 
Tested E. coli isolates included 33 well-characterised isolates belong to EcoR 
collection (The Escherichia coli Reference Collection). [85] Ten of them were 
positive and all of these belong to theB2 phylogenetic group. [86] 
 88
Results 
Results show that polyketide-PAI (asnW) occurred only among extraintestinal strains. 
None of enteropathogenic, enteroinvasive, enterotoxigenic, enteroaggregative or 
enterohemorrhagic strains amplified the PKS-PAI (asnW) sequences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40. E. coli isolates possess a PKS-PAI according to PCR results (in red). 
 
 
4.2.5. IDENTIFICATION OF HEMOLYSIN-PRODUCING E. COLI       
ISOLATES 
 
Production of hemolysin can be plasmid or chromosomally determined. Haemolytic 
E. coli are frequently isolated from the faeces of normal pigs, and those with oedema 
disease or diarrhoea. Alpha-haemolysin is also frequently produced by strains isolated 
from cases of human urinary tract infections and other extraintestinal infections. It is 
produced early in the growth phase. It lyses erythrocytes from cattle, pigs, horses, 
rabbits, guinea pigs, chickens and humans, and acts as a pore-forming cytolysin, 
causing dissipation of transmembrane ion gradients, while retaining cytoplasmic 
proteins. Thus water moves into the cell as a result of the increased intracellular 
osmotic pressure, causing the cell to swell and finally burst. Ca2+ ions are required for 
proper haemolysin function. [87-89] Haemolysin affects not only erythrocytes but has 
cytocidal effects on a variety of cell types including HeLa cells.  
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A total of 61 PKS-PAI (asnW)-positive isolates were tested for hemolysin production:  
17 were established as non-hemolysin-producing isolates (Table 17). These strains 
were used for toxin activity assay.  
A total of 61 PKS-PAI (asnW)-positive isolates were tested for hemolysin production:  
17 were established as non-hemolysin-producing isolates (Table 17). These strains 
were used for toxin activity assay.  
 
 
4.2.6. TOXIN ACTIVITY ASSAYS 
 
The goal of this study was to gain first insight into the function of the PKS cluster. 
For this reason, the effect of potentially secreted compounds was examined on human 
cervix epithelioid carcinoma cells (HeLa cells). Initially, some control experiments 
with prepared genetic constructs were performed. All constructs were obtained from 
Stefan Homburg (Institut für Molekulare Infektionsbiologie der Universität 
Würzburg). 
HeLa cells were grown in Dulbecco's Modified Eagle Medium (DMEM) 
supplemented with 10% heat-inactivated fetal calf serum and glutamine. For 
cytotoxicity assays, cells were seeded into 96-well plates for 24 hours. Then 
monolayer cells were infected with overnight cultures: 
- MG1655 – laboratory strain – negative control – no effect was suspected; 
- IHE3034 – MNEC strain; 
- IHE3034∆PKS – IHE3034 mutant with deleted PKS genes cluster – again, no 
effect was suspected; 
- MG1655/IHE3034 BAC11 – effect would confirm, that cytotoxity activity is 
combine with a PKS genes cluster  
- J96-M1 – strain possessing a PKS-PAI and suspected to produce a PKS-toxin 
- J96-M1∆PKS – J96-M1 mutant with deleted PKS genes cluster – no effect 
was suspected; 
 
After 3.5 hour of co-incubation, the growth media were removed and cells were 
washed three times with washing buffer. Next, cells were grown at 37°C, 5% CO2, 
95% humidity and controlled after 24-48 hours. 
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The results of that experiment are shown on Figure 41. The remarkable effects on 
HeLa cells were observed in both suspected strains (IHE3034 and J96-M1) as well as 
in case of MG1655/IHE3034 BAC11 strain. The HeLa cells were significantly bigger. 
No toxic activity was detected, when PKS-PAI was deleted from the chromosome. 
PKS+ strains are those, which possess PKS-PAI and demonstrate morphologic 
changes in the HeLa cells. This results confirmed suspicions that PKS cluster encode 
a compound with modulatory activity on eukaryotic cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IHE3034∆PKS IHE3034 
MG1655 Control: non infected HeLa cells  
K12/BAC_PKS3034 
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             J96-M1                                                    J9696 M1∆PKS 
 
Figure 41. Assay of the toxicity of the E. coli isolates possess PKS-PAI to HeLa cells – preliminary 
test. Cells were photographed with the 40× objectives on a Nikon microscope that was fitted with a 
Nikon camera, after 48 h from co-incubation. Non-infected HeLa cells and cells infected with 
laboratory strain MG1566, as a negative control, showed no changes. Coincubation with strain 
IHE3034 and J96-M1 induced morphologic changes on HeLa cells. No change was observed in case of 
both PKS deletion mutants, when toxic effect was observed for K12/BAC_PKS3034 (laboratory strain 
with BAC clone possessing whole PKS cluster)  
 
 
 
TABLE 18. E. COLI STRAINS WHICH WERE TESTED FOR TOXIC ACTIVITY 
STRAIN PATHOTYP PHENOTYPE 
- non infected HeLa cells PKS-
MG1655 laboratory strain PKS-
536hly- * UPEC PKS-
EcoR55 UPEC PKS-
RZ-411 UPEC PKS-
F18 Faecal isolate PKS-
F18Col - Faecal isolate PKS-
IHE3080 MENEC PKS-
IHE3034∆PKS ** constructed PKS-
J96-M1 ∆PKS ** constructed PKS-
MG1655/IHE3034 BAC11** constructed PKS+
IHE3034 MENEC PKS+
B13155 MENEC PKS+
DSM6601 Faecal isolate PKS+
CFT073hly- *** UPEC PKS+
J96-M1 UPEC PKS+
2E2U UPEC PKS+
764-2 UPEC PKS+
RZ-439 UPEC PKS+
RZ-495 UPEC PKS+
RZ-500 UPEC PKS+
RZ-525 UPEC PKS+
B616 Sepsis PKS+
HK2 Sepsis PKS+
* Gabor Nagy 
** Stefan Homburg 
*** Ulrich Dobrindt 
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After this series of preliminary tests, all seventeen previously selected strains (Table 
18) were tested for polyketide-derived toxic activity. Within 48 hours after co-
incubation 11 (58%) PCR-positive strains showed the cytopathic effects, while 
control cells (infected with MG1655, as well as non infected HeLa monolayer calls) 
and six remaining strains showed a normal morphology (Figure 42). A correlation 
between pathotype and PKS-phenotype was not observed. Morphologic changes were 
found in 8 (42%) uropathogenic E. coli. Among the bacteria tested, both sepsis cause 
strains had an obvious effect, as well as two out of three MNEC isolates were PKS+. 
The citotoxity effect could be detected in one faecal- derived isolate, when two 
remaining had no obvious activity.  
 
 
MG1655 – negative control IHE3034 – positive control 
536hly- CFT073hly -
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F18 DSM6601 
F18Col- HK2 
IHE3038 B13155 
EcoR55 B616 
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RZ411 RZ500 
RZ495 RZ439 
2E2U  764-2 
 
 
Figure 42.  Assay of the toxicity of the E. coli isolates possess PKS-PAI to HeLa cells. Non infected 
HeLa cells (A.) and cells infected with laboratory strain MG1566 (B.), as a control, showed no 
changes, when toxic delivered effect were observed in case of strains: CFT073hly-, DSM6601, KK2, 
RZ500, RZ495, rz439, 3E2U and 764-2. No effects were observed after coinbubation with strains: 
536hly-, F18, F18Col-, and RZ411. Cells were photographed with the 40× objectives on a Nikon 
microscope that was fitted with a Nikon camera, after 48 h from co-incubation. 
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Interestingly, induced changes, which were detected, in some cases seemed to be 
clearer, more explicit. To determine the basis for the unexpected differences in 
morphology, 96-hours experiment was performed. After appropriate time of 
incubation (48, 72 or 96 h), the cells condition was controlled (Figure 43). Within 96 
hours after co-incubation, no changes were observed in case of non-infected cell and 
cells infected with laboratory strain MG1655 as well as all strains previously showing 
PKS- phenotype. Cells were able to grow and proliferate. However, differences in 
cytotoxic effect induced by PKS-derived toxin were still observable.  Only IHE3034-
infected cells were able to survive 96 hours after co-incubation. In the remaining 
cases apoptosis was observed within 72 hours after bacterial infection.  
 
In conclusion, of 19 E. coli strains, experiment successfully identified 13 positives 
isolates. The cytotoxicity assay with selected E. coli strains showed that the presence 
of the asnW-associated PKS island is not a guarantee for an effective secretion of PKS 
toxin. At the same time it was possible to prove that PKS gene cluster encodes a 
compound inducing morphologic changes on human cervix epithelioid carcinoma 
cells. The experiment showed that a polyketide-derived toxin causes cythopathicity 
and cell cycle arrest in HeLa cell culture.  
To further understand the function, these in vitro results obtained with cell culture 
must be expanded in conjunction with supporting or associated in vivo studies, 
biochemical analysis and assay with the isolated and characterized compound.  
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A. 
  Non infected  
 
 
 
 
 
B. 
  MG1655 
C. 
  IHE3034 
D. 
  K12/BAC_PKS 
E. 
 536hly- 
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F. 
 CFT073hly-  
 
 
G. 
  DSM6601 
H. 
  RZ-495 
 
 
Figure 43. Time-depending assay of the toxicity of the selected E. coli isolates to HeLa cells. Each row 
shows the same sample after 24, 48 and 96 hours, respectively. Non infected HeLa cells (A.) and cells 
infected with laboratory strain MG1566 (B.), as a control, showed no changes, when apoptosis were 
observed in case of strains: K12/BAC_PKS (D.), CFT073hly- (F.), DSM6601 (G.) and RZ-495 (H.) 
after 96 h. Coincubation with the 536hly- strain (E.) indicated no morphologic changes on HeLa cells. 
Coincubation with strain IHE3034 (C.) induced cell arrest but no apoptosis 96 hour after infection.  
Cells were photographed with the 40× objectives on a Nikon microscope that was fitted with a Nikon 
camera. 
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5. DISCUSSION 
 
 
Uropathogenic E. coli are intestinal commensals as well as pathogens of the urinary 
tract. Identification of genes specific to UPEC that permit replication, survival and 
disease in the urinary tract is critical to understanding their pathogenesis.  
The approach was to investigate loci common in UPEC strains, but missing in enteric 
pathogenic E. coli strains as well as laboratory MG1655 strain. 
 
 
5.1. INSERTION ELEMENTS 
 
The general characteristics and genetics of insertion sequence (IS) elements are well 
established. For E. coli IS elements, mechanism of transposition and mutation are 
known and their recombinogenic role in bacterial genome has been investigated. 
[90,91] In E. coli the IS elements are dispersed around the chromosome (also found 
on the pARK2 plasmid). Despite their widespread occurrence and potential for 
horizontal gene transfer, the observed distribution remains somehow enigmatic. 
Natural populations of E. coli harbour at least 20 classes of IS and are highly 
polymorphic with respect to their distribution and copy numbers. [92, 93] 
Most of the 536 IS elements are found within PAIs. However some are present 
outside of large pathogenic islands. 
 Six copies of IS1397 were found in the 536 genome (two in CFT073). IS1397 
elements are IS3 family members, which are specifically inserted into the loop of 
palindromic units (PUs). IS1397 is shown to transpose into PUs with sequences close 
or identical to the E. coli consensus, even in other enterobacteria (Salmonella enterica 
serovar Typhimurium, Klebsiella pneumoniae, and Klebsiella oxytoca). [94] 
Interesting is that there is no IS1397 element within PAIs and the localization of all 
IS1397 is always specific. In two cases significant differences in genetic organization 
were observed. In corresponding MG1655 regions additional metabolic pathways 
were found: the cyanate uptake system and 3 -phenylpropionate degradation operon.  
Cyanase is an inducible enzyme in E. coli that catalyzes bicarbonate-dependent 
decomposition of cyanate. It is encoded as part of an operon we have named the cyn 
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operon, which includes three genes in the following order: cynT (cyanate permease), 
cynS (cyanase), and cynX (protein of unknown function).Cyanate at concentrations of 
about 1 mM is toxic to strains of E. coli lacking the cyanase gene, but strains in which 
the inducible gene for cyanase is present can grow on cyanate as the sole source of 
nitrogen at concentrations as high as 20 mM. Uptake of cyanate involves the product 
of the permease gene in an energy-dependent process. It appears that the cyn operon 
has evolved to function in detoxification/decomposition of cyanate arising from both 
intra- and extracellular sources. [95] 
3-phenylpropionate degradation is one of only two aromatic-ring-cleavage pathways 
found in E. coli. That E. coli can degrade aromatic acids suggests a wider natural 
distribution for E. coli than the anaerobic environment of the animal gut. [96] 
However both systems are absent from E. coli 536 as well as CFT073.  
   
Although there is a significant number of IS100 elements (12 in whole genome) only 
three are encoded outside PAIs. The most obscure seems to be a presence of two 
IS100 elements (RECP02670, RECP02671) together with IS911 (RECP04737, 
RECP02673) within a 4-kb 536 specific sequence. This region encodes fourteen short 
ORFs showing no similarity to any known proteins. Interestingly one of the IS100 
element (RECP04681, RECP04682) disrupts phage integrase. This phenomenon 
occurs only in case of E. coli 536. Corresponding phage integrases from E. coli 
MG1655, CFT073 and 0157:H7 are not disrupted.  
 
There are 19 copies of IS200 in the CFT073 genome. IS200, the smallest known 
element, is confined to the salmonellae and several lineages of E. coli. However it is 
absent from the rest fully sequenced E. coli genomes.  
IS 200 is an insertion element abundant in the genus Salmonella [97] and sporadically 
found in strains of Shigella [98], Escherichia coli [99] and Yersinia [100] The 
chromosome of Salmonella typhimurium LT2 contains six copies of IS 200 [97, 101, 
102]; in other S. typhimurium strains the number of IS 200 copies ranges from 1 to 
>12 [98]. 
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The classes of IS detected within E. coli are generally not present in the species typed 
to Salmonella. In contrast to the situation in E. coli, a single class of element-IS200- 
has been recovered from S. typhimurium. A comprehensive analysis of all known 
IS200 (Beuzon et al., 1997) suggests a very low transposition frequency and supports 
the hypothesis that IS200 is an ancestral element of the Enterobacteriaceae. [103] 
 
 
 
5.2. VIRULENCE FACTORS 
 
5.2.1. PATHOGENIC ISLANDS 
 
 
About 450 genes of strain 536 are found in CFT073 but are absent from MG1655 as 
well as from EDL933. These genes represent candidates, which could be involved in 
generating and maintaining an urovirulent phenotype. Furthermore, about 370 genes 
of E. coli 536 (Figure 31) are absent from all E. coli genomes sequenced so far, 
indicating their implication in an E. coli 536-specific phenotype. Many of the genes of 
these two groups are organized in so-called pathogenic islands (PAIs), five of which 
have been previously identified and described in detail in E. coli 536. [104, 105] PAI 
I, II, III and V contain genes, which either are not found in strain CFT073, or which 
are located in similar islands located elsewhere on the genome of CFT073, whereas 
PAI IV is very similar in both uropathogenic strains. In the following, we will mainly 
focus on the description of island-like genomic regions (20 kb or bigger) outside of 
the large PAIs. Interestingly, four of such additional island-like regions can be 
detected in the vicinity of PAIs III and IV, designated PAIs IIIa, IIIb, IVa and IVb 
(Figure 31). They exhibit a different G+C content as compared to the core genome 
and are flanked by tRNAs and/or mobile elements – features, which have been found 
to be characteristic to pathogenic islands in a variety of E. coli strains and some other 
species. [106-109] 
 
 
 
 101
Discussion  
An island-like region is located upstream of PAI III, associated with a tRNA (aspV) 
as well as with a Rhs-element-like region (rearrangement hot-spots). This aspV-
associated island, designated PAI IIIa, is absent from CFT073 but present in the 
EDL933 genome. It encodes 28 proteins (RECP00217-245), most of which of 
unknown function. However, some proteins show similarity to virulence factors. For 
instance, a gene with strong similarity to icmF of Vibrio cholerae is present 
(RECP00220), an in vivo induced gene involved in the regulation of motility and 
adherence to epithelial cells. [112] This protein shows also significant similarity to 
IcmF of Legionella pneumophila, a protein belonging to the icm cassette responsible 
for macrophage killing and intracellular survival of the organism. [110] Another 
protein (RECP00234) is highly similar to Hcp, a 28-kDa secreted protein of Vibrio 
cholerae, which is regulated co-ordinately with the hemolysin HlyA. [111] Recently, 
a comparative in silico study was undertaken with 27 genomes containing icmF 
homologs. [114] A partially conserved gene cluster surrounding the icmF genes was 
identified in several genomes including Yersinia, Vibrio and Salmonella species, 
designated IAHP (IcmF associated homologous proteins) cluster. Gene composition 
and organization varies greatly among different species, indicating a strong genomic 
rearrangement. PAI IIIa of E. coli 536 can be regarded as a member of the IAHP 
cluster. Interestingly, a second IAHP-like cluster can be found within the genome of 
strain 536. This cluster (RECP02765-2793), designated PAI VI, is also associated 
with a tRNA (metV) and exhibits an aberrant G+C content. It is highly homologous to 
a metV-associated cluster in strain CFT073. [113] Like PAI IIIa, it encodes homologs 
of IcmF and Hcp. However, its gene composition and organization differs greatly 
from PAI IIIa. Furthermore, weak, if detectable, similarities of proteins of PAI IIIa to 
proteins of PAI IV indicate that these islands must have been acquired independently 
from different sources. It has to be shown if these two IAHP clusters in strain 536 
complement each other or represent independent systems, which may be involved in 
surface architecture or secretion.  [114] 
A few kb downstream of PAI III another island-like region (PAI IIIb) flanked by a 
phage integrase gene is found, which is present also in CFT073 but absent from other 
E. coli strains. Some putative virulence-associated genes are encoded here, such as an 
adhesion and a protein harbouring an autotransporter domain. 
The island PAI IV of E. coli 536, highly similar to a part of the so-called ‘high 
pathogenicity island’ of Yersinia species, encodes among others a system homologous 
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to the Yersiniabactin (Ybt) synthetase, an iron-chelating siderophore. [115, 116] Two 
of its proteins, HMWP1 (RECP01925) and HMWP2 (RECP01924), belong to the 
class of non-ribosomal peptide synthetases/polyketide synthases (NRPS/PKS), multi-
domain enzymes with 9 and 7 subunits, respectively ([117], Figure 32). Unlike in 
strain 536, both highly homologous ORFs in CFT073 are disrupted. This corresponds 
to findings, which have proven the absence of a Ybt-like siderophore in strain 
CFT073, in contrast to strain 536, which was tested Ybt-positive (Dobrindt, U., 
unpublished). Since iron acquisition is of crucial importance for bacterial growth in a 
mammalian host, this difference may also explain to a certain extent that virulence of 
strain 536 is higher compared to strain CFT073 when tested in the mouse model 
(Dobrindt, U., unpublished). 
 
 
Figure 44. Domain structure analysis of RECP01924 and RECP01925 E. coli 536 genes. HMWP1/P2 
are the main subunits of the Yersiniabactin synthetase of Y. pestis. The domain prediction programs 
PFAM and SEARCHPKS were used in combination. A, Adenylation domain (AMP-binding domain); 
ACP, Acyl/Aryl/Peptidyl carrier protein; AT, Acyltransferase; Cy, Cyclization/Condensation domain; 
ER, Enoyl reductase; KR, Ketoacyl reductase; KS, Ketoacyl synthase; MT, Methyltransferase (MT 
domains are weakly predicted by PFAM and SEARCHPKS); TE, Thioesterase 
 
 
 
Downstream of PAI536 IV a region could be identified, which is flanked by a phage 
integrase gene and associated with a tRNA gene (asnW). The region, designated 
PAI536 IVb, encodes several large proteins with a predicted molecular weight of up to 
350kDa, eight of which fall into the class of the above-mentioned NRPS/PKS. This 
class of enzymes has attracted special attention recently, due to their identification in 
the course of various genome-sequencing projects. [118] It has been shown that they 
are responsible for the synthesis of a variety of lipopeptides involved in, for instance, 
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intercellular communication, iron acquisition, competition or self-defence. [118-120] 
More details of this gene cluster will be discussed later.  
Further downstream of the NRPS/PKS genes several IS elements with truncated 
transposase genes are present as well as a siderophore system cluster composed of 
four genes (RECP01996-99). 
Examining the upstream region of PAI IV, a small island again flanked by a tRNA 
(serU) and a phage integrase gene is present, designated PAI IVa. Except of an ORF 
with similarity to a shufflon encoded on the plasmid R64 of E. coli, which is involved 
in the biological swhich for generating alternative type IV pili, PAI IVa contains 
mainly genes of unknown function. [121] 
 
 
 
5.2.2. SMALL GENE CLUSTER/SINGLE GENES SPECIFIC TO   
UROPATHOGENIC STRAINS 
 
 
Apart from the large pathogenic islands, other regions within the genome of E. coli 
536 were identified, which are absent from MG1655 and present/absent from other 
pathogenic strains. Table 19 summarizes the location and functional category of some 
genes or gene clusters found in such regions, they will be discussed here (for instance 
C1-C15 (C-gene cluster) marked on the Figure 33).  
Generally speaking, the majority of the regions encode proteins, which have either an 
implication on the provision or modification of cell membrane/surface components 
and putative virulence factors like adhesins or are involved in special metabolic 
activities (substrate uptake, sugar utilization systems, mechanisms involved in pH 
homeostasis, etc.). 
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TABLE 19: SELECTION OF GENES AND CLUSTERS OF E. COLI 536 NOT FOUND IN MG1655, 
WHICH ARE LOCATED OUTSIDE OF THE LARGE PAIS.  
CATEGORY ORF NUMBER FUNCTION  CFT 073 
EDL 
933 
RECP00109-113 colicin cluster (HNH endonuclease, immunity protein) +/- - 
RECP00361 putative adhesin/invasin + + 
RECP00374 putative autotransporter/adhesin + - 
RECP00423 putative autotransporter/pertactin  + + 
RECP00675 outer membrane protein + - 
RECP01198-1199 putative adhesins (fragment) + - 
RECP01227-1232 iron transport + + 
RECP01331-1335 drug resistance, transmembrane proteins + + 
RECP01379-1380 drug resistance efflux pump - - 
RECP01398 putative autotransporter/adhesin + - 
RECP01444-1445 Rhs/Vgr-family proteins + + 
RECP01846 flagellin (H31) - - 
RECP01855 outer membrane porin + - 
RECP01887 outer membrane porin  + - 
RECP01969 TonB-dependent outer membrane receptor + + 
RECP02038-2046, C2 O-antigen synthesis/modification + - 
RECP02343 outer membrane usher protein  + + 
RECP02476 outer membrane protein, RatA homolog (Salmonella) + - 
RECP02477 outer membrane protein, SinI homolog (Salmonella) + - 
RECP02478 putative invasin/intimin, SinH homolog (Salmonella)  + - 
RECP02897 outer membrane lipoprotein + + 
RECP03074-3079 iron uptake system + + 
RECP03142-3146, C3 fimbrial proteins  - - 
RECP03472-3481, C4 fimbrial proteins  + - 
RECP03558-3567 hemin transport system  + + 
RECP03664-3665 lipoprotein, putative autotransporter/adhesin + + 
RECP03682-3694, C1 LPS biosynthesis + - 
RECP03963 hemolysin-coregulated protein (Hcp) + - vi
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RECP04046  putative RafY-like glycoporin  + + 
RECP00690-697 membrane proteins/transporter; Fe-dehydrogenase + - 
RECP02352-2355, C5 sucrose utilization – PTS-independent system - + 
RECP02716-2720, C6 sucrose utilization – PTS-dependent system - - 
RECP02882-2887 putative ABC-type cobalt transport system + + 
RECP03056-3059 dehydrogenases + - 
RECP03060-3062, C15 C4-dicarboxylate transport system + - 
RECP03180-3183, C8 (N-acetyl)galactosamine utilization, PTS-dependent + + 
RECP03301-3308 putative galacticol/D-tagatose utilization  + - 
RECP03719-3726, C9 putative fructose utilization, PTS-dependent + - 
RECP03964-3983, C12 putative sugar utilization, carbamate kinase + - 
RECP04021-4028, C10 putative sugar utilization  + - 
RECP04033 lipase + - 
RECP04116-4117 hippuricase system + + 
RECP04166-4172, C7 sorbose utilization – PTS-dependent system + + 
RECP04208-4216, C13 2-oxoglutarate utilization system  + - 
RECP04248-4252 dipeptide uptake system + - 
RECP04377-4388 several oxidoreductases   + - 
RECP04427-4431, C11 arginine degradation  + - 
RECP04583-4585, C14 C4-dicarboxylate transport system + - 
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RECP04586 Na+/H+ antiporter + - 
RECP00047-48 putative toxin-antitoxin system + + 
RECP00780 putative GipA-like factor  + - 
RECP02893 membrane protease  + - 
RECP03489-3490 DNA processing enzymes  + + 
RECP04088-4092 DNA uptake/degradation + - 
RECP04112 starvation sensing protein  + - 
ot
he
rs
 
RECP04572-4578 type I restriction-modification system + + 
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TABLE 20. E. COLI 536 LPS BIOSYNTHESIS CLUSTER (C1) – COMPARISON  
PERCENTAGE OF IDENTITY ORF 
NUMBER FUNCTION CFT073 EDL933 K12 
RECP03682 2-amino-3-ketobutyrate coenzyme A ligase 96 95 95 
RECP03683 ADP-L-glycero-D-manno-heptose-6-epimerase 100 99 99 
RECP03684 ADP-heptose-LPS heptosyltransferase II 95 96 95 
RECP03685 Lipopolysaccharide heptosyltransferase-1 100 97 94 
RECP03686 Lipid A-core surface polymer ligase WaaL 92 <20 28 
RECP03687 Putative beta1,3-glucosyltransferase WaaV 98 24 33 
RECP03688 UDP-galactose:(galactosyl) LPS alpha1,2-galactosyltransferase WaaW 100 36 38 
RECP03689 Lipopolysaccharide core biosynthesis protein WaaY 100 53 52 
RECP03690 UDP-galactose:(glucosyl) LPS alpha1,2-galactosyltransferase WaaT 99 43 42 
RECP03691 UDP-glucose:(glucosyl) LPS alpha1,3-glucosyltransferase WaaO 97 55 51 
RECP03692 Lipopolysaccharide core biosynthesis protein WaaP 93 92 78 
RECP03693 UDP-glucose:(heptosyl) LPS alpha1,3-glucosyltransferase WaaG 100 99 90 
RECP03694 Lipopolysaccharide core biosynthesis glycosyl transferase WaaQ 95 95 70 
 
 
 
Figure 45. Contig regions for orthologs of RECP03686-94 E. coli 536.  
    #3682      #3683  #3684   #3685    #3686        #3687  #3688  #3689 #3690   #3691  #3692  #3693   #3694 
     
HtrL
HtrL O-ligase
E. coli CFT073
E. coli K12
E. coli 157:H7
E. coli 536
     #6112  #6111 
 
 
 
Belonging to the former category, a LPS biosynthesis cluster is present (RECP03682-
94, C1), which differs significantly from the one of strain MG1655, in terms of 
sequence similarity as well as the G+C content of this region. A separate cluster was 
found (RECP02038-46, C2), which encodes several glycosyltransferases unique to 
strains 536 and CFT073.  
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These enzymes are probably involved in O-antigen synthesis and modification. Again, 
the cluster exhibits an aberrant G+C content. MG1655 cluster possess three genes in 
addition: lipopolysaccharide 1,6-galactosyltransferase (REC06111), 
lipopolysaccharide core biosynthesis protein RfaS (REC06112) and HtrL involved in 
lipopolysaccharide biosynthesis phenotype (Figure 45). Table 20 shows a comparison 
of genes belonging to the hypervariable LPS biosynthesis cluster.  
 
Two additional fimbrial gene clusters were found, one of which (RECP03142-46, C3) 
is unique to strain 536. These genes could be involved in the assembly of cable-like 
pili similar to the ones found in Burkholderia cepacia. [122] The second one 
(RECP03472-81, C4) is present only in the uropathogenic strains. 
Two ORFs are disrupted in MG1655 but intact in strain 536, such as ORF 
RECP01969, a TonB-dependent receptor, showing highest similarity to outer 
membrane receptors for ferrienterochelin and colicins, and ORF RECP02343, an 
outer membrane usher protein, located within a region encoding fimbrial genes.   
Some clusters encoding specialized metabolic activities will be discussed in the 
following. A mechanism to modulate infection of the murine urinary tract has been 
identified and characterized recently: the D-serine catabolism, carried out by a D-
serine deaminase system, is thought to provide a growth advantage in the urinary 
tract. [123] The system is composed of the deaminase, a transcriptional activator and 
a putative D-serine permease. Examining the CFT073-homologous genomic region in 
strain 536 only a truncated cluster could be found, replaced partly by a sucrose 
utilization gene cluster. This is also the case in strain EDL933. Instead and unlike in 
CFT073, a second full length D-serine deaminase cluster can be found within PAI II 
of strain 536, which may indicate that the ability to catabolize D-serine is indeed of 
essential benefit in the course of an urinary tract infection. 
Worth mentioning is the presence of two sucrose utilization systems, both of which 
are absent from CFT073 and MG1655.  
The ability to utilize sucrose (Scr) as a sole carbon source is a highly variable 
phenotype among enteric bacteria. More than 90% of wild-type strains of Klebsiella 
spp. but less than 50% of E. coli and less than 10% of Salmonella strains are Scr+. 
[124] The corresponding genes belong to the set of optional genes, which may be 
present in an individual genome of a species or may be lacking. [125, 126] The 
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characterization of such optional genes supplies valuable information about the 
mechanisms of horizontal gene transfer and gene adaptation in new hosts. [127] 
The genes of a phosphotransferase system (PTS)-independent cluster (RECP02352-
55, C5) replace the permease and regulator genes of the above-mentioned D-serine 
deaminase cluster. The PTS-independent system is composed of a sucrose permease 
(putative sucrose:H+ symporter), a fructokinase, a sucrase and a transcriptional 
regulator. The genes are flanked by a tRNA gene (argW). It has been suggested, that 
this tRNA gene is used by a mobile genetic element for site-specific integration into 
the chromosome in E. coli EC3132. [128] 
The second sucrose utilization operon encodes a PTS-dependent system 
(RECP02716-20, C6), composed of a fructokinase, a sucrose porin, a sucrase, the 
sucrose-specific IIBC component of PTS and a sucrose operon repressor. 
Homologous systems are absent from E. coli strains CFT073, EDL933 and MG1655, 
but are encoded on plasmids of Salmonella species, Klebsiella pneumoniae and some 
E. coli isolates. [129-131] 
A similar PTS-dependent utilization system specific for L-sorbose (RECP04166-72, 
C7) is present in strain 536 and other pathogenic E. coli, but absent from MG1655. It 
is composed of seven genes, which catalyze the uptake (four genes) and conversion of 
L-sorbose to D-fructose-6-phosphate, catalyzed by L-sorbose 1-phosphate reductase 
and sorbitol-6-phosphate 2-dehydrogenase. [132] 
Five additional regions encoding sugar utilizing systems have been detected, 
RECP03180-83 (C8), RECP03719-26 (C9), RECP04021-28 (C10), RECP03964-83 
(C12), and RECP03301-08 all of which are absent from MG1655. Three systems with 
unclear specificities occur only in the UPEC strains. One system (C8) is probably 
involved in the uptake and degradation of N-acetyl-galactosamine (PTS-dependent) 
and one (RECP03301-08) is probably responsible for galacticol/D-tagatose 
utilization. [133, 134] 
Several genes present only in uropathogenic strains may be involved in pH 
homeostasis. The pH of urine usually tends to be rather acidic (varies from 4.5 to 8.0, 
averaging 5.5 to 6.5.). In order to respond to such acidic conditions there are several 
systems available in E. coli 536. For instance, two additional Na+/H+ antiporters, 
RECP04586 and RECP04522, could be involved in regulating the intracellular H+ 
concentration. The gene of the latter antiporter is located within PAI II and absent 
from other E. coli strains.  
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Lysine decarboxylase has been shown to be involved in conferring acid tolerance by 
consuming protons and neutralizing the acidic by-products of carbohydrate 
fermentation. [135] Three copies, each composed of the decarboxylase gene and a 
lysine/cadaverine antiporter, are present in the genome of E. coli 536, one of which is 
located within the PAI III (RECP00319-20). An arginine catabolism system 
(RECP04427-31, C11), which is present in CFT073 but absent from other E. coli, 
could have a similar role in pH homeostasis, as it has been shown for the oral 
pathogen Streptococcus gordonii. [136] The cluster contains five genes, whose gene 
products catalyze the conversion of arginine to ornithine using arginine deiminase and 
ornithine carbamoyltransferase. An arginine/ornithine antiporter guarantees the 
interchangeability of substrate and product. In addition to its role in pH homeostasis, 
the system can also be of importance in substrate-level ATP synthesis in the course of 
anaerobic arginine fermentation. Carbamoyl phosphate, the by-product of the above-
mentioned ornithine carbamoyltransferase reaction, is converted to NH3 and CO2 
catalyzed by carbamate kinase, the gene of which is also encoded within the cluster. A 
second carbamate kinase specific to the two UPEC strains is located within a cluster 
(RECP03967-83, C12) encoding several metabolic enzymes with unknown 
specificities. A further system with implications in substrate-level ATP synthesis 
preferably under anaerobic conditions could be the 2-oxoglutarate degradation cluster 
(RECP04208-16, C13). The ATP is generated in the succinyl-CoA synthetase 
reaction. The cluster also contains the genes of a two-component system putatively 
responding to C4-dicarboxylates as well as a dicarboxylate transporter. Two other C4-
dicarboxylate transport systems, RECP04583-85 (C14) and RECP03060-62 (C15), 
could be detected in the genome of E. coli 536, both of which are not present in 
MG1655 and EDL933. In general, C4-dicarboxylate transport systems allow C4-
dicarboxylates like succinate, fumarate, and malate to be taken up. [137] 
In both prokaryotic and eukaryotic organisms, peptides exhibit an important 
nutritional role. [138] Systems to transport peptides occur in many species and 
generally function to accumulate intact peptides intracellularly, where they are 
hydrolysed. This mechanism confers many advantages, being energetically more 
favourable than one of extracellular peptide cleavage followed by uptake of 
constituent amino acids; and, by avoiding competition between individual residues, it 
also allows a more balanced uptake of amino acids. Uropathogenic specific dipeptide 
uptake system has been localized (RECP04248-52) in the 536 genome.  
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It is worth to mention a hippuricase system. The ability to hydrolyze N-
benzoylglycine (hippurate) to benzoic acid and glycine seems to be a strict pathogenic 
feature among E. coli strains.  It is present in genomes of both uropathogenic strains, 
EDL933 and in genomes of such bacteria like Pseudomonas aeruginosa and 
Burkholderia pseudomallei.  
Our bodies convert benzoic acid, which is found in most foods, into hippuric acid, a 
simple amide, in order to detoxify it.  Furthermore hippurate keeps the urine accidic 
that is a natural way against bacterial infection. 
Methenamine hippurate (previously known as hexamine hippurate in the UK) is an 
antibiotic that is used to treat and prevent urinary tract infections. It is absorbed from 
the gut and passes into the urine where it releases the chemical formaldehyde 
(however this can only occur if the urine is acidic). This chemical causes the 
breakdown of proteins essential to the bacteria, which ultimately results in the death 
of the bacteria (http://www.netdoctor.co.uk/medicines/100004085.html). According to 
Lee, et al. (2002), methanamine hippurate or mandelamine has not yet been 
conclusively shown to be useful for preventing UTI’s or bacteriuria although it may 
reduce bacteriuria in some populations. [139] 
E. coli 536 possesses two genes RECP04116 and RECP04117 (hippurate hydrolase 
and transmembrane transporter protein, respectively) which could create a effective 
hippuricase system.  
 
 
 
5.2.3. AUTOTRANSPORTERS 
 
 
All Escherichia strains carry a wide range of determinants involved in host interaction 
and virulence, many of which have been extensively studied. Numerous 
epidemiologic studies have suggested a role for P, type I and other fimbriae, afimbrial 
adhesins, hemolysin, aerobactin, capslule, and cytotoxic necrotyzing factor in the 
pathogenesis of urinary track infections. Comparisons of many of these systems in the 
four species identify differences that might bear virulence profiles of these organisms. 
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In contrast to Gram-positive bacteria, which possess only one biological membrane, 
called the cytoplasmic membrane, the cell envelope of Gram-negative bacteria is 
composed of two biological membranes, the inner membrane, i.e. the cytoplasmic 
membrane, and the outer membrane. This dual membrane envelope presents a real 
challenge for the transport of molecules into and out of these microorganisms. The 
passenger domain of an autotransporter protein corresponds to the secreted effector 
molecule. To date, all of the functionally characterized autotransporters have been 
implicated in bacterial virulence either by displaying enzymatic activity (protease, 
peptidase, lipase, esterase), mediating actin-promoted bacterial motility, or acting as 
adhesins, toxins/cytotoxins, immunomodulatory proteins, or permitting maturation of 
another virulent protein. Table 21 shows autotransporters found in E. coli genomes. 
 
Antigen 43 (Ag43) is a self-recognizing surface adhesin. Expression of Ag43 confers 
aggregation and fluffing of cells, promotes biofilm formation and is associated with 
enhanced resistance to antimicrobial agents. Although ortholog of flu is present in 
each of the four species, we found additional genes encoding Ag43-like proteins in 
case of pathogenic strains (both uropathogenic (RECP00323, RCFT01230) and also 
the enterohaemorrhagic strain EDL9333 (RECS06274)). [140] 
 
Several of putative autotransporters show a high homology to pertactin, or 
haemagglutinin protein virulence factors. Pertactin and filamentous haemagglutinin 
have been identified as Bordetella adhesins. Both proteins contain an arg-gly-asp 
(RGD) motif that promotes binding to integrins, known to be important in cell 
mobility and development. [141, 142] There is present only one such an ortholog in 
UPEC strains (RECP03665 and RCFT04329). These autotransporter families are 
characteristic for enterohaemorrhagic strain (RECS04480, RECS06178, RECS01707, 
RECS03081, RECS06796) but and are also present in non-pathogenic K12 srtain 
(REC04813, REC05325, REC05586). 
Several types of autotransporters are present only in case of uropathogenic species. 
 
We identified Shigella flexneri orthologs SepA and Pic in the genomes of 
uropathogenic srtains. SepA, extracellular serine protease, which induces mucosal 
atrophy and tissue inflammation, indicating that it is involved in tissue invasion by 
Shigella flexneri Construction and phenotypic characterization of a sepA mutant 
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suggested that SepA plays a role in epithelium invasion or destruction. [143] This 
ortholog is present in both UPEC strains (RECP00340, RCFT00374), in contrast to 
protein Pic, which we could find only in CFT073 strain (RCFT00333). Pic (protein 
involved in intestinal colonization) is an extracellular serine protease that displays in 
vitro mucinolytic activity, serum resistance, and hemagglutination. Both SepA and 
Pic belong to the Tsh subfamily, otherwise known as the SPATE (Serine Protease 
Autotransporters of Enterobacteriaceae) subfamily, and both possess a highly 
conserved serine protease motif shared by other members of the group. [144] 
 
Sat is a large (107kDa) autotransporter toxin; which is secreted only by E. coli 
CFT073, a highly virulent strain isolated from blood and urine of a woman with acute 
pyelonephritis. Sat exhibited cytopathic activity on kidney, bladder and other cell line, 
as well as elicited a strong antibody response after experimentally infection. [145] 
Two putative autotransporters are present in the 536 genome (RECP00423, 
RECP01398), which are disrupted by transposase genes in MG1655. ORF 
RECP00423 is present in all pathogenic strains and contains also a pertactin domain, 
found in cell adhesion proteins, for instance in the immunogenic outer membrane 
protein P69 of Bordetella pertussis. [146] ORF RECP01398 is 536-specific gene and 
encodes a putative 250kDa protein, which contains several cell-cell adhesion 
domains. 
 
Hemolysins (cytolysins) were described to be important virulence factors of bacteria 
causing extraintestinal diseases and are active on different cells, such as lymphocytes, 
granulocytes, erythrocytes, and renal tubular cells. They are bacterial RTX-toxins 
(Repeat In Toxin) that function by assembling identical subunits into a membrane-
spanning pore. Cell lysis (and death) is caused by the leakage of small molecules and 
ions through the large water-filled central channel. 
The best characterized is α-hemolysin. [147, 148] These protein orthologs we found 
only in genomes of uropathogenic strains. In contrast, only in case of 
enterohaemorrhagic strains we located hemolysin E (HlyE) that is a novel pore-
forming toxin. HlyE is unrelated to the α-hemolysins (HlyA), and the 
enterohaemolysin encoded by the plasmid borne ehxA gene of E. coli 0157:H7 Sakai. 
However, it is evident that expression of HlyE gives a hemolytic phenotype in E. coli 
and may contribute to the colonization of the host. [149] 
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 TABLE 21. AUTOTRANSPORTERS ENCODED IN THE GENOMES OF E. COLI 536, E. COLI CFT073,  
E. COLI 0157:H7 SAKAI, E. COLI 0157:H7 AND E. COLI K12 
  536 CFT073 O157:H7 Sakai  O157:H7 K12
SepA, serine protease RECP00340 RCFT00374 n n n 
Pic serine protease n RCFT00333 n n n 
Autotransporter Sat 
 
n RCFT03537 n n n 
Antigen 43      
      
RECP02965 RCFT03573 RECS06067 RECO05638
 
REC01948
Antigen 43 RECP00323 RCFT01230 RECS06274 n n
Hemolysin A RECP04474 RCFT03488 n n n 
Hemolysin A RECP03768 n n n n 
Hemolysin E RECP01213 RCFT01578 RECS01677   RECO01732 REC04802
Putative hemolysin RECP04493 RCFT00330 n n n 
Hemolysin in 3 fragments n RCFT01167-1169 n   
      
n n
Putative RTX family exoprotein A n RCFT00344 n n n 
Putative haemagglutinin/invasin RECP03665 RCFT04329 RECS04480 RECO04448 n
Hemagglutinin/hemolysin-related protein n n RECS06178 RECO05537 n 
Putatiive pertactin n n RECS01707 RECO01759 REC04813 
Putatiive pertactin RECP02194/2195 RCFT02657/2658 RECS03081   RECO03026 REC05325
Putatiive pertactin n n RECS06796 RECO06255 REC05586 
Putative autotransporter/adhesin RECP01398 n RECSO06488/6487 RECO05869/5870 REC01361/1365
Putative adhesion/invasin RECP00361    
   
RCFT00396 RECS00336 RECO00332 n 
Putative adhesion/invasin n n RECS06668 RECO06100/6099 REC01929
Putative invasin RECP01932 RCFT02374 n n n 
Putative invasin n n RECS07004 RECO06511 n 
Puative autotransporter RECP00423 RCFT00456 RECSO00424 RECO00420 REC00355/358
Putative autotransporter      n n n n REC01332
Putative autotransporter n RCFT02820 n n n 
Putative autotransporter n n RECS02117 REO01955 REC04960 
Putative autotransporter n n RECS00542 RECO00538 n 
Putative autotransporter n n RECS00541 RECO00537 n 
Putative autotransporter RECP00374 RCFT00407 RECSO05907 RECO05332 n 
Putative autotransporter RECP02240 RCFT02704 RECSO03116 RECO03061 REC05356 
Putative autotransporter RECP01203 RCFT01567 RECS06372  RECO05754 REC01135
Pseudogenes are underlined.
 
  
 
Discussion 
 
5.3. ANALYSIS OF THE POLYKETIDE SYNTHASE GENE CLUSTER  
(PKS-PAI (ASNW)) OF NEWBORN MENINGITIS E. COLI 
STRAIN IHE3034 AND UROPATHOGENIC STRAIN 536 
 
 
The asnW-associated island is interesting as polyketide biosynthesis is uncommon for 
E. coli. The previously sequenced CFT073 genome as well as the genome of E. coli 
536, as presented in this work, contain a cluster of genes encoding polyketide 
synthases (PKSs), and polyketide-modifying enzymes. Database searches of ORFs: 
#01945, #01946 and #01949 show highest similarities, albeit only partially, to 
characterized systems involved in the synthesis of melithiazol or myxothiazol by 
myxobacteria, both of which act as electron transport inhibitors of the respiratory 
chain [150, 151] and of antibiotics such as surfactin and iturin A. [152] The other 
proteins (#01951, #01952, #01958, #01959) show highest partial similarities to 
systems of the cyanobacteria Nostoc sp. and Lyngbya majuscula involved in the 
biosynthesis of nostopeptolide and barbamide, a chlorinated metabolite with 
molluscicidal activity, respectively. [153, 154] Strikingly, and in analogy to the Ybt-
like synthetase genes, the corresponding genes  #01946 and the 10kb gene #01959 are 
disrupted in CFT073.  
 
In order to get a first glance of their function in E. coli 536 and E. coli IHE3034, the 
domain structures were analyzed, indicating a complex composition (Figure 46).  
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Figure 46. Functional domain structure prediction of non-ribosomal peptide synthetases/ polyketide 
synthases encoded within PKS- PAI (asnW) in E. coli 536 (PAI536 IVb) and E. coli IHE3034 (PKS- 
PAIIHE3034). In both cases the same ORF numbers are used. The domain prediction programs PFAM 
and SEARCHPKS were used in combination. A, Adenylation domain (AMP-binding domain); ACP, 
Acyl/Aryl/Peptidyl carrier protein; AT, Acyltransferase; Cy, Cyclization/Condensation domain; ER, 
Enoyl reductase; KR, Ketoacyl reductase; KS, Ketoacyl synthase; MT, Methyltransferase (MT domains 
are weakly predicted by PFAM and SEARCHPKS); TE, Thioesterase. 
 
 
Biosynthesis of polyketides shares striking similarities with the fatty acid 
biosynthesis. Polyketides are synthesized by sequential reactions catalysed by                       
a collection of enzyme activities called polyketide synthases (PKSs). These are large 
multienzyme protein complexes that contain a coordinated group of active sites. The 
PKS genes for a certain polyketide are usually organized in one operon. At least two 
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architecturally different types of PKSs have been discovered in the microbial world. 
Type I systems consist of very large multifuctional proteins which can be either 
processive or iterative. These PKSs are large multidomain proteins carrying all the 
active sites required for polyketide biosynthesis.  The iterative Type II systems consist 
of complexes of mono-functional proteins. In these synthases, active sites are 
distributed among several smaller, typically monofunctional polypeptides. Type II 
synthases catalyse the formation of compounds that require aromatization and 
cyclization, but not extensive reduction or reduction/dehydration cycles. Generally 
speaking, the order of modules and domains of a complete polyketide synthase is as 
follows (in the order N-terminus to C-terminus): starting or loading module: AT-
ACP-; elongation or extending modules: -KS-AT-[DH-ER-KR]-ACP-; termination or 
releasing module: -TE. The polyketide chain and the starter groups are bound with 
their carboxy group to the SH groups of the ACP and the KS domain through a 
thioester linkage: R-C(=O)OH + HS-protein <=> R-C(=O)S-protein + H2O. The 
growing chain is handed over from one SH group to the next by trans-acylations and 
is releases at the end by hydrolysis or by cyclization. There are three biosynthesis 
stages. During the starting stage the starter group, usually acetyl-CoA or malonyl-
CoA, is loaded onto the ACP domain of the starter module catalyzed by the starter 
module AT domain. The elongation stage itself is a complex path where reactions go 
as following: 
 
- The polyketide chain is handed over from the ACP domain of the previous 
module to the KS domain of the current module, catalyzed by the KS domain. 
- The elongation group, usually malonyl-CoA or methyl-malonyl-CoA, is 
loaded onto the current ACP domain catalyzed by the current AT domain. 
- The ACP-bound elongation group reacts in a Claisen condensation with the 
KS-bound polyketide chain under CO2 evolution, leaving a free KS domain 
and an ACP-bound elongated polyketide chain. The reaction takes place at the 
KS-bound end of the chain, so that the chain moves out one position and the 
elongation group becomes the new bound group. 
- Optionally, additional domains can alter the new fragment of the polyketide 
chain stepwise. The KR (keto-reductase) domain reduces the β-keto group to a 
β-hydroxy group, the DH (dehydratase) domain splits off H2O, resulting in the 
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α-β-unsaturated alkene, and the ER (enoyl-reductase) domain reduces the α-β-
double-bond to a single-bond. 
This cycle is repeated for each elongation module. And finally in the termination 
stage the completed polyketide chain is hydrolyzed be the TE (thio-esterase) domain 
from the ACP-domain of the previous module. Given that a structure of the asnW-
associated polyketide might be predicted. Figure 47 shows the proposed structure of 
the putative polyketide compound (Dobrindt, U., not published.). The order of the 
different building blocks that are separated by the red line is so far unknown. The 
order of the genes coding for PKS- or NRPS cluster usually correlates well with the 
order of building blocks within the final molecule. However, maybe not in case of the 
asnW-associated island: in the KS module of ORF1951, a serine residue replaces a 
conserved cysteine residue, which is typical for the PKS module that builds the “start 
unit”. However, #01951 is not located at the beginning of the gene cluster, but in 
between other PKS genes. 
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Figure 47. Proposed structure of the putative polyketide produced by the asnW island-encoded gene 
products. 
 
 
 
To gain first insights into the function of the PKS clusters and its occurrence in an        
E. coli strains effects on human cervix epithelioid carcinoma cells are examined 
(HeLa cells). A total of 185 isolates (Table 11) were subjected to PCR assay. The 
results of PCR demonstrated that 61 (33%) did generate a PKS pattern (Table 17) and 
polyketide-PAI (asnW) occurred only among extraintestinal strains. None of 
enteropathogenic, enteroinvasive, enterotoxigenic, enteroaggregative or 
enterohemorrhagic strains amplified the PKS-PAI (asnW) sequence. Subsequently, 
non-hemolysin-producing isolates were tested for cytocidal activity. Of 19 E. coli 
strains, the test successfully identified 13 positives isolates.  
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Interestingly, the results showed that a polyketide-derived toxin causes cythopathicity 
and the arrest of the cell cycle in HeLa cell culture, although the presence of the PKS-
PAI is not a guarantee for an effective secretion of PKS-derived substances. 
 
 
To explain this phenomenon, since nucleotide sequence for three pathogenic strains is 
available, the genetic background was investigated.   
To keep in mind, infection with uropathogenic strain 536 induces no morphologic 
changes after co-incubation with eukaryotic cell line, while the second UPEC CFT073 
showed a significant cytotoxic effect. The meningitis causing isolate IHE3034 gives 
also PKS+ phenotype, although it seems that the IHE3034 PKS toxin has got a weaker 
activity. The IHE3034 PKS-PAI region shows 99% identity to homologue regions 
from uropathogenic strains E. coli 536 and CFT073. (Figure 48.) 
 
 
E. coli IHE3034 asnW PKS-PAI  
E. coli 536 asnW PKS-PAI  
E. coli CFT073 asnW PKS-PAI  
#01959 
#01959 
#01946 
#01946 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 48. Linear comparison of asnW PKS-PAI E. coli IHE3034, 536 and CFT073.  Block  indicates a 
putative regulatory region, which differs in all strains.  
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As mention above, two genes from the region are disrupted in CFT073 (#01946 and 
#01959 homologs). Apparently, sequencing mistakes exist in the genome of CFT073. 
 
The analysis of the short region upstream of #01956 the first gene of the PKS operon 
and followed by a putative transcriptional regulator gene consists of a series of repeat 
blocks [ACAGATAC]n (Figure 49). The amount of blocks is different in all 
investigated strains. It is 13 for IHE3034, 10 for E. coli 536 and finally 7 for CFT073. 
This observation leads to the hypothesis that the effect of PKS toxin is connected with 
the number of repeats in this regulatory region. Probably it indicates PKS+/PKS- 
phenotype (536: PKS- in comparison to IHE3034: PKS+), as well as it might regulate 
the expression level (differences between IHE3034 and CFT073). 
 
 
 
 
Figure 49.  Sequence alignment of a regulatory region upstream of #01959. 
 
 
 
The discovery that extraintestinal E. coli strains produce a polyketide-derived toxin is 
highly significant.  Polyketides are lipid-like molecules that, although relatively small 
compared with proteineous toxins, have potent biological activities. Well-known 
polyketides include antibiotics (erythromycin), immunosuppressants, (rapamycin, 
FK506), antifungal agents (amphotericin B), antihelmetic agents (avermectin), and 
cytostatins (bafilomycin). Most complex polyketides are made as secondary 
metabolites by soil bacteria in the order Actinomycetales. [155-157]  
However no polyketide causes cythopathicity and cell cycle arrest in cell culture. This 
has now been shown in E. coli. Although, most of the pathogenic E. coli strains 
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remain extracellular, UPEC can invade and replicate within uroepithelial cells, it is 
possible that they play an important role in intracellular survival or/and protects                  
E. coli from predatory eukaryotes in its natural habitat. This complex polyketide may 
represent the first of a newly discovered class of virulence factors associated with 
pathology in diseases caused by extraintestinal E. coli strains.  Next, the compound 
should be purified and characterized in details. 
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6. SUMMARY 
 
 
 
6.1. GENOME PROJECT ESCHERICHIA COLI 536 
 
 
6.1.1. The genome sequence of Escherichia coli human pyelonephritis isolate 
536 was obtained and compared to the to the genome sequence of strain 
CFT073 (O6:K2:H1), another well-studied highly virulent uropathogenic 
E. coli (UPEC) strain, as well as to the genomes of non-pathogenic 
MG1655 (K12) and enterohemorrhagic strain EDL933 (O157:H7).  
 
6.1.2. The single circular chromosome of E. coli 536 is composed of 4,938,875 
bp. The genome was sequenced with a 6-fold coverage. The whole 
chromosome encodes 4,747 putative genes, no extrachromosomal plasmid 
was found.  The genome of strain 536 contains only one cryptic prophage 
region. Analysis of base composition showed the G+C content of the 536 
genome is 50.5%. 
 
6.1.3. The four-way comparison revealed a highly mosaic genome structure. It is 
apparent that genomic differences are not exclusively linked to the 
presence or absence of large pathogenic islands PAIs. Instead, also the 
distribution of smaller gene clusters seems to confer strain-specific traits. 
The comparison revealed a set of 3650 “backbone” genes (77%), which 
are present in all   E. coli strains and are essentially co-linear. 
 
6.1.4. The genome comparison of three pathogenic and one non-pathogenic 
strain of E. coli revealed only 78 genes, which are present exclusively in 
all three pathogenic strains. These genes, arranged in small gene clusters 
that are scattered around the genome, can be classified in several 
heterogeneous functional categories such as transport (35 genes), iron 
acquisition (17), drug resistance (5), DNA modification (4), and others. No 
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main virulence determinants are among these proteins. Rather, they seem 
to have an implication in improving the pathogens’ fitness with respect to 
e.g. utilization of additional nutrients. Apparently, no broad ‘pathogenic 
backbone’ has evolved in disease-causing E. coli isolates. 
 
6.1.5. Although the genome of E. coli CFT073 is about 292 kb larger than the 
one of strain 536, much of the additional information seems to be of no 
functional implication on virulence, as over 50% of these additional genes 
are located within cryptic prophages. In addition, the sequencing project 
reveals about 470 genes of E. coli 536, which are absent from CFT073 and 
MG1655. These findings indicate that the differences between strains 536 
and CFT073 in their potential to cause disease as well as in the graveness 
of the urinary tract infection are not due to a simple gene loss or gain, 
respectively. Rather, they seem to be the consequence of using a different 
set of genes, which results in an individual virulent phenotype.    
 
6.1.6. A major surprise from the uropathogenic E. coli genome projects was the 
discovery that the genomes contain a number of polyketide synthesis 
(PKS) genes. The region, designated PAI536 IVb, encodes several large 
proteins with a predicted molecular weight of up to 350kDa, eight of 
which fall into the class of the above-mentioned NRPS/PKS (#01945, 
#01946 and #01949, #01950, #01951, #01952, #01958, #01959). 
 
 
 
6.2. SEQUENCING AND ANALYSIS OF PLASMID pARK2 
ENTEROTOXIGENIC ESCHERICHIA COLI STRAIN 2173 
 
6.2.1. The complete sequence of the 88,480 bp E. coli 2173 pARK2 plasmid was 
obtained. The plasmid was sequenced with a 9-fold coverage. The coding 
regions account for 83.6% of the plasmid. Analysis of base composition 
revealed a G+C content of the plasmid of 51%. pARK2 comprises                    
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a mosaic structure of potential pathogenesis-associated genes, IS elements, 
maintenance genes, transfer genes and unknown ORFs.  
 
6.2.2. 104 ORFs were identified, most of them are encoded on the same DNA 
strand. Plasmid pARK2 consists of two large distinct regions: a 71.7 kb 
large region that is essentially homologous to the non-R-determinant 
region of plasmid R100, and a 16.7 kb region which carries the sta and stb 
genes encoding heat-stable enterotoxins. 
 
 
 
6.3. SEQUENCING AND ANALYSIS OF A POLYKETIDE SYNTHASE 
GENE CLUSTER (PKS-PAI (ASNW)) OF THE NEWBORN 
MENINGITIS ISOLATE  E. COLI IHE3034 
 
6.3.1. The whole sequence of the IHE3034 BAC11 insert was obtained and 
analysed. It is composed of 67,932 bp and was sequenced with a 9-fold 
coverage. 41 ORFs were identified, and most of them are oriented in the 
same direction. 
 
6.3.2. Obtained protein-coding regions include the PKS-PAI associated with the 
asnW tRNA gene and 15 flanking ORFs. The PKS-PAI shows 99% 
identity on nucleotide level to the homologous region of the sequenced 
uropathogenic strains E. coli 536 and CFT073. Analysis of base 
composition showed a G+C content of the insert of 53,2%, which is higher 
than in the E. coli 536 whole genome (50,52%).  
 
6.3.3. In order to investigate the occurrence of the identified PKS cluster in an   
E. coli strain collection PCR screening was applied. The PCR analysis 
demonstrated that 61 (33%) of 185 strains were PKS-positive. Results 
show that polyketide-PAI (asnW) occurred only among extraintestinal 
strains. None of enteropathogenic, enteroinvasive, enterotoxigenic, 
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enteroaggregative or enterohemorrhagic strains amplified the PKS-PAI 
(asnW) sequences. 
 
6.3.4. The goal of this study was to gain first insight into the function of the PKS 
cluster. For this reason, the effect of potentially secreted compounds was 
examined on human cervix epithelioid carcinoma cells (HeLa cells). In 
conclusion, of 19 E. coli strains, the test successfully identified 13 positive 
isolates. 
 
6.3.5. PKS gene cluster encodes a compound inducing morphologic changes on 
human cervix epithelioid carcinoma cells. It was demonstrated that a 
polyketide-derived toxin causes cythopathicity and cell cycle arrest in 
HeLa cell culture. 
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